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ABSTRACT 
 
Gastrointestinal (GI) helminths pose a significant threat to the livestock industry and are a recognized 
cause of global morbidity in humans. Control relies principally on chemotherapy but in the case of 
nematodes is rapidly losing efficacy through widespread development and spread of resistance to 
conventional anthelmintics and hence the urgent need for novel classes of anthelmintics. Cysteine 
proteinases (CPs) from papaya latex have been shown to be effective against three murine nematodes 
Heligmosomoides bakeri, Protospirura muricola and Trichuris muris in vitro and in vivo and against 
the economically important nematode parasite of sheep Haemonchus contortus. Preliminary evidence 
suggests an even broader spectrum of activity with efficacy against the canine hookworm Ancylostoma 
ceylanicum, juvenile stages of parasitic plant nematodes of the genera Meloidogyne and Globodera and 
a murine cestode Hymenolepis microstoma in vitro. This project focused on tapeworms. Using 2 
different rodent cestodes Hymenolepis diminuta and Hymenolepis microstoma and 1 equine cestode 
Anoplocephala perfoliata I have been able to show that CPs do indeed affect cestodes whether young 
newly hatched scoleces in vitro (by causing a significant reduction in motility leading to death of the 
worms) or mature adult worms in vitro (by causing a significant reduction in motility leading to death 
of the worms) and in vivo (resulting in a significant, but relatively small, reduction in worm burden and 
biomass), despite no effects on worm fecundity. Although only minimally efficacious against 
Hymenolepis microstoma and moderately efficacious against Hymenolepis diminuta in vivo, efficacy 
was enhanced by the synergistic effects of the immune system demonstrated against Hymenolepis 
diminuta in the non-permissive host. The results offer the possibility that with further refinement, CPs 
may be developed into broad spectrum anthelmintics that in addition to their marked effects on 
nematodes also remove any concurrently residing tapeworms. 
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µm  Micrometer 
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Log10    logarithm base 10 
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mmol   milimol 
MW  Molecular weight 
nmol   nanomol 
NSA   Nonenyl succinic anhydride 
p.i.   Post infection 
PLS   Papaya latex supernatant 
rmGLM  Repeated measures general linear model 
SEM   Scanning electron microscopy 
TEM   Transmission electron microscopy 
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CHAPTER 1 
 
1.0 Summary 
This chapter provides background information pertinent to this  research project,highlighting key 
problems, as well as current knowledge on the subject, before taking the reader to the main aims and 
objectives of the work described in this thesis. 
 
1.1 Background 
Intestinal helminths pose a significant threat to the livestock industry (Nieuwhof and Bishop, 2005) and 
are a recognized cause of global morbidity in humans (Chan, 1997a). Control relies principally on 
chemotherapy (Behnke et al., 2008) but in the case of nematodes is rapidly losing efficacy through 
widespread development and spread of resistance to conventional anthelmintics (Kaplan, 2004) and 
hence the urgent need for  novel classes of anthelmintics (Stepek et al., 2006a). One such alternative 
may be the use of natural plant products as anthelmintics, as traditionally used for centuries in the past 
in local native medicine among indigenous communities of the tropics (Robbins, 1930).  
Earlier observations demonstrated potent anthelmintic activity of papaya latex, pineapple and 
figs (Berger and Asenjo, 1939, 1940; Robbins, 1930), whose active components were later identified as 
cysteine proteinases (Walti, 1938). Interest in this subject resumed much later with the demonstration 
that worm burdens in pigs infected with Ascaris suum could be greatly reduced by treatment with 
papaya latex (Satrija et al., 1994) and that mice infected with Heligmosomoides bakeri ( polygyrus) 
could also be effectively treated (Satrija et al., 1995). There was even a successful clinical trial in Brazil 
(Hansson et al., 1986). However, unequivocal confirmation of the effect of papaya latex on the 
nematode cuticle was quite recent (Stepek et al., 2005). 
Cestodes are also important parasites of livestock and humans (Muller, 2001) and preliminary 
evidence suggests that cysteine proteinases do affect the cestode  tegument (Stepek et al., 2007e). If this 
is verified it will greatly extend the usefulness of cysteine proteinases as anthelmintics, because the 
broader the spectrum of activity, the greater their chances of acceptance by the end-user community and 
therefore the more likely they are to be produced commercially (Behnke et al., 2008). 
 
1.1.2  Cestodes as a global problem  
Collectively gastrointestinal nematodes which affect half of the worldÕs population have been shown to 
cause more morbidity than malaria or even motor vehicle accidents (Chan, 1997a). However, the 
importance of other parasitic helminth infections such as trematodes (Utzinger et al., 2000) and 
cestodes has been largely underestimated (Budke et al., 2009). One particular group which fails to gain 
world attention, despite its often lethal prognosis, encompasses the zoonotic larval cestodes (Hotez et 
al., 2007) and only recently did the World Health Organization (WHO) included echinococcosis and 
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cysticercosis in its list of  neglected tropical diseases as part of an integrated strategy to alleviate 
poverty (WHO, 2006).  
Overall global estimation of disease burden arising from  cestode  infections is difficult due to 
limited data (Budke et al., 2009). Nonetheless, sporadic data support the fact that cestode infections are 
an impediment to human and livestock health (Benner et al., 2010; Flisser et al., 2003; Li et al., 2006). 
For example, the number of disability adjusted-life years (DALYs) estimated to be lost as a result of 
cystic echinococcosis puts this species at least at the same level as the better known neglected tropical 
diseases such as dengue fever, onchocerciasis and trypanosomiasis (Budke et al., 2006). 
 
1.1.3  Taeniasis 
T. solium and T. saginata are two most important taeniasis affecting humans (WHO, 2006). The 
discovery of T. asiatica as a distinct species (Eom and Rim, 1993) despite sharing morphological 
similarities with T. saginata but using pigs as intermediate host and parasitizing visceral organs (Galan-
Puchades and Fuentes, 2009) is  forcing us to rethink the current methods of control (Ito et al., 2006). 
The consumption of raw and undercooked meat containing the infective cysticerci results in 
the completion of the Taenia spp.  lifecycle (Fan et al., 1992). Intestinal taeniasis are generally mild but 
reports of massive T. saginata specimens causing obstruction are not uncommon (Bordon, 1992; 
Karanikas et al., 2007).  The experience of motile proglottids  crawling out of the anus often causes 
psychological distress (Muller, 2001). Control measures rely heavily on abattoir inspection for the 
presence of cysticerci or ÕmeasleyÕ meat (Scandrett et al., 2009) because to change eating habits is 
almost impossible as they are ancestral traditions rather than personal (Dupouy-Camet and Peduzzi, 
2004). Though intestinal taeniasis due to T. saginata is not a cause for concern, the diagnosis of T. 
solium taeniasis is a medical emergency due to the possibility of autoinfection that may lead to the 
potentially fatal neurocysticercosis (Muller, 2001). 
 
1.1.4  Neurocysticercosis 
Neurocysticercosis is the commonest helminthic disease of the central nervous system and a leading 
cause of acquired epilepsy worldwide (Sinha and Sharma, 2009). In spite of its fatal prognosis it is 
potentially eradicable (Alarcon, 2006) and control has been successfully achieved in Europe and North 
America through improvement in sanitary conditions and functional abattoir control systems (Gonzalez 
et al., 2003). It is caused by infection with the larval stage of T. solium also known as cysticercus 
cellulosae mainly from food contaminated with pig faeces containing T. solium eggs (Roberts and 
Janovy, 2006).  This is not surprising when humans live closely with pigs under poor sanitary 
conditions in the endemic areas of Mexico, South America and Asia (Muller, 2001). The main 
symptoms include seizures and space occupying lesion symptoms due to raised intracranial pressure 
and unless treated this infection is almost always fatal (Sinha and Sharma, 2009).  
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1.1.5  Cystic echinococcosis 
Although not essentially confined to the tropics, echinococcosis has been listed among the neglected 
tropical diseases which warrant serious attention (WHO, 2006). Cystic echinococcosis with an 
approximate worldwide prevalence of 6 million (Siracusano et al., 2009) is caused by E. granulosus 
sensu stricto (sheep strain), now known to comprise 5 independent species (Nakao et al., 2007). 
Together with the  sylvatic polycystic forms found exclusively in Central and South America, caused 
by either E. vogeli or E. oligarthrus the latter of which had been recently reclassified as unicystic 
(D'Alessandro and Rausch, 2008), echinococcosis remains as one of the most lethal helminthic 
zoonoses (Knapp et al., 2009). Humans become infected by handling infected dogs or items 
contaminated with their fresh faecal products (Thompson, 1986). As ruminants, especially sheep, are 
perfect intermediate hosts, it is mostly endemic in impoverished pastoralists community worldwide 
such as for example North Africa, Argentina and Central Asia (Muller, 2001) but echinococcosis has 
also been a problem in recent decades among pastoral communities in the islands off the coast of 
Scotland and in Wales. The majority of cysts develop in the liver followed by the  lungs (Bal et al., 
2008) but rarely in other organs such as the heart and brain (Aleksic-Shihabi and Vidolin, 2008). Apart 
from exerting pressure as the cyst enlarges within the organs that are invaded, the infected host is at risk 
of anaphylaxis when there is spontaneous rupture of the cyst as can occur under particular 
circumstances (Castanares-Zapatero and Laterre, 2009).  
 
1.1.6  Alveolar echinococcosis 
In contrast to the well encapsulated and benign cyst of E. granulosus, alveolar echinococcosis caused 
by E. multilocularis is aggressive, invading adjacent structures like a cancer (Muller, 2001) and in fact 
is often misdiagnosed as liver carcinoma (Stefaniak, 2006). This is essentially a sylvatic species with 
transmission involving wild canid species such as foxes as definitive hosts and wild rodents as 
intermediate hosts (Roberts and Janovy, 2006). There is also increasing evidence of domestic dogs 
playing an important role in its life cycle (Antolova et al., 2009). It is prevalent in communities in the 
northern hemisphere where hunting and contact with wild canids are inevitable (Deplazes, 2006).  
Despite this, there is increasing evidence that alveolar echinococcosis is becoming cosmopolitan due to 
foxes encroaching into urban perimeters (Kamiya, 2007). !
 
1.1.7  Diphyllobothriasis 
Diphyllobothriasis is the most important fish-borne zoonosis (Chai et al., 2005) with an estimated 20 
million cases worldwide (Scholz et al., 2009).  Traditionally endemic to Scandinavia, Russia and the 
great lakes of North America (Ruttenber et al., 1984), where currently  incidence is decreasing, cases 
are emerging in Alpine lake regions of Central Europe (Dupouy-Camet and Peduzzi, 2004). It is caused 
by the pseudophyllidean cestode Diphyllobothrium spp. and is associated with the consumption of raw 
and undercooked fish, which are the second intermediate hosts containing the plerocercoid larvae 
(VonBonsdorff, 1977), such as  sushi or sashimi in Japan (Arizono et al., 2009) and salted or marinated 
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raw fish dishes in Europe (Dupouy-Camet and Peduzzi, 2004). Fourteen species of the genus 
Diphyllobothrium are known to infect man with D. latum and D. nihonkaiense being the most important 
(Scholz et al., 2009) of which the latter is now recognized as a separate species from D. latum (Yamane 
et al., 1986).  Apart from man as its definitive host, a wide range of piscivorous carnivores can also act 
as reservoir hosts (VonBonsdorff, 1977) possibly contributing to the continuation of its life cycle 
(Dupouy-Camet and Peduzzi, 2004). The adult worm, which is possibly the largest common parasite of 
man, has been reported to grow to up to 25m in length with 4,000 proglottids comprising the strobila 
(Scholz et al., 2009). The adult worm which resides in the small intestine has an extraordinary affinity 
for vitamin B12 which it obtains by dissociation of the vitamin B12-intrinsic factor complex and 
competitive absorption of dietary vitamin B12 often leading to megaloblastic anaemia in infected 
subjects (Vuylsteke et al., 2004).  
 
1.1.8  Rare cases of cestode infections 
 
1.1.8.1 Dipylidiasis 
There are a number of rarer cestode species known to affect man and this includes species from the 
genus Dipylidium which are both found in dogs and cats as their definitive hosts. Infection is acquired 
through accidental ingestion of the flea intermediate host C. felis or C. canis which contains the 
cysticercoid larvae and mainly affects young children (Neira et al., 2008). Pathology is minimal if not 
asymptomatic and incidence is limited to sporadic case reports from cosmopolitan areas worldwide 
(Molina et al., 2003). 
 
1.1.8.2 Sparganosis 
Another important infection to note is sparganosis which arises through tissue infection of the genus 
Spirometra and other non-human Diphyllobothrium species, mainly occurring in the far east (Muller, 
2001). Drinking water contaminated with cyclops harboring the infective procercoid larvae was found 
to be an important risk factor apart from other modes of infection such as  eating frog and snake meat or 
the traditional practice of poultice where dried parts of snake or frog is put in contact with the mucous 
membrane like the conjunctiva (Wiwanitkit, 2005). 
 
1.1.8.3 Coenurosis 
Coenurosis is one of the rarer forms of cysticercosis caused by infection with the larvae of Taenia 
multiceps, also known as Coenurus cerebralis, resulting in cystic lesions in the brain. Reported cases 
are rare but often lethal without surgical intervention (Benifla et al., 2007).  Wild canids complete the 
sylvatic cycle and involve a wide range of wild rodent intermediate hosts (Muller, 2001).  
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1.1.9  Cestodes of veterinary importance 
 
1.1.9.1 Cestodes of small ruminants 
While gastrointestinal nematodes cause significant losses in the livestock industry (Nieuwhof and 
Bishop, 2005), the pathogenecity of cestodes in small ruminants is continuously being debated 
(Schoenian, 2009) because there is a steady  prevalence of infection in many places (Moazeni and Nili, 
2004; Panitz et al., 2009).  Nevertheless, extreme monieziosis has been known to cause intestinal 
obstruction (van Schalkwyk et al., 2005). While most agree that Moniezia expansa infection in sheep 
are not associated with productivity loss (Elliott, 1986; Love, 2007; Mason et al., 2002),  a productivity 
trial using 300 undrenched Romney lambs in New Zealand saw a significant weight gain in the group 
treated with praziquantel + levamisole compared to the groups treated with levamisole only or untreated 
controls (Southworth et al., 1996). A more recent report from Kenya showed that the intensity of M. 
expansa infection in goats was associated with poor body condition and hence productivity loss 
(Kanyari et al., 2009). Small ruminants like sheep and goats are important intermediate hosts to E. 
granulosus causing cystic echinococcosis and T. ovis causing ovine cysticercosis (Smyth, 1994). 
Despite an overall falling trend in incidence of cystic echinococcosis in sheep worldwide (Cabrera et 
al., 2003; Singh and Dhar, 1988), this parasite still continues to affect the sheep industry in many 
different regions (Benner et al., 2010; Kassem, 2006; Theodoropoulos et al., 2002). 
 
1.1.9.2 Cestodes of large ruminants 
The most important cestode affecting large ruminants such as cattle is T. saginata which causes 
millions in lost profits due to condemned carcasses (Dorny and Praet, 2007; Jahed Khaniki et al., 2010). 
Cattle  become the intermediate host of the larval cysticercus bovis when grazing on pasture 
contaminated with human manure (Smyth, 1994). Bovine cysticercosis is still prevalent in many parts 
of the developing world due to poor sanitary conditions but surprisingly is still a problem in Europe due 
to the use of sewage sludge to fertilise pastures (Cabaret et al., 2002; Dorny and Praet, 2007). 
Monieziosis on the other hand is only important in calves (Borthakur and Das, 2006). 
 
1.1.9.3 Equine cestodes 
It was not until the last decade that infection with the equine cestode Anoplocephala perfoliata was 
recognized as a significant cause of morbidity in horses due to the long held belief of its rather 
questionable pathogenicity and the unavailability of accurate diagnostic tools (Proudman and Trees, 
1999). Intestinal problems may range from mild colic (Proudman et al., 1998) to localised necrosis 
(Rodriguez-Bertos et al., 1999). Recently, an ELISA based method has been made commercially 
available for diagnosis but as with other antibody based diagnostics, it only detects exposure rather than 
actual infection (Matthews et al., 2004). 
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1.1.10  Cestodes in companion animals 
 
1.1.10.1 Feline cestodes 
In companion animals like cats, prevalence of cestode infections is high especially in feral populations 
(Abu-Madi et al., 2009; Millan and Casanova, 2009). The commoner species affecting cats include 
Taenia taeniaformis, Joyeuxiella pasqualei, Dipylidium caninum, Diplopylidium spp. and 
Diphyllobothrium spp. Despite the high prevalence of infection, they rarely cause clinical disease 
(Conboy, 2009). However, there have been reports of intestinal obstruction (Wilcox et al., 2009) as well 
as unusual cestode infections in cats like Echinococcus multilocularis that are lethal to humans (Nonaka 
et al., 2008) 
 
1.1.10.2 Canine cestodes  
Dogs play a very important role as definitive hosts to many cestodes notably, Echinococcus granulosus, 
Dipylidium caninum, and Taenia ovis (Muller, 2001). However, as definitive hosts, clinical disease is 
rare (Smyth, 1994). 
 
1.1.11 Controlling cestode infections 
As with many other infectious diseases, effective and long term control of cestode infections depends 
on collateral strategies including education and sanitation (Muller, 2001), as evident for example in the 
west where cysticercosis has been virtually eradicated through improvements in sanitation and efficient 
meat inspection (Gonzalez et al., 2003). 
 
1.1.11.1 Surgical intervention 
Unlike in the case of gastrointestinal nematodes where control is principally based on chemotherapy, 
surgery plays an important part in the management of most cestode infections mediated by larval 
stages. Symptomatic neurocysticercosis often requires surgery alongside chemotherapy and treatment 
with corticosteroids due to space occupying lesions in the central nervous system (Sinha and Sharma, 
2009). Coenurosis, a rare zoonoses affecting the brain, is often lethal without surgery (Benifla et al., 
2007). Large cystic echinococcosis  will need specialized surgery as the threat of anaphylaxis is not 
uncommon (Castanares-Zapatero and Laterre, 2009). However, smaller uncomplicated cysts may just 
benefit from albendazole therapy (Stojkovic et al., 2009). Alveolar echinoccosis often needs radical 
resection of the liver and only in palliative cases does chemotherapy play some role (Stefaniak, 2006). 
In the special case of  sparganosis, surgery is the only known treatment (Muller, 2001). 
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1.1.11.2 Arthropod control 
Unlike in soil-transmitted gastrointestinal nematodes, where grazing management involves rotation of 
pastures and mixed species flocks/herds to limit transmission to livestock (Stepek et al., 2006a), control 
of exposure to the oribatid mite intermediate associated with ruminant cestode infections (Jimenez et 
al., 2007; Meana et al., 2005) is more difficult. It  has been suggested that the application of acaricides 
on pasture may be an effective method for controlling moneziosis (Haq, 1998). Another example of 
arthropod control which would be useful in limiting cestode infections is the elimination of dog and cat 
fleas Ctenocephalides canis and Ctenocephalides felis that serve as intermediate hosts to Dipylidium 
caninum. 
 
1.1.11.3  Immunotherapy 
Although there are no available vaccines yet for humans against cestode infections, or in fact any 
helminth infections (Muller, 2001), indirect protection is now available through livestock vaccination 
against the metacestodes of taeniid and echinococcus species (Smith and Zarlenga, 2006). It was the 
recombinant antigen vaccine derived from the oncospheres of T. ovis  that led to subsequent successes 
in T. saginata, E. granulosus and more recently T. solium and E. multilocularis (Lightowlers et al., 
2003) 
1.1.11.4 Synthetic chemotherapy 
While the control of nematodes may rely on a wide variety of anthelmintic classes, cestodes are only 
susceptible to salicylanilides, isoquinolines and benzimidazoles (Muller, 2001; Roberts and Janovy, 
2006; Smyth, 1994).  
 
1.1.11.5  Niclosamide 
Niclosamide is an effective intestinal taenicide under the class salicylanilide. It is widely used for 
intestinal taeniasis but is not effective against other helminths. It acts by inhibition of mitochondrial 
oxidative phosphorylation (Weinbach and Garbus, 1969). It is however not effective against larval 
tissue cestodes as it is not significantly absorbed from the gastrointestinal tract. It is also used as a 
molluscide in schistosomiasis control programmes (Muller, 2001). 
 
1.1.11.5  Praziquantel 
Originally jointly developed by Bayer and Merck in the 1970s  as the much anticipated broad spectrum 
fluke treatment (Seubert et al., 1977), praziquantel  remains as  the primary treatment for 
schistosomiasis (Doenhoff et al., 2008). As part of its broad spectrum activity it is being used 
extensively for the treatment of other trematodes, and cestodes (King and Mahmoud, 1989). Its usage in 
treatment of cestode infections (Muller, 2001) includes tissue metacestode infections such as 
echinococcosis (Craig and Ito, 2007) and cysticercosis (Sinha and Sharma, 2009). Despite its poor 
water solubility and  lipophilia, it is well absorbed from the GI tract (Cinto et al., 2009). Praziquantel is 
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known to induce muscle contraction and tegumental disruption that leads to surface antigen exposure to 
the host immune system (Tallima and El Ridi, 2007a) but the exact mechanism of action however, is 
still unclear. The only plausible theory to date is that it targets calcium channels causing a rapid influx 
of calcium ions and subsequently muscle contraction and damage. This idea, however, has been 
challenged by experiments using cytochalasin D in which praziquantel induced worm death and 
calcium influx are not correlated (Doenhoff et al., 2008).  
 
1.1.11.6  Benzimidazoles 
Benzimidazoles are effective against nematodes, cestodes and trematodes making this family of drugs 
the best choice as broad spectrum anthelmintics (McKellar and Scott, 1990). Benzimidazoles act by 
binding to the microtubular subunit protein β-tubulin disrupting microtubule structure and functions, 
which are essential components for cell integrity, mitosis, motility and active transport. When impaired 
by the drug, death of the organism follows soon (Lacey, 1988). In the treatment of cestodes, it is the 
drug of choice for the adjunctive treatment of alveolar echinococcosis (Mantion et al., 2008) and 
hydatid cyst (Junghanss et al., 2008) but has also seen an increase in use as  a complete alternative to 
surgery in uncomplicated cases of cystic echinococcosis (Stojkovic et al., 2009). The resistance to 
benzimidazoles among veterinary nematodes has been identified as being mediated by the single amino 
acid substitution from phenylalanine to tyrosine in β-tubulin gene (Schwab et al., 2005) but no such 
mechanisms have been proposed with regards to resistance to among cestodes. 
 
1.1.12  Problems associated with synthetic chemotherapy 
Control measures are not without problems (Behnke et al., 2008) and the most important being the 
accelerated development and spread of drug resistance (Kaplan, 2004) which arises essentially from the 
recurrent excessive use of the main drug classes (Wolstenholme et al., 2004). Worsening the matter, 
resistance in one drug inextricably results in resistance to all the drugs with similar mechanisms of 
action within the same class (Michel, 1985). Unlike in nematodes which have reached a multiple drug 
resistance level (van Wyk et al., 1997), evidence of resistance in cestodes is limited. Nonetheless, a 
controlled slaughter trial using lambs in New Zealand revealed a lack of efficacy of praziquantel 
against Moniezia expansa suggesting resistance (Southworth et al., 1996). Another efficacy trial of 
albendazole and fenbendazole against Moniezia expansa, Moniezia benedeni and Thysanosoma 
actinioides in three farms in Bolivia revealed a disturbing trend of clear resistance to febendazole while 
albendazole was losing efficacy (Linares and Rojas, 2009). However benzimidazoles are not the 
treatment of choice for platyhelminth infections (Mansour, 2002).  In humans, just as there have been 
reports of nematocidals losing efficacy (Albonico et al., 2003), an Ethiopian patient infected with T. 
saginata was unsuccessfully treated with niclosamide (Vermund et al., 1986). In view of the 
unlikelihood of a new synthetic anthelmintic in the near future,  alternative strategies are urgently 
needed (Stepek et al., 2006a).  
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1.1.13 Usefulness of plant extracts as cestocidals 
 
1.1.13.1 Earliest works 
Since helminths have been known to afflict humans and livestock since antiquity (Cox, 2004), it might 
be expected that traditional remedies mostly from plant extracts have been used to treat them (Behnke 
et al., 2008). While ethno-medical evidence of use of plants as anthelmintics abounds (Prakash and 
Mehrotra, 1987), specific indications of use of cestocidals remain elusive apart from  the use of 
powdered fern extract by the ancient Greeks (350-250 B.C.), mentioned in Nordic literature (Waller et 
al., 2001). Evidence of efficacy of plant extracts as cestocidals are rather recent compared to the earlier 
trials using ascarid models with fig species (Robbins, 1930), pineapple juice (Berger and Asenjo, 1939) 
and crystalline papain (Berger and Asenjo, 1940). 
 
1.1.13.2  More recent works 
One of the earliest supportive evidence was from experiments using the H. nana model and assessing 
the anthelmintic effects of whole extracts of coleus leaves and croton twigs (with ED100 values of 0.5ml 
of 42% in distilled water  and 0.5ml of 72.46% in distilled water respectively)(He et al., 1992). One of 
the more convincing findings was the ability of chloroform extracted Indian mulberry fruit to 
significantly reduce egg counts and worm counts in H. nana infected mice with an ED50 value of 
0.669g per kg body weight (Widdhiasmoro, 2000). The most convincing evidence by far is the 100% 
reduction in worm counts of H. nana in infected mice treated with a papaya seed infusion at a dose of 
1.2g kg
-1
 BW for 3 consecutive days (Lamtiur, 2000).  
 
1.1.13.3  More convincing evidence 
Using  murine cestode models, mature  Hymenolepis microstoma incubated in papaya latex, ficin and 
stem bromelain showed a significant reduction in motility compared to controls in vitro (Stepek et al., 
2007e). In screening the efficacy of various Cassia plant species for cestocidal activity Kundu and 
Lyndem (2012) observed through scanning electron microscopy studies tegumental damage on 
Raillietina tetragona that was comparable to those mediated by praziquantel. 
 
1.1.13.3  Controversial evidence 
Despite these promising results, there is also contradictory evidence. H. microstoma incubated in 
kiwifruit extract did not show a significant reduction in motility compared to controls (Stepek et al., 
2007e). H. nana infected mice treated with L. leucephala seed infusion showed an intriguingly 
significant increase in H. nana population (Kustiawan, 2001). Treatment with juice from young 
pineapples was not effective in vivo in H. nana infected mice despite positive in vitro result (He et al., 
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1992). H. nana infected mice treated with the lattices of Ficus carica and Ficus insipida failed to 
produce significant elimination of worms (de Amorin et al., 1999). 
 
1.1.14  Cysteine proteinase as anthelmintics? 
As the threat of drug resistance is real (Kaplan, 2004) and prospects of a synthetic anthelmintic are 
unlikely in the near future (Behnke et al., 2008), a potential alternative would be the use of natural plant 
latices and fruits containing the enzyme cysteine proteinase of which papaya, pineapple and fig species 
are good examples (Behnke et al., 2008). Reports of their use as anthelmintic by indigenous people go 
back more than a 100 years (Robbins, 1930) and they were even used in Europe decades ago (Jonxis 
and Bekius, 1953). Pilot observations demonstrated their ability to digest nematodes (Berger and 
Asenjo, 1939; Robbins, 1930) after which its enzymic basis was known (Walti, 1938). This was 
followed by the demonstrations of reductions in worm burden in pigs with A. suum (Satrija et al., 1994) 
and mice with H. bakeri (Satrija et al., 1995) and a clinical trial (Hansson et al., 1986). However, it was 
not until recently that these effects was proved to be mediated by the enzyme (Stepek et al., 2005). 
However, evidence demonstrating their wide spectrum of activity are mostly limited to gastrointestinal 
nematodes; H. bakeri (Stepek et al., 2005), T. muris (Stepek et al., 2006b) and P. muricola (Stepek et 
al., 2007b).  
 
1.1.14.1  Cysteine  proteinase  
While we are still learning more about their many therapeutic use, cysteine proteinases may have 
evolved primarily as a defence mechanism against arthropod attacks (Konno et al., 2004) or even 
parasites where they have been shown to be effective against them (Stepek et al., 2007a). However, 
their more critical role in plant biology, such that in wound sealing, leaf senescence and ripening, 
should not be dismissed (El Moussaoui et al., 2001). Phylogenetically, cysteine proteinases that have 
been shown to have anthelmintic activity are classified under the papain family C1 and clan CA 
(MEROPS, 2009). At a molecular level, they work by the target polypeptide binding to the active site 
cleft where the important cysteine and histidine residues are present and mediate hydrolysis of the 
target (Behnke et al., 2008). (see Fig 1.1 (a) & (b)) 
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Fig 1.1 The three dimensional structure of papain* 
(a) Ribbon diagram of a papain molecule. Cysteine (yellow) and histidine (blue) residues are shown in 
ball and stick representation (b) The three dimensional surface view of a papain molecule revealing the 
active site substrate-binding cleft, running from top to bottom. The main hydrophobic-binding pocket 
(green) where the side-chain of a hydrophobic amino acid in the substrate polypeptide binds. * adapted 
from (Stepek et al., 2004) 
 
This property coupled with the fact that they are irreversibly inhibited on a 1:1 molar basis by trans-
epoxysuccinyl-L-leucylamido-butane (E-64), makes quantification of enzyme activity possible through 
titration assays using commercially available substrates. The substrate benzoyl-arginyl-p-nitroanilide 
(Bz-Arg-pNA) is useful when used with papain, chymopapain, and crude papaya latex, while pineapple 
juice, kiwifruit extract, Ficin, F. carica and F. benjamina latex will cleave benzyloxycarbonyl-
phenylalanyl-arginyl-p-nitroanilide (Z-Phe-Arg-pNA) (Stepek et al., 2005). Stem bromelain however 
binds reversibly (Ritonja et al., 1989) to the substrate benzyloxycarbonyl-arginyl-arginyl-p-nitroanilide 
(Z-Arg-Arg-pNA) (Stepek et al., 2007e). (see table 1.1) 
 
Table 1.1 Naturally occurring cysteine proteinases and their plant source * 
Plant species Enzyme Artificial substrate 
C. papaya(papaya) Papain  Bz-Arg-pNA 
 Chymopapain  Bz-Arg-pNA 
 Caricain  Bz-Arg-pNA 
 Glycyl endopeptidase  Bz-Arg-pNA 
A. comosus(pineapple) Stem bromelain  Z-Arg-Arg-pNA 
 Fruit bromelain  Z-Phe-Arg-pNA 
 Ananain  Z-Phe-Arg-pNA 
 Comosain  Z-Phe-Arg-pNA 
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A. chinensis (kiwifruit) Actinidain  Z-Phe-Arg-pNA 
*Adapted from (Stepek et al., 2004) 
 
1.1.14.2  Cysteine proteinase as cestocidals? 
 
The prospect of cysteine proteinase as a broad spectrum anthelmintic started with the observation of 
effects of pineapple juice on a porcine acanthocephalan (Berger and Asenjo, 1939) but this did not have 
the same effect using papain (Berger and Asenjo, 1940).  
To date, the effects of cysteine proteinase affecting cestodes have not been fully evaluated and existing 
evidence of efficacy against cestodes is limited and to a certain extent controversial (de Amorin et al., 
1999; He et al., 1992). The earliest work using cysteine proteinase on cestodes was that of pineapple 
juice on H. nana (He et al., 1992) which was successful in vitro but failed in vivo. More convincing 
evidence was published quite recently showing that Hymenolepis microstoma is susceptible to papaya 
latex, ficin and stem bromelain in vitro and tegumental damage occurs and can be detected by electron 
microscopy (Stepek et al., 2007e). Controversial evidence showed that kiwifruit extract did not affect 
Hymenolepis microstoma in vitro and trials using Hymenolepis nana models  failed to reduce worm 
burden using ficus spp latex (de Amorin et al., 1999) and young pineapple juice (He et al., 1992). 
 
1.1.15  Animal models used in this project 
 Although many different species of cestodes parasitize humans (e.g. Taenia solium, T. saginata ) and 
livestock (e.g. Monezia expansa of sheep), most are host specific and cannot be grown in rodents. 
Experiments using livestock are expensive and are not permitted unless likely agents have been tested 
first in laboratory animals. Likewise, human trials would be unethical without evidence of efficacy and 
safety from animal trials. Laboratory facilities at Nottingham are suitable for rodent trials. For these 
reasons rodents and rodent helminths are the best starting point for this line of research. Furthermore, 
rodents are the lowest vertebrate group in which well characterised host-parasite relationships with 
minimal severity have been developed. So the rodent specific species are the best available models and 
certainly the best studied cestodes of all. Hymenolepis diminuta a natural parasite of rats (model of gut 
lumen cestodes) and Hymenolepis microstoma, a natural parasite of Mus spp. (model of cestodes that 
attach outside the gut lumen where its scolex is located in the bile duct in the liver) are both currently 
maintained in Nottingham and have been so since 1976 through the regular passaging of the rodent host 
and maintenance of the intermediate host T.  confusum. Due to the availability of obtaining horse 
tapeworms from certain abbatoirs (TurnerÕs abbatoir in Cheshire and Lawrence J. PotterÕs abbatoir in 
Somerset), the horse cestode A. perfoliata will also be used to test the efficacy of CPs. But this is 
limited only to in vitro experiments as I do not have license to conduct animal experiments involving 
horses.  
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1.1.16 Cestode biology 
Cestodes belong to the phylum Platyhelminthes as they are dorsoventrally flattened. Cestodes possess a 
scolex which is the organ of attachment to the host which in the case of H. diminuta are unarmed but is 
well equipped with hooks in H. microstoma. Unlike trematodes, they do not possess any alimentary 
tract and nutrition is obtained by means of diffusion through their tegument and by active transport 
mechanisms in the tegument that selectively carry certain amino acids, sugars and other molecules 
internally. Unlike the tough cuticular layer of nematodes, the tegument is a syncitial ectocytoplasmic 
layer that facilitates the process of nutritive uptake through the presence of microtriches which increase 
the absorptive surface area, much like the microvilli of the intestinal mucosa (Holy and Oaks, 1989). It 
has been clearly demonstrated in nematodes that cysteine proteinase exert damage to the cuticles as 
early as 30min (Stepek et al., 2005) by initially causing it to crinkle before the whole architecture is lost 
eventually.  At the weakest point the high hydrostatic pressure within the pseudocoelomic cavity bursts 
open the worm, releasing internal organs and this results in death of the organism (Behnke et al., 2008). 
On further incubation of nematodes they become completely digested (Berger and Asenjo, 1939, 1940; 
Robbins, 1930).   However, the exact proteolytic mechanism and target proteins on the cuticle are still 
not known (Behnke et al., 2008). It is therefore quite reasonable to suspect that the cestode tegument 
might also be the target site of damage by cysteine proteinase, based upon limited preliminary 
observations in H. microstoma (Stepek et al., 2007e) and H. diminuta (Bolton, 2007). However, it is 
quite premature to make any conclusions about this since the tegument is a completely different 
structure from that of the cuticle and hence the basis of the current project was to clearly demonstrate 
firstly whether or not cestodes are susceptible to the effects of cysteine proteinse and then to elucidate 
the mechanistic basis of this process. With respect to reproduction, cestodes are hermaphroditic and 
their functional reproductive organs of both sexes are contained in the mature proglottids which are 
shed as they become gravid after cross fertilization from other proglottids or self fertilization (Muller, 
2001). 
 
1.1.17  Murine cestode life cycle 
The definitive host of H. diminuta is the rodent R. norvegicus but it can also grow in other rodents such 
as hamsters and Mus spp. but in most abnormal hosts destrobilisation occurs after a few days of 
infection,  rendering the worms sterile (Smyth, 1994). Although rare, they have also been reported to 
infect humans (Wiwanitkit, 2004). In the natural environment, eggs released together with gravid 
proglottids in the faeces of the infected rodent will be eaten by the intermediate host. The most 
important intermediate hosts are the flour beetles Tribolium confusum and Tenebrio molitor. In the 
intermediate beetle host, the hexacanth embryo within the egg hatches and migrates to the haemocoele 
cavity of the beetle where it differentiates and then lies dormant until the insect is consumed by a 
suitable mammalian host. When a suitable host accidentally ingests the infected beetle, the 
cysticercoids become activated on stimulation by the correct temperature, Ph and proteolytic enzymes 
in the stomach. When this is followed by exposure to bile salts and trypsin in the small intestine, they 
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excyst . The newly excysted scolex then attaches itself to the intestinal mucosa where it matures into 
adulthood and reproduction (Smyth, 1994). H. microstoma a cestode of Mus spp. shares the same life 
cycle as H. diminuta. However, H. microstoma occupies an extra-intestinal location namely the 
common bile duct and extra hepatic ducts (Moss, 1971).  
 
Fig 1.2 The life cycle of H. microstoma  (Cunningham and Olson, 2010). 
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1.1.18  Equine cestode lifecycle 
Recently equine cestode infections was recognized as a significant risk factor for the problem of 
intestinal colic in horses (Proudman et al., 1998). Three species of cestodes parasitize the intestines of 
horses with Anoplocephala perfoliata being the most prevalent from the rarer Anoplocephala magna 
and Paranoplocepahala mamillana (Gasser et al., 2005). All species exploit the oribatid mite species 
which infests pastures as their intermediate host. 
 
Fig 1.3 The lifecycle of equine cestodes  
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1.2 Aims and objectives 
 
It has been clearly demonstrated in nematodes that CPs exert damage to the cuticles by hydrolysing 
certain proteins present in the nematode cuticle before the whole architecture is lost at the weakest 
point, causing the high hydrostatic pressure within the pseudocoelomic cavity to burst open the worm 
usually releasing internal organs and resulting in death of the organism (Behnke et al., 2008). On  
further incubation the nematodes become completely digested (Berger and Asenjo, 1939, 1940; 
Robbins, 1930).   However, the exact proteolytic mechanism and target proteins on the cuticle remain 
unknown (Behnke et al., 2008). It is therefore quite reasonable to suspect that the cestode tegument 
might also be the target site of CPs based upon limited preliminary observations in H. microstoma 
(Stepek et al., 2007e). However, this remains speculative since the cestode tegument is completely 
different in structure from that of the nematode cuticle.  
The experiments described in this thesis address the key hypothesis that cestodes are susceptible 
to digestion by CPs, and that therefore naturally occurring CPs from plants and their fruits 
constitute a source of novel anthelmintic drugs for the treatment of cestode infections in people 
and in our domestic livestock. 
 Using H. diminuta and H. microstoma as main laboratory model systems I aim to: 
¥ clearly determine first whether or not adult cestodes are susceptible to the effects of 
CPs in vitro. 
¥ describe in detail the nature of the damage taking place in the tegument after 
exposure to CPS, through careful observation of the changes occurring as evident by 
scanning (SEM) and transmission electron microscopy (TEM). 
¥ determine whether or not the oral administration of CPs reduces parasite burdens as 
reflected in changes in faecal egg counts and worm burdens recovered at autopsy  
¥ assess whether or not the juvenile stages of cestodes are affected by CPs by using an 
assay in which freshly in vitro hatched cysticercoids will be exposed to CPs. 
Scoleces of cestodes are known to be considerably more resilient in the presence of 
anthelmintics so this will be a particular challenge and there is contradictory 
evidence on the ability of CPs to affect juvenile stages of C. elegans (Behnke et al., 
2008). 
¥ assess the efficacy of CPs against cestodes of horses, since cestode infections are 
particularly pathogenic in these animals (Proudman and Trees, 1999), and resistance 
to the current anthelmintic is a big problem in the equine livestock industry 
(Matthews et al., 2004). 
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In all this work, I will explore the effects of natural plant products from sources such as for example 
papaya latex, extracts from pineapple as well as commercially available purified cysteine proteinases 
such as papain and stem bromelain.  
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CHAPTER 2  
 
Materials and methods 
 
2.0 Summary 
This chapter details the general materials and methods used throughout the thesis. It is important, 
however, to refer to specific experiments for detailed experimental design and results. 
 
2.1 Enzyme preparations 
The enzymes used for in vitro experiments were in the supernatant of papaya latex extract (PLS)  or 
pineapple extract, purchased papain and stem bromelain provided from Hong Mao Biochemicals Co. 
Ltd., while the enzymes used for in vivo experiments were crude papaya latex (CPL) and PLS only. 
 
2.1.1 Crude Papaya Latex 
The same CPL (catalogue no P3250, Sigma-Aldrich UK) used in previous published works (Stepek et 
al., 2005; Stepek et al., 2007a; Stepek et al., 2006b, 2007b, c, e) was used in the work described in this 
thesis.  Five mg of CPL were dissolved in 8mls of water as first described by Stepek et al. (2005). To 
measure the operational molar concentration of this preparation the amount of active CP present in a 
1ml assay was determined by titration against the CP inhibitor E-64 (Sigma-Aldrich). This preparation 
was made fresh on the day of use and was only used in Experiment 1 in Chapter 5. 
 
2.1.2 Papaya Latex Supernatant 
Papaya latex was sourced from Enzymase (Brussells, Belgium; http://www.enzymase.com/). The latex 
was in the spray-dried form which had undergone several patented processes of mechanical filtration 
under lower temperatures to remove impurities and contaminants before finally being spray-dried. Four 
kg of spray-dried papaya latex were dissolved in 12 litres of water. The solution was centrifuged at 
17,700 g at 4 ¼C (Beckman rotors, UK model J2-21) to obtain the supernatant. The papaya latex 
supernatant (PLS) was dialysed against polyethylene glycol 20,000 (VWR
 
international) through 
dialysis membrane [MW Cut-off 3,500 ( SpectraPOR
¨
 45mm diam.)] concentrating it to a third of its 
original volume. The concentrated PLS was aliquoted into individual containers and frozen at -80 ¼C. 
The operational molar concentration of active CPs for this preparation and throughout the purification 
process was determined by measuring the amount of active CPs present in a 1 ml assay through titration 
against the CP inhibitor E-64 (Sigma-Aldrich). The frozen PLS was thawed and diluted with HanksÕ 
saline to the exact molar concentration of active CPs used in individual in vitro experiments or with 
water to the exact amount of active CPs present in a single dose for in vivo experiments. Part of this 
frozen PLS was freeze-dried using Chemlab instruments, England SB4 freeze-drier at 4¡C. The freeze-
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dried PLS was only used in Experiments 1&3 in Chapter 3. The frozen PLS however was used 
throughout the thesis. This PLS preparation was also used in recent publications (Buttle et al., 2011; 
Luoga et al., 2011). 
 
2.1.3 Pineapple extract 
Fresh and ripe pineapples Ananas comosus were purchased from SainsburyÕs supermarket. The skin, 
leaves and stem were removed and the fruit portion was juiced using a Philips juicer HR1861. The juice 
was then filtered through Whatman filter paper under vacuum suction to remove impurities. The 
filtered juice was concentrated through dialysis against polyethylene glycol 20,000 (VWR
 
international) 
through a dialysis membrane [MW Cut-off 3,500 ( SpectraPOR
¨
 45mm diam.)]  All the purification 
steps were conducted in the presence of ice whenever possible, to avoid enzyme denaturation. No 
further extraction method such as for example acetone precipitation was applied because of the 
substantial loss of active CPs encountered during earlier attempts. The pineapple extract was then 
frozen at -80¡C. The operational molar concentration of active CPs for this preparation and throughout 
the purification process was determined by measuring the amount of active CPs present in a 1 ml assay 
through titration against the CP inhibitor E-64 (Sigma-Aldrich). The frozen pineapple extract was 
thawed and diluted with HanksÕ saline to the exact molar concentration of active CPs used in individual 
in vitro experiments. The pineapple extract was only used in the in vitro experiments described in 
Chapter 4. 
 
2.1.4 Stem bromelain 
Purified stem bromelain was sourced from Hong Mao Biochemicals Co., Ltd.  (Rayong, Thailand). 
Two hundred gm of purified stem bromelain were dissolved in 1 litre of water. The solution was then 
centrifuged at 17,700 g at 4¡C (Beckman rotors, UK model J2-21) to obtain the supernatant. The 
supernatant was frozen in -80¡C. The operational molar concentration of active CPs for this preparation 
was determined by measuring the amount of active CPs present in a 1 ml assay through titration against 
the CP inhibitor E-64 (Sigma-Aldrich). The frozen stem bromelain was thawed and diluted with HanksÕ 
saline to the exact molar concentration of active CPs used in individual in vitro experiments. Purified 
stem bromelain was only used in the in vitro experiments in Chapter 4. 
 
2.1.5 Papain 
The same purified papain (catalogue no P3125; Sigma-Aldrich UK) used in earlier publications (Stepek 
et al., 2005; Stepek et al., 2007a; Stepek et al., 2006b, 2007b, c, e) was used in the experiments 
described in this thesis. The lyophilized papain was dissolved proportionately in HanksÕ saline to the 
exact molar concentration of active CPs required for individual in vitro experiments. Purified papain 
was only used in the in vitro experiments in Chapter 4. 
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2.1.6 CP active-site titration 
The method of determining the operational molar concentration of active CPs was adapted from Zucker 
et al. 1985 using E-64 as titrants. Ten µl (depending on CP; neat for pineapple extract and 1:100 for 
PLS and stem bromelain) of the enzyme solution were added to 250 µl of 0.2 M sodium phosphate 
buffer/16mM L-cysteine (pH 6.85). From 0 to 100 µl of 20 µM E-64 were then added (11 tubes, 10 µl 
increments). 1mM EDTA was added to make up the remaining assay volume of 1ml (975 µl for PLS; 
987.5 for pineapple extract and stem bromelain) before vortexing and incubating the mixture at 40¡C 
for 15 min. Either 25 µl of 10 mM Bz-Arg-pNA for PLS or 10mM 12.5 µl of Z-Phe-Arg-pNA for 
pineapple extract or 10 mM 12.5 µl Z-Arg-Arg-pNA for stem bromelain were added making the final 
assay volume 1 ml. After 10 min at 40 ¡C the reaction was stopped by the addition of 1ml 0.1M sodium 
chloroacetate/ 0.2 M sodium acetate buffer (pH 4.3) (see appendix 1). The released 4-nitroaniline was 
determined by spectrophotometric absorbance measurement at 410 nm (Mole and Horton, 1973b). 
Since E-64 inhibition results in a stoichiometric inactivation of CPs on a 1:1 molar basis, the result was 
a linear fall in the concentration of 4-nitroaniline released with increasing concentrations of E-64. The 
intercept of the line with the abscissa denotes the molar concentration of active CPs present (see 
appendix 2 for an example of this). 
 
2.1.7  Measurement of enzyme activity in the rodent GI tract 
 
This protocol was modified from (Stepek et al., 2007b). Fifty µl sample from the mouse GI tract or 100 
µl from the rat GI tract were added to 250 µl of phosphate buffer, pH 6.85, containing 16 mM L-
cysteine with and without 20 µM E-64 (final volume of 1ml). After 15 min, the reaction was stopped by 
the addition of 1ml 0.1M sodium chloroacetate/ 0.2M sodium acetate buffer (pH 4.3) and the 
absorbance at 410 nm was measured on a spectrophotometer. Enzyme activity was calculated using a 
molar coefficient of 8800 M
-1
cm
-1
(Mole and Horton, 1973a). One unit of enzyme activity was defined 
as that which produced 1 nmol min
-1
 of product under these assay conditions. The addition of E-64 to 
half of the assays was necessary in order to distinguish between CP and trypsin which also cleaves Bz-
Arg-pNA. 
 
2.2 In vitro experiments 
 
2.2.1 Animals 
Male C3H mice from Harlan, U.K. and male BKW mice from B&K, U.K., were used for the 
production of H. microstoma worms for in vitro experiments. Male Wistar and Lister hooded rats from 
Charles River, UK were used for the production of H. diminuta for in vitro experiments. 
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2.2.1 Parasites 
The parasite models used in this project were the rat tapeworm H. diminuta, the mouse tapeworm H. 
microstoma and the horse tapeworm A. perfoliata. 
2.2.2 H. diminuta parasite production 
Rats were infected with 50 H. diminuta cysticercoids dissected from infected flour beetles T. confusum 
which were suspended in 1 ml of distilled water. The rats were culled on day 14 of infection by an 
overdose of CO2 and cervical vertebrae dislocation. The small intestine was removed and worms were 
flushed out with HanksÕ saline using a 50 ml syringe. The flushed out worms were transferred into a 
collecting Petri dish containing pre-warmed at 37
o
C HanksÕ saline before being transferred into 
individual treatment wells for motility assays or imaging experiment. 
 
2.2.3 H. microstoma production 
Mice were infected with 12 H. microstoma cysticercoids, dissected from infected flour beetles T. 
confusum, which were suspended in 0.2 ml of distilled water. Mice were culled on day 14 of infection 
by an overdose of CO2 and dislocation of cervical vertebrae. Because the scoleces of H. microstoma are 
mainly attached to the bile duct, the liver was removed first from its attachments to the diaphragm and 
other gut structures in order to expose an intact bile duct. The bile duct was then opened up carefully 
using sharp-ended dissecting scissors starting proximally from its base at the liver and then moving 
distally away from the liver  towards the duodenum. This incision was then continued in both directions 
of the duodenum, one way towards the stomach and the other all the way towards the ileo-caecal 
junction. The opened intestine was then placed in a glass Petri dish containing pre-warmed   HanksÕ 
saline (37 
o
C) for 30 min to allow the worms to move away from the tissues. Worms were identified 
and transferred into another collecting Petri dish containing pre-warmed at HanksÕ saline (37
o
C ) before 
being transferred to individual treatment wells for motility assay or imaging experiments. 
 
2.2.4  Collection of A perfoliata  
The horse tapeworm A. perfoliata was collected from TurnerÕs abattoir, Cheshire and from the 
Lawrence J. Potter abattoir, Somerset. Upon receipt of the whole horse GI tract which was removed by 
slaughterhouse personnel, a small incision ~5 cm was made at the ileocaecal junction so as to create an 
opening. About 500ml of caecal fluid were collected and stored in a flask, the fluid acting as a 
maintenance medium during transportation of the worms to the laboratory. Worms attached to the 
mucosal surface of the intestine were removed and transferred into the flask containing the caecal fluid. 
The flask was then stored inside a polystyrene box pre-warmed with water bottles containing water 
which had been boiled earlier. Worms were then conveyed rapidly back to the University of 
Nottingham and transferred immediately into HanksÕ saline at 37¡C before commencing in vitro 
motility assays or imaging experiments. 
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2.2.5 Production of rodent cestode cysticercoids  
Gravid proglottids at the terminal ends of the strobila (~2 cm) of either H. microstoma or H. diminuta 
were fed to T. confusum beetles which had been starved for at least 5 days. After a few days, when the 
proglottids have been consumed, the beetles were maintained with their regular diet of a 50/50 mixture 
of wholemeal flour and white flour with additional BrewerÕs yeast. After 30 days a few representative 
beetles from either infection were dissected to ascertain the presence of fully developed cysticercoids. 
Fully developed cysticercoids are ready for use in juvenile cestode motility assays by artificial 
excystation. 
 
2.2.6 Artificial excystation of cysticercoids 
This process was conducted based upon an amended protocol by (Goodchild and Davis, 1972). 
Dissected cysticercoids from infected T. confusum beetles were incubated in acid-pepsin solution pre-
warmed at 37¡C for 15min in the 37¡C incubator. Acid-pepsin solution was then removed and washed 
3x with TyrodesÕ saline. Trypsin-tyroglycocholate solution, pre-warmed at 37¡C, was added and 
incubated at 37¡C for 5 min after which scoleces could be seen evaginating and leaving their cysts. 
 
2.2.6 In vitro motility assays 
For adult worm motility assays, BD Falcon
TM
 12 wells tissue culture plates were used with individual 
assay consisting of 2ml volume. For motility assays using juvenile artificially excysted scoleces, BD 
Falcon
TM
  48 wells plastic tissue culture plates were used with individual wells consisting of 0.5ml 
volume. Different concentrations of active CPs were prepared by proportionate combination of CP, 
HanksÕ saline (see appendix 1) and L-cysteine. E-64 was also used as a control treatment to block the 
effects of CPs. 
 
2.2.7 In vitro motility grading for adult worms 
A semi-objective motility grading system was designed, based upon Stepek et al. 2005 in which 
incubated worms were observed and graded for their motility on a scale of 0 to 5. 
Table. 2.1 Motility grading scale for adult cestodes 
Score Motility 
0 Motionless 
1 Motile only when prodded 
2 Motile only at end parts of worm 
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3 Marked reduction in motility 
4 Slightly less motile 
5 Full motility 
              
2.2.8 In vitro motility grading for artificially excysted scoleces 
Due to the relative difference in motility compared to adult worms an amended grading system was 
formulated, based upon the system mentioned above for adult worms. 
 
Table 2.2 Motility grading scale for artificially excysted scoleces  
Score Motility 
0 Motionless 
1 Motile only when prodded 
2 Reduction in motility 
3 Full motility 
 
2.2.9  Data storage 
Data from motility experiments were recorded manually during experiments and were then entered into 
Microsoft Excel 2010 documents using a Samsung laptop P510. Data was also converted to Graphpad 
prism files to generate figures. 
 
2.2.10 Data analysis 
Data from motility assays were analysed using repeated measures general linear models  (rmGLM) 
using the statistical software SPSS (version 21.0). Time was fitted as a within subject factor while the 
concentration of active CPs was fitted as a between subject factor. Where the data did not meet the 
MauchleyÕs sphericity test the Huynh-Feldt adjustment was used to interpret data on the side of caution. 
In gauging variation in CP efficacy motility data at 30min incubation were used to generate 
concentration-inhibition curves in Graphpad prism 5 software. 
 
2.2.11 Light microscopy imaging 
Images of artificially excysted juvenile cestodes were digitally captured using MA88 300 Hirocam 
digital microscope eyepiece 3.0 Megapixels which was fitted to a light microscope viewed at 
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magnifications of x20. Digitally captured images was processed by the accompanying software 
TSview. 
 
2.3 In vivo experiments 
 
2.3.1 Animals 
C3H mice from Harlan, UK and Wistar rats from Charles River, UK were used in the in vivo work 
described in this thesis. The animals were provided with water and food ad libitum. All animal 
procedures were carried out using UK Home Office license number 40/9618, 40/9617, 40/6326 and 
40/1313 under the regulations of the Animals (Scientific Procedures) Act 1986. 
 
2.3.2 Faecal egg counts 
Rodent faeces were collected for egg counts using the McMasters flotation technique every other day 
for 3 days before treatment and every other day for 3 days during treatment. To collect individual faecal 
samples, animals were temporarily separated into individual cages without bedding for 2 hours, early in 
the morning, after which the faeces were collected and transferred into pre-weighed universals. During 
faecal collection, all animals had access to water but not food, which could have contaminated the 
faeces. The faecal samples together with their universals were then weighed and recorded. Ten ml of 
saturated sodium chloride solution were added to each universal and allowed to soak and to break up 
for 1h using a rotary mixer. For egg counting, each homogenised faecal sample was washed through a 
sieve with 50mls of saturated sodium chloride solution to remove excessive fibre and debris. Using a 
Pasteur pipette, a small volume was transferred out from the 60mls faecal-sodium chloride mixture, 
whilst maintaining a gentle stir of the solution, to ensure randomised dispersion of eggs. The sample 
solution was transferred into a 2-chamber McMaster slide with each chamber holding a volume of 0.15 
ml. Using a light microscope at magnification of 10x, eggs that float within the designated grid lines 
were counted for each chamber. The mean value from both chambers counted was used to calculate the 
number of eggs per gram of faeces (EPG) using the following formula which is a modified formula 
(Behnke and Parish, 1979) originally developed for counting nematode eggs in sheep (Gordon and 
Whitlock, 1939). 
 EPG !
!∀#∃%&!!∀!!∀∀#!!∀#∃%&∋
!∀#∃%&!!∀!!∀#∃#%
!
!∀!#∃!!∀#∃%&
!∀#∃%&!!∀#∃%&∋
  = 400 x 
!∀#∃!!∀#∃%&!!∀!!∀∀#!!∀#∃%&∋
!∀#∃%&!!∀!!∀#∃#%
 
 
2.3.3 Assessment of worm burdens and worm biomass 
On the final day of each experiment all the animals were autopsied to ascertain worm burdens and  
worm biomass. The intestine was opened up using blunt ended scissors, starting from the lower half of 
the stomach right up to the caecum, concentrating mainly around the bile duct and duodenum where H. 
microstoma usually reside. The opened up intestine was then transferred into a Petri dish containing 
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pre-warmed HanksÕ saline (37¡C ) to allow worms to detach from the tissues of the intestine. Individual 
worms were first identified by their scoleces under the light microscope before being counted and 
transferred into pre-weighed  aluminium foil, that had been fashioned into cups. They were weighed in 
these cups and the weight of empty cups was subtracted to obtain the value for the wet biomass of the 
parasite burdens from individual mice. Apart from the wet biomass, the dry biomass was determined by 
baking the worms in an oven at 60¡C continuously for 5-10 hours daily for 2 consecutive days, as 
opposed to the usual method of baking continuously for 24 hours (Hopkins et al., 1972b), followed by 
reweighing and subtraction of the weight of the empty cups. The two periods of drying were necessary 
to conform to local safety regulations aimed at avoiding a fire hazard, when could have occurred had 
the oven been left unattended overnight. 
 
2.3.4  Induction of immunosuppression in mice 
In order to achieve delayed rejection of H. diminuta in the non-permissive mouse host, mice were 
injected subcutaneously with dexamethasone (Voren
TM 
suspension Boehringer-Ingelheim, UK). Mice 
were also given oxytetracycline hydrochloride (Terramycin, Pfizer Ltd) in their drinking water at a 
concentration of 3g/litre for the duration of the experiment to prevent opportunistic infection during 
periods of immunosuppression. 
 
2.3.5  Data storage 
Data from faecal egg counts and autopsy indices were first recorded  manually during experiments and 
were then entered into Microsoft Excel 2010 documents using a Samsung laptop P510. Data was also 
converted to Graphpad prism 5 files to generate figures.  
 
2.3.6 Data analysis 
Data from in vivo experiments were analysed using SPSS software (version 21.0). For Faecal egg 
counts data were analysed using repeated measures general linear models (rmGLM). In experiments 
assessing treatment efficacy the non-parametric tests, Mann-Whitney U and Kruskal-Wallis, were used 
depending on number of treatment groups being tested. In experiments assessing dose-dependency, data 
were analysed using SpearmanÕs correlation test.  
 
2. 4 Observations of changes and structural damage of cestodes  by SEM 
 
2.4.1 Preparation of fixation reagents 
Worms were incubated in different treatments or control media at 37¡C. At timely intervals of 10min, 
20min and 60min one worm was removed and fixed in 2.5% glutaraldehyde for one hour. 
Glutaraldehyde was then replaced with 0.1M phosphate buffer pH 7.2 for another hour or overnight at 
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4¡C. In the case of in vivo experiments, proglottid segments found in the colon were directly fixed in 
glutaraldehyde 2.5% and the same steps as detailed above were repeated. 
 
2.4.2 Staining 
Osmium tetroxide stain was prepared by breaking a 1 glass vial containing osmium tetroxide into a 
glass bottle containing 10ml 0.1M phosphate buffer, under the fume hood. Fixed worms in 0.1M 
phosphate buffer pH7.2 were stained in osmium tetroxide solution just enough to submerge the whole 
worm or segment for an hour. Osmium stained worms turn black in colour and the osmium solution 
was then removed. Stained worms were washed in distilled water 3 times before dehydration. 
 
2.4.3 Critical point drying 
On the day of drying, dehydrated worms or segments in 70% ethanol were removed and dehydrated 
further in 90% and 100% ethanol with 15min intervals in between. The dryer Polaron E1000 was 
adjusted to an optimal temperature of 18-20¡C by running tap water through the system. The dryer was 
also tested for leaks.  The specimens were placed in wire mesh baskets which was placed into a metal 
container filled with 100% ethanol. The metal container was then placed into the drying chamber and 
was tightly closed. The pressure was turned up to approximately 800 bars so that the CO2 was liquefied 
and entered the chamber. The meniscus (the level of liquid CO2 visible) then rose to the top. Ethanol 
was released by opening the ethanol valve for 20 seconds and the CO2 valve was opened so that liquid 
CO2 would replace the ethanol within the worm. This process was repeated several times until no more 
wet ethanol could be detected upon releasing the ethanol valve. The hot water bath was now turned on 
to reach a temperature of 40¡C. The hot water was run through the system until the critical point drying 
had been achieved, when the meniscus disappeared. 
 
2.4.4 Sputter coating with gold 
Dried worms were mounted onto aluminium stubs with the use of quick drying silver paint (Agar 
scientific ltd, Essex, UK). The mounted worms on stubs were placed onto the disc in the Polaron E5100 
sputter coater. The pump was turned on to create a vacuum and left for 10min. When the Argon 
indicator rose and passed the mark indicating a vacuum, the right knob was set to HT. Then the voltage 
(middle knob) was set clockwise to 2.5 volts and was left to rise until 18-20 volts and then left for about 
60 seconds for coating to occur. Then the voltage was turned off and the vacuum was released. The 
gold coated worms were then ready for viewing under SEM. 
 
2.4.5 Scanning electron microscopy (SEM) 
Gold coated worms were viewed using JEOL JSM-840 scanning electron microscope. 
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2.5 Observation of changes and structural damage of cestodes by transmission electron 
microscopy (TEM) 
 
2.5.1 Fixation 
Adult worms were incubated in different treatments or control wells at 37¡C. At timely intervals of 
10min, 20min and 60min 1 worm was removed and immersed in 2.5% glutaraldehyde for 5min before 
being taken out again. The partially fixed worm was inspected under light microscopy for signs of 
damage.  Where damage on the tegument was apparent, a cross sectional incision was made with a 
sharp blade and another cut was made adjacent to the first cut, practically reducing the worm to a mere 
~5mm x5mm segment of interest and the rest of the worm was discarded. The segment of interest was 
again fixed in 2.5% glutaldehyde for 1 hour. Glutaraldehyde was then replaced with 0.1M phosphate 
buffer pH 7.2 and left again for another hour or overnight at 4¡C. 
 
2.5.2 Staining 
Osmium tetroxide stain was prepared by breaking 1 glass vial containing osmium tetra oxide into a 
glass bottle containing 10ml 0.1M phosphate buffer under the fume hood. Fixed segments in 0.1M 
phosphate buffer pH 7.2 were stained in osmium tetroxide solution, just enough to submerge the whole 
segment for an hour. Osmium stained segments turn black in colour and the osmium solution was then 
removed. Stained segments were washed in distilled water 3 times before dehydration. 
 
2.5.3 Dehydration 
Dehydration with ethanol was carried out by adding 30% ethanol. This process was repeated with 50% 
ethanol with 15min duration in between, before finally leaving the worms at 70% ethanol for an 
indefinite period.  
 
2.5.4 Embedding in resin 
SpurrÕs resin was prepared by mixing 10g ERL 4206 (3,4 Epoxy Cyclohexyl Methyl 3,4 epoxy 
cyclohexyl carboxylate), 6g DER 736 (Diglycidyl ether of polypropylene glycol), 26g NSA (Nonenyl 
succinic anhydride) and 0.4g DMAE (Dimethylaminoethanol) in the fume cupboard. The resin solution 
was then refrigerated overnight at 4¡C. On the day of embedding, dehydrated worms in 70% alcohol 
were dehydrated further in 90% ethanol and then in 100% ethanol. Fresh resin was poured into mould 
blocks (1 block per sample) until level with the top of each mould. The mould was then kept at 4¡C 
overnight. The hardened resin block was sectioned using a Reichert Ultracut microtome.  
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2.5.5 Staining the sections 
The sections were stained in lead citrate and uranyl acetate before viewing.  
 
2.5.6  Transmission electron microscopy (TEM)  
Lead citrate and uranyl acetate stained sections were viewed under JEOL 1010 transmission electron 
microscope. 
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CHAPTER 3 
 
Thermostability profile of papaya latex supernatant  
 
3.0 Summary  
Papaya latex supernatant (PLS) is a partially refined form of papaya latex which was used in recent 
publications (Buttle et al., 2011; Luoga et al., 2011) and throughout the experiments reported in the 
following chapters of this thesis. In order to develop PLS into a useful anthelmintic it is important for it 
to be thermostable, and although the thermostability profiles of CPs have been well documented in 
earlier publications, nevertheless it was important here also to establish clearly the rate at which activity 
is typically lost in CP preparations held in various storage conditions for use in the present program of 
research. In this chapter PLS was found to be stable for almost 1 year when frozen or if freeze-dried 
and refrigerated. It was also stable at 37 ¼C for the entire 2 hours duration of typical in vitro motility 
assays. Active PLS was detectable along the whole gastrointestinal tract of both rodent model systems 
used in this project; M. musculus and R. norvegicus, and it was confirmed that the levels of activity  
dropped rapidly in the stomach and upper small intestine whilst increasing in the large intestine and 
accumulating over a period of 2-3 hours post oral administration. 
 
3.1  Introduction 
Plant products from pineapple (Berger and Asenjo, 1939), papaya (Berger and Asenjo, 1940) and figs 
(Robbins, 1930) have been shown to possess anthelmintic properties and the active principles mediating 
the effects have long been identified (Walti, 1938) but only recently confirmed to be CP (Stepek et al., 
2005). In order to develop natural plant products into useful anthelmintic agents, isolation and 
characterisation of their active principles are essential (Behnke et al., 2008). However, the processes of 
isolation and purification of proteins are often detrimental to their biological activity and structure 
(Arakawa et al., 2001) rendering them thermo specific and heat labile (Somero, 1995). Many factors 
may contribute to protein inactivation but most notably extremes of temperature and pH.  
Heat denaturation of proteins is well-known and starts with reversible structure unfolding and 
later due to prolonged heat exposure leads to permanent structural change such as aggregation and 
mispairing of thiol groups (Roy and Gupta, 2004). Protein inactivation due to cold denaturation is 
equally important as most purified proteins are often freeze-dried for longer shelf life and logistics. 
Cold denaturation is however a multifaceted phenomenon centred around ice crystal formation with the 
resulting abrupt changes in solute concentration and pH (Arakawa et al., 2001; Cao et al., 2003; Roy 
and Gupta, 2004) and due to physical disruption by ice crystals. 
Various methods of quantifying enzyme activity have been developed ranging from classical 
substrate labelled chromogenic assays (Goddard and Reymond, 2004) to real-time assays (Konarzycka-
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Bessler and Bornscheuer, 2003). Specific inhibition of CPs by E-64 has enabled convenient 
chromogenic based assay through titration (Zucker et al., 1985) which have been used to date 
throughout all the work on CP anthelmintic development starting from crude papaya latex (Stepek et 
al., 2005; Stepek et al., 2007a; Stepek et al., 2006b, 2007b, c, e) to the more refined papaya latex 
supernatant (Buttle et al., 2011; Luoga et al., 2011). Due to its commercial value the thermostability 
profile of papaya latex proteases have been investigated by many of which most observed an obvious 
heat lability (Chaiwut, 2007; Hinkel, 1951; Ortiz et al., 1980). Within the context of anthelmintic 
development CPs have been shown to survive stomach acidity to reach the colon (Stepek et al., 2007b) 
to affect T. muris (Stepek et al., 2006b) despite controversial in vitro work suggesting irreversible 
damage to papain subjected to low pH (Huet et al., 2006). The aims of this chapter are to investigate the 
thermostability of PLS because it is being used throughout the thesis and questions of whether the 
enzyme is still active or not after storage, freeze-thawing and even as it is being administered in the 
animal is obvious. In this chapter I report experiments in which I have investigated the basic 
thermostability profile of PLS within the context of the question .  
 
3.2 Experimental design and results 
 
3.2.1 Experiment 1  
 
Processing PLS 
 
3.2.1.1  Experimental design 
This experiment was conducted primarily for the papaya latex used in the sheep trial at the Moredun 
Institute (Buttle et al., 2011). Papaya latex was sourced from Enzymase (Brussells, Belgium; 
http://www.enzymase.com/). This enzyme is in the spray-dried form which had undergone several 
patented processes of mechanical filtration under lower temperatures to remove impurities and 
contaminants before finally being spray dried and is also known as Papain P1. For this experiment 4 kg 
of spray-dried papaya latex was reconstituted into solution by addition of 12l distilled water. The 
papaya latex solution was centrifuged at 17,700 x g at 4 ¼C to obtain the supernatant. The papaya latex 
supernatant (PLS) was dialysed against polyethylene glycol 20,000 through dialysis membrane MWCO 
3500 SPECTRA/POR
¨
 7, concentrating the enzymes and removing water to facilitate freeze-drying and 
logistics. The resultant dialysed PLS was then frozen at -80 ¼C before being freeze-dried in a SB4 
freeze-drier (Chemlab, England). The amount of active CP present in a 1ml assay (see chapter 2 for 
methodology) was determined in the different forms of processed papaya latex as it underwent 
refinement from solution to the final freeze-dried product. 
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3.2.1.2 Results 
There was no loss of active CP during centrifugation of papaya latex solution to obtain the supernatant. 
However, during dialysis of papaya latex supernatant there was a 33.9% loss of active enzymes (Fig 
3.1). There was also further loss of active CP (33.8%) when the dialysed PLS was frozen at -80¡C (Fig 
3.1). During freeze-drying however, the amount of active enzymes actually increased by 20.2% (Fig. 
3.1). 
 
Fig 3.1 PLS processing. 
Amount of active CPs in different forms of processed papaya latex as it underwent refinement from 
solution to the final freeze-dried product. The amount of active CPs expressed in nmols are the molar 
equivalent of the inhibitor E-64 used to block active CP in a 10µl volume in a titration assay (see 
chapter 2). The solution was made by reconstitution of spray dried papaya latex from Enzymase 
(Brussels, Belgium) with water at a ratio of 1:3. The solution was then centrifuged at 17,700 g at 4¡C to 
obtain the supernatant. Papaya latex supernatant (PLS) was then dialysed against polyethylene glycol to 
concentrate active CPs. The concentrated PLS was frozen at -80¡C before finally being freeze-dried 
ready for use in the sheep trial. Note the 33.9% loss of active CPs during dialysis and also the further 
33.8% loss during freezing. Freeze-drying however saw a 20.2% increase in active CPs. Error bars 
represent the standard error of the mean. 
 
3.2.2 Experiment 2 
 
The stability of PLS during storage 
 
3.2.2.1  Experimental design 
This experiment was carried out to determine the stability of PLS which was used throughout the thesis 
in terms of amount of active CP retained or lost when stored at different storage conditions against 
time. Papaya latex was processed in the same manner as in Experiment 1 starting from reconstitution of 
the same spray dried powder from Enzymase (Brussells, Belgium) into solution before centrifugation to 
obtain the supernatant. Unlike in Experiment 1 here PLS was not dialysed because there was no need to 
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concentrate the enzymes for logistical reasons and was immediately aliquoted into small 1.5ml micro 
centrifuge tubes in a batch of 5 for each storage conditions ; ambient temperature, 4¼C, -20 ¼C and -80 
¼C. Each vial receiving 1ml of the solution. The amount of active CP present in a 1ml assay (see 
Chapter 2 for methodology) from the samples from different storage conditions were determined at 1 
week, 1 month, 6 months and 1 year post processing.  
3.2.2.2 Results  
The original amount of active CPs in this PLS preparation (post centrifuge) was 0.825nmols (the 
amount of active CP present in 1ml assay). This amount then declined by around 70.1% (Fig 3.2) from 
its original value after 1 week of storage at ambient temperature after which rather gradual further loss 
of active enzymes commenced until only 1.3% (Fig 3.2) of the original amount of active CPs remained 
at 1 year. When stored in the refrigerator at 4¼C the rate of loss was rather gradual with an initial loss of 
3.0% after 1 week followed by 15.2% after 1 month and 39.4% after 6 months (Fig 3.2). After 1 year 
storage at 4¼C, the amount of active CPs has been reduced by 71.2% from its original value (Fig 3.2). 
When PLS was frozen in the freezer at -20 ¼C the loss was rather minimal with an initial loss of about 
9.1% after which the subsequent loss of 15.2% after 1 month stabilised up to 1 year. Similarly when 
PLS was deep frozen at -80 ¼C the amount of active CP stabilized at around 80% of the original starting 
value and stayed at this level without further loss for up to 1 year post processing. 
 
 
Fig 3.2 PLS storage stability 
Amount of active CP in post centrifuge PLS as it was being stored at different temperature conditions at 
different time points. The amount of active CPs expressed in nmols are the molar equivalent of the 
inhibitor E-64 used to block active CP in a 10µl volume in a titration assay (see chapter 2). Note that 
the amount of active CPs decreased when PLS was stored at ambient temperature and at 4¼C. The 
amount of active CPs was relatively preserved when PLS was stored at lower temperatures such as -20 
¼C and -80 ¼C. Error bars represent the standard error of the mean. 
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3.2.3 Experiment 3 
 
Thermostability of freeze-dried PLS 
 
3.2.3.1  Experimental design 
This experiment was basically an extension of Experiment 2 assessing enzyme stability of papaya latex 
in the freeze-dried form. For this, data were collected from 2 different papaya latex enzyme 
preparations intended for use in 2 different livestock trials; the sheep trial in Moredun Institute, 
Scotland of which the results have been published recently (Buttle et al., 2011) and the pig trial in 
University of Ghent, Belgium which is still an on-going trial. In both preparations, papaya latex were 
sourced from Enzymase (Brussels, Belgium) and were processed the same way (see chapter 2 for 
methodology) until they were in the freeze-dried form. 
 
3.2.3.2 Results 
The process of freeze-drying alone caused loss of active enzyme by 10-15% in both preparations (Fig 
3.3). After 1 week the amount of active enzyme in the freeze-dried PLS stored at ambient temperature 
deteriorated further by about 30% from the original level after which it stabilized (Fig 3.3). After 1 year 
of being stored at ambient temperature, the amount of active enzymes retained was just 50% from the 
original level (Fig 3.3). When freeze-dried PLS was stored at 4¼C however, apart from the initial loss 
following the freeze-drying process, the amount of active enzymes present was relatively preserved 
with just about 15% loss from the original level up to 1 year (Fig 3.3). 
 
 
Time (weeks)
A
ct
iv
e 
C
P
 (
n
m
o
l)
0 20 40 60
0.0
0.5
1.0
1.5
ambient temp
4¡C
34 
 
Fig 3.3 Freeze-dried PLS storage 
Amount of active CP present in freeze-dried PLS as it was being stored at different temperature 
conditions at different time points. The amount of active CPs expressed in nmols are the molar 
equivalent of the inhibitor E-64 used to block active CP in a 10µl volume in a titration assay (see 
chapter 2).  Note that the amount of active CPs decreased when freeze-dried PLS was stored at ambient 
temperature but was relatively preserved at 4¡C. Error bars represent the standard error of the mean.  
  
35 
 
3.2.4 Experiment 4 
 
Thermostability of PLS during in vitro motility assay condition 
 
3.2.4.1  Experimental design 
This experiment was conducted to determine the stability in terms of amount of active CPs retained or 
lost when PLS was incubated at 37¼C for the duration of in vitro motility assay. PLS from Experiment 1 
was used throughout the whole experiment. 
 
3.2.4.2 Results 
PLS was relatively stable throughout the duration of 120min at 37¡C which is the standard duration for 
in vitro motility assays used in Chapter 4. There was no obvious loss in the amount of active CP 
throughout the whole experiment. 
 
Fig 3.4 PLS stability during in vitro assay 
The amount of active CP present in PLS incubated at 37¼C for 120min. The amount of active CPs 
expressed in nmols are the molar equivalent of the inhibitor E-64 used to block active CP in a 10µl 
volume in a titration assay (see chapter 2). No obvious loss in amount of active CP was noted. Error 
bars represent the standard error of the mean. 
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3.2.5 Experiment 5 
 
Thermostability of PLS undergoing repeated freeze-thaw cycles 
 
3.2.5.1  Experimental design 
This experiment was conducted to determine the PLS stability in terms of amount of active CPs 
retained or lost when going through repeated freeze-thaw cycles. If papaya latex is to be used in the 
frozen form it is important to determine its stability because frozen PLS obviously needs to be thawed 
before use and sometimes left over from the initial thaw can be refrozen for next use to avoid waste. 
PLS from Experiment 1 was used in this experiment. Dialysed PLS kept at -80¼C from Experiment 1 
was thawed and the amount of active CP present in 1ml assay (see chapter 2 for methodology) 
determined. The same sample was refrozen at -80¼C and left for about 1 month before repeating the 
same freeze-thaw cycle with amount of active CPs determined each time. 
 
3.2.5.2 Results 
Apart from the initial loss of active CPs following the first freezing, post dialysis, there was no further 
loss of active CPs after repeated freeze-thaw cycles of up to 5 times. 
 
Fig 3.5 Freeze-thawing PLS 
Amount of active CPs in PLS deep frozen at -80¼C which underwent repeated freeze-thaw cycles. The 
amount of active CPs expressed in nmols are the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10µl volume in a titration assay (see chapter 2). No obvious deterioration of the amount 
of active CP noted up to 5 freeze-thaw cycles. Error bars represent the standard error of the mean.!
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3.2.6 Experiment 6 
 
PLS activity in the mouse GI tract 
 
3.2.6.1  Experimental design 
This experiment was conducted to reconfirm the earlier observation that PLS was active along the 
mouse GI tract (Stepek et al., 2007b). Six C3H mouse were purchased from Harlan. Mice were treated 
to a single dose of PLS at 240nmols each at 0min. 1 mouse was killed at 10min, 20min, 60min, 90min, 
120min and 180min. Each was dissected to remove their whole GI tract intact and washed in PBS 
buffer. The GI tract was divided into 4 segments; stomach, upper intestine, lower intestine (the small 
intestine was divided into 2 equal length portions), and the colon (the caecum was not included). Each 
of the segments was opened and its contents washed in 5mls of PBS before being filtered. The enzyme 
activity of each segment was then determined by enzyme activity assay using Bz-Arg-pNA as substrate. 
Naturally occurring trypsin in the mammalian GI tract also cleaves the Bz-Arg-pNA  substrate. Hence 
E-64 was used to block any PLS activity, the residual activity providing an indication of trypsin 
activity. Thus PLS activity could be determined by subtracting trypsin activity from total activity. The 
concentration of enzyme activity was calculated using a molar extinction coefficient of 8800 M
-1
cm
-
1
(Mole and Horton, 1973a) (see chapter 2 for methodology). 
 
3.2.6.2 Results 
In the mouse GI tract enzyme activity in the stomach and upper small intestine rapidly declined within 
90min of treatment after which only negligible amounts persisted. In contrast, enzyme activity in the 
lower small intestine and the colon slowly rose within 90min after which it was relatively stable until 
the end of the experiment at 3hrs. 
 
Fig 3.6 PLS activity in mouse GIT 
The enzyme activity (units/ml) of PLS throughout the C3H mouse GI tract  over time. The unit of 
activity was defined as that which produced 1 nmol min
-1
 of product (see chapter 2 for methodology).  
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Note the rapid decline of PLS enzyme activity in the stomach and small intestine and a steady increase 
in the colon. Trendlines are fitted to guide the eye.  
 
3.2.7 Experiment 7 
 
PLS activity along the rat GI tract 
 
3.2.7.1  Experimental design 
This is a similar experiment to Experiment 6 but to observe PLS activity along the rat GIT since the rat 
model is also used in some chapters of this thesis. Six Wistar rats were purchased from Harlan. Rats 
were treated to a single dose of PLS at 2.4µmols each at 0min. 1 rat was killed at 10min, 20min, 60min, 
90min, 120min and 180min. Each rat was dissected to remove their whole GIT intact and washed 
briefly in PBS buffer. The GIT was divided into 4 segments; stomach, upper intestine, lower intestine 
(the small intestine was divided into 2 equal length portions), and the colon (the caecum was not 
included). Each of the segments was opened and its contents washed in 5mls of PBS before being 
filtered. The enzyme activity of each segment was then determined by enzyme activity assay using Bz-
Arg-pNA as substrate. Naturally occuring trypsin in the mammalian GI tract also cleaves the Bz-Arg-
pNA  substrate. Hence E-64 was used to block PLS activity in order to get pure PLS only activity by 
subtracting the PLS blocked (trypsin) values from the combination value (PLS and trypsin).  
 
3.2.7.2 Results 
In the rat GI tract enzyme activity in the stomach and upper small intestine declined rapidly  within 
60min after which only negligible amounts persisted (Fig 3.7). In contrast, enzyme activity in the colon 
only rose after 90min and was well maintained until the end of the experiment at 3hrs (Fig 3.7) The 
enzyme activity in the lower small intestine was not stable with a sharp rise within 60min and a sudden 
plummet by 90min after which it rose sharply for a second time peaking at 2hrs (Fig 3.7). 
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Fig 3.7 PLS activity in the rat GIT 
The enzyme activity (units/ml) of PLS throughout the Wistar rat GI tract  over time. The unit of activity 
was defined as that which produced 1 nmol min
-1
 of product (see chapter 2 for methodology).  Note the 
rapid decline of PLS enzyme activity in the stomach and small intestine but increased steadily in the 
colon. Trendlines are fitted to guide the eye. 
 
3.3 Discussion 
Stepek et al. (2007b) have shown that crude papaya latex was active along the mouse GI tract and it 
was also effective in vivo at reducing worm burdens of nematodes residing in different regions of the 
gut (Stepek et al., 2006b, 2007b, c). However, crude papaya latex lacks refinement and hence in 
Experiment 1, papaya latex was taken a step further in refinement by centrifugation to obtain the 
supernatant. This process has been shown to retain enzyme activity (Fig 3.1) whilst removing some 
contaminants present in the latex. However, this approach is not entirely new since in fact PLS was 
shown to be more active than its precursor form in an earlier publication (Frankel et al., 1937). 
Nonetheless, it is important to highlight this fact again since PLS is going to be used throughout the 
following chapters of this thesis. Dialysis was carried out only to concentrate active enzymes for 
logistical reasons (it is easier to transport and store a small volume of concentrated stock and later 
dilute to final desired concentrations rather than vice versa) and to facilitate freeze-drying. This process 
however resulted in a 33.9% loss of active CPs (Fig 3.1). It is unclear as to how this could have 
happened but postulations include oxidation (Kimmel et al., 1955) and possibly even osmotic loss 
through defective membrane pores. Oxidation in particular is perhaps more plausible as the amount of 
active CPs was increased in the final freeze-drying step suggesting that active enzymes presumed lost 
earlier might only be temporarily inactivated rather than irreversibly denatured (Stephen et al., 1993). It 
was also evident that PLS underwent further loss of active CPs during freezing which will be discussed 
later in this discussion. It was then imperative for the now partially refined PLS to be kept stable before 
use.  
 Due to its commercial value the papaya latex thermostability profile has been investigated by 
many of which most observed its heat lability (Chaiwut, 2007; Hinkel, 1951; Ortiz et al., 1980) just like 
most proteins (Somero, 1995). More detailed studies on the thermostability of each of the 4 different 
proteinases that constitute papaya latex have also been investigated (Sumner et al., 1993). Experiment 2 
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was carried out to justify the use of PLS from the same stock over long periods of storage duration 
besides comparing the different possibilities for storage of PLS to enable better logistics in practical 
usage. For this, the exact preparation protocol as used for Experiment 1 (see chapter 2 for methodology) 
which has now been published (Buttle et al., 2011; Luoga et al., 2011), was carried out to produce PLS 
which was then stored at different temperatures ranging from ambient temperature to -80 ¼C, the latter 
being used for the entire thesis. It was apparent that PLS when stored at relatively higher temperatures 
such as 4 ¼C and higher underwent a gradual loss of active CPs over the span of 1 year (Fig 3.2). When 
PLS was stored at much higher temperatures such as ambient temperature the amount of active CP was 
drastically reduced by 70% within the first week post processing after which it gradually fell to almost 
no detectable active CPs by 1 year (Fig 3.2). This was in contrast to the considerably more stable 
profile of PLS stored frozen both at -20 ¼C and -80 ¼C. The results are quite comparable to the literature 
where Ortiz et al. (1980) recorded a 20% loss of activity within 24hrs of storage under tropical 
conditions. 
Experiment 4 was carried out to investigate PLS stability maintained at 37 ¼C simulating a 
typical in vitro motility assay, such as those employed in different experiments in Chapter 4.  It is 
perhaps surprising that there was no loss in active CPs noted throughout the whole experimental 
duration of 120min, although in contrast to the above when active CPs were lost at ambient temperature 
over a week (Fig 3.2), these experiments at 37 ¼C were on a much shorter time frame of just 2 hours.  
The addition of cysteine to mimic exact in vitro motility assay conditions may have perhaps contributed 
to additional stabilisation of PLS as cysteine influencing papain stability has been reported (Homaei et 
al., 2010) and the role of excipients in thermo protection is well accepted (Arakawa et al., 2001).  
 As much as the observations of PLS behaviour at higher temperatures are in agreement with 
the literature so is its response to lower temperatures. It was evident that freeze-drying (Figs 3.1 & 3.3), 
freezing (-20¼C) and deep freezing (-80¼C) (Figs 3.1 & 3.2) of PLS resulted in minimal loss of active 
enzymes amounting to no more than 15-20% after which no further deterioration ensued (Fig 3.2 & 
3.3). This loss of active CPs can be explained by cold denaturation. It was interesting to note that there 
was no apparent difference in the stability of PLS stored frozen in the fridge freezer at -20¼C or deep 
frozen at -80¼C. This observation is particularly appealing for the prospects of PLS logistics as it would 
be easier to distribute to remote locations without deep freezing facilities. Unlike heat denaturation 
which is clearly correlated to temperature (Somero, 1995) the mechanism of protein inactivation by 
cold denaturation is multifaceted with much damage attributed to crystallisation of water through 
physical and chemical changes (Arakawa et al., 2001).  
 Therefore, one would naturally expect that repeated freeze-thawing will inactivate or at least 
reduce the amount of active CPs as was shown by Cao et al. (2003). Surprisingly, the PLS was fairly 
stable throughout repeated freeze-thaw cycles of up to 5x. This might be due to the fact that PLS is not 
a singular purified enzyme but rather a partially refined enzyme complex which readily contains many 
components other than proteases which apart from physically protecting the proteases also contribute to 
the stability of CP as excipients. Despite this resistance to repeated freezing-thawing cycles, the PLS 
used throughout the rest of this thesis never underwent repeated freeze-thaw cycles apart from one 
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instance of freezing during the initial process of aliquoting and samples were only used once after 
thawing before being discarded.  
 A more practical approach for PLS storage and logistics would be lyophilized PLS. Although 
no experiments conducted throughout the thesis utilised lyophilized (freeze-dried) PLS as a CP source, 
it is nevertheless interesting to observe the effects of different storage conditions on lyophilized PLS. 
Lyophilized or freeze-dried PLS stored in the refrigerator at 4 ¼C was more stable than when stored at 
room temperature over the period of 1 year (Fig 3.3). The long term stability of lyophilized proteins has 
been discussed and the factors affecting it are thought to include moisture and oxidation as suggested 
by (Arakawa et al., 2001; Roy and Gupta, 2004).  
 Within the context of the objectives of the work reported in this thesis, apart from 
investigating PLS thermostability it was also important to investigate how PLS behaves in the animal 
model itself as to date it has been reported only for oral treatment with crude papaya latex (Stepek et 
al., 2007b). The results from Experiment 5 can only concur with the findings of Stepek et al. (2007b) in 
which PLS activity declined within 60min in the stomach by 75% before steadily rising in the colon 
and lower part of the small intestine. Similar observations were also made in the rat model (Experiment 
6) confirming at least that active PLS was still detectable in the colons of both rodent model systems 
used throughout the thesis despite the reported concerns about inactivation of orally administered CPs 
by stomach acid (Huet et al. (2006). 
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CHAPTER 4 
 
Assessment of the anthelmintic efficacy of cysteine proteinases against cestodes in vitro 
 
4.0 Summary  
Despite limited literature documenting the efficacy of CPs on cestodes in vitro, the experiments 
described in this chapter showed that both naturally occurring fruit-derived CPs such as PLS and 
pineapple extract, as well as commercially available purified CPs such as papain and stem bromelain, 
were efficacious in vitro against both juvenile, artificially excysted scoleces, as well as against adult 
worms of both rodent cestodes, H. microstoma and H.diminuta,. Significant reduction in motility, 
ultimately leading to death of the worms, was observed with both species, and against both freshly 
excysted scoleces and adult worms. CPs appear to attack the tegument resulting in generalised erosions 
mainly in the strobila. The scolex was more resistant to CP attack but was still affected to some extent. 
 
4.1 Introduction 
Parasite motility assays remain the most popular, frequently used methods for assessing antiparasitic 
drug efficacy (Cox, 1993). Nevertheless, whilst not requiring sophisticated methodologies, such assays, 
gauging parasite motility visually, either directly or via light microscopy, are laborious, subjective and 
difficult to standardize (Smout et al., 2010). While effort towards standardization has proven costly 
(von Samson-Himmelstjerna et al., 2009),  nevertheless it has led to the developments of some more 
automated techniques such as the light disruption based micromotility meter (Bennett and Pax, 1986; 
Folz et al., 1987). Other techniques that have helped to address the issue of subjectivity include assays 
based on migration (Wagland et al., 1992), feeding (Alvarez-Sanchez et al., 2005) and development 
(Kotze et al., 1999), but none of these can be easily scaled up sufficiently to enable high throughput 
screening of hundreds/thousands of new, potentially useful compounds. Nevertheless, the research to 
develop an automated, objective and high throughput screening method continues, as we seek novel 
compounds to combat the threat of anthelmintic resistance (Smout et al., 2010). In the context of 
cestodes, assessing motility per se might not be representative of the true stress being experienced by 
the worms as worm motility not being controlled by central nervous system but rather by the peripheral 
nervous system because the strobila is still capable of movement after removal of the scolex (Sukhdeo, 
1992a). Sukhdeo and Kerr (1992) observed a retrograde peristaltic wave-like movement along the 
strobila with a frequency of 25 cycles per min in the anterior segments of the worm decreasing linearly 
to 7 cycles per min in the posterior segments. Ideally cestode motility assays should be designed to 
grade the change in frequency of cycles per min in the strobili. This however clearly imposes limitation 
on the number or samples that could be assessed at the same time manually. 
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Because helminths have been known to afflict humans and livestock since antiquity (Cox, 
2004), it is not unexpected that in the past traditional remedies, mostly from plant extracts, have been 
used to treat them (Behnke et al., 2008). While ethno-medical evidence of use of plants as 
anthelmintics abounds (Prakash and Mehrotra, 1987), historical record of specific use of plant based 
cestocidals remain elusive, apart from  the use of powdered fern extract by the ancient Greeks (350-250 
B.C.), mentioned in Nordic literature (Waller et al., 2001). Scientific evidence of plant extracts 
possessing cestocidal properties are rather recent and limited. Few plants with possible active principles 
suspected of mediating cestocidal activity have been reported, but among these are reports that the 
tuberous root of the plant Flemingia vestita  has an active principle thought to be genistein (Tandon et 
al., 2003), that the alkaloid content of Adhatoda vasica is cestocidal (Yadav and Tangpu, 2008) and that 
Acacia spp. contain saponins and tannins with cestocidal properties (Ghosh et al., 1996). There are also 
several reports of plants showing cestocidal activity, but with unknown active principles, as for 
example in the case of  Strobilates discolour (Tangpu et al., 2006) and Cassia spp. (Kundu and 
Lyndem, 2012; Kundu et al., 2012) and Solenostemon spp. leaves and Croton spp. twigs (He et al., 
1992). However, despite the exciting prospect that some of these plant sources may eventually yield 
new cestocidal drugs, so far none have been tested rigorously and in no case have the active principles 
been proven conclusively to mediate the purported cestocidal activity. 
Plant products from pineapple, papaya and figs, which contain the active principles CPs, 
however, have been systematically tested against nematodes and their anthelmintic properties have 
been confirmed to be mediated by the CPs (Stepek et al., 2005). Therefore, CPs hold a real potential for 
development into mainstream anthelmintic. In comparison to nematodes, little is known about the 
effects of CPs on cestode infections. There is some evidence that CPs are detrimental to the survival of 
cestodes in in vitro maintained assays (He et al., 1992; Stepek et al., 2007e), but data also indicate that 
this is not reflected in a reduction of parasite burdens when CPs are administered to infected hosts (de 
Amorin et al., 1999; He et al., 1992). 
In this chapter I tested the hypothesis that plant derived CPs are detrimental to cestodes 
maintained in temporary in vitro assays. I used two species of laboratory maintained cestodes, the 
murine species H. microstoma and the rat parasite H. diminuta, and in both cases I assessed the effects 
of a range of CPs, at a range of concentrations, on newly excysted scoleces obtained from cysticercoids 
derived from beetles and on adult worms extracted from infected rodent hosts. 
 
4.2 Experimental design and results 
 
Effects of CPs against adult cestodes in vitro. 
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4.2.1 Experiment 1  
 
Confirmation of the effects of CPs against cestodes 
 
4.2.1.1  Experimental design 
 
CPs have been shown to be the  active principles in papaya latex affecting nematodes since their effect 
can be totally blocked in the presence of the specific CP inhibitor E-64 (Stepek et al., 2005). 
Experiment 1 was designed to confirm that the motility decreasing effects seen in earlier pilot 
experiments (not shown) were indeed mediated by CP. The rat cestode H. diminuta was used as a 
model in this experiment. Fourteen day old adult H. diminuta were sourced from infected male Wistar 
rats from Charles River, UK. Worms dissected from their host were transferred into various treatment 
wells (1 worm per well) containing either HanksÕ saline, 1mM Hanks cysteine (HC), E-64 1600µM, 
PLS 1500µM+1mM HC+E-64 1600 µM, PLS 1500µM+1mM HC (3 replicates per treatment n=3) and 
incubated at 37¡C for 2hrs. During this period their motility was recorded every 15min using a semi-
objective scale of 0-5 (see Chapter 2). Data were analysed using SPSS software. 
 
4.2.1.2 Results 
There was a reduction of motility in the worms incubated in either PLS alone or PLS +1mM HC (see 
Fig 4.1) compared to the other control groups and this was totally inhibited in the presence of E-64. In a 
3-way rmGLM with time as the within subject factor and presence/absence of PLS and cysteine as 
between subject factors, the main effect of PLS was hugely significant (F1,8=4900, P<0.001). The main 
effects of cysteine, however, was not significant (F1,8=1.778, P=0.219) and there was no significant 
interactions between PLS and cysteine (F1,8=0.444, P=0.524). In a second rmGLM the effect of 
PLS+cysteine was compared to that of PLS+cysteine+E-64 and the main effect of presence/absence of 
E-64 was highly significant (F1,4=3267, P<0.001). E-64 alone had no effect on the motility of H. 
diminuta (rmGLM comparing motility in the control treatment of HanksÕs alone with HanksÕ+ E-64; 
F1,4=0.2, P=0.678). 
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Fig 4.1 The effects of PLS, cysteine & E-64 on cestode motility 
 Motility of adult H. diminuta exposed to 1500µM PLS in an experiment incorporating the 
presence/absence of CP (PLS), the activator cysteine and the inhibitor E-64. The concentration of active 
CP expressed in µM is the molar equivalent of the inhibitor E-64 used to block active CP in a 10µl 
volume in a titration assay (see chapter 2). Error bars represent the standard error of the mean (n=3). 
4.2.2 Experiment 2  
 
The efficacy of various CPs against adult H. diminuta in vitro. 
 
4.2.2.1  Experimental design 
Experiment 2 was a series of experiments assessing the efficacy of various CPs against the adult H. 
diminuta in vitro. H. diminuta were sourced from infected male Wistar and male Lister hooded rats 
from Charles River, UK (see Chapter 2). Adult H. diminuta were transferred into various treatment 
wells (1 worm per well) containing CPs of varying active enzyme concentrations as well as controls (3 
replicates per treatment n=3) and incubated at 37¡C for 2hrs. During this period their motility was 
recorded every 15min using a semi objective scale of 0-5 (see Chapter 2). Data were analysed using 
SPSS software and IC50 values were generated using GraphPad Prism 5 software. 
 
4.2.2.2 Results 
In all CPs tested the motility of adult H. diminuta was rapidly reduced in the presence of higher 
concentrations of active CPs, but more gradually in the presence of moderate concentrations of active 
CPs (see Figs 4.2 A-D). Pineapple extract, PLS, papain and stem bromelain each caused a significant 
reduction in motility which in all cases was both time      ( F8,80 = 18.48  P<0.001; F8,112 = 105.852  
P<0.001 ; F8,96 = 24.674  P<0.001 and F8,112 = 51.307  P<0.001, respectively)  and concentration ( F4,10 
= 159.815  P<0.001; F6,14 = 68.494  P<0.001; F5,12 = 31.995  P<0.001 and F6,14 = 72.023  P<0.001, 
respectively) dependant. Motility however, was relatively preserved when worms were incubated in the 
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presence of low concentrations of active CPs or in the control solutions of HanksÕ saline with or 
without cysteine and also in the presence of CP pre-treated with E-64 (see Fig 4.2 A-D). Although all 
CPs tested were efficacious, efficacy varied between the enzymes with pineapple extract being most 
efficacious at IC50 of 199µM and stem bromelain being the least efficacious with 1C50 of 1374µM (see 
Fig 4.3 & Table 4.1). 
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Fig 4.2 Motility of adult H. diminuta in various CPs in vitro 
Motility of adult  H. diminuta  incubated in various CPs in vitro (A) pineapple extract (B) PLS (C) 
papain (D) stem bromelain. The concentration of active CP expressed in µM is the molar equivalent of 
the inhibitor E-64 used to block active CP in a 10µl volume in a titration assay (see chapter 2). Error 
bars represent the standard error of the mean (n=3). 
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Fig 4.3 Concentration-inhibition curves of the efficacy of various CPs against adult  H. diminuta in 
vitro.  
The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10µl volume in a titration assay (see chapter 2). Error bars represent the standard 
error of the mean (n=3). 
 
Table 4.1 IC50 values of various CPs against adult H. diminuta in vitro. 
CP IC50(µM)* 
Pineapple extract 199 
PLS 818 
papain 892 
Stem bromelain 1374 
* The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10µl volume in a titration assay (see chapter 2) 
 
4.2.3 Experiment 3 
 
Observation of CP mediated damage under scanning electron microscopy (SEM) 
 
4.2.3.1  Experimental design 
Following the promising results from Experiments 1&2, Experiment 3 comprised a series of 
experiments to document visually the effects of CPs on H. diminuta in vitro through scanning electron 
microscopy. Adult H. diminuta were obtained from infected male Wistar and male Lister hooded rats 
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purchased from Charles River, UK. Worms (3 worms per well) were incubated either in PLS 1500µM. 
papain 1500µM, pineapple extract 300 µM, stem bromelain 2000µM or HanksÕ saline at 37¡C. At 
timely intervals, one worm was removed, fixed in glutaraldehyde, stained in osmium tetraoxide, 
dehydrated in ethanol, critically point dried, gold coated and viewed under scanning electron 
microscopy (see Chapter 2 for further details of the methods used). 
 
4.2.3.2 Results 
There were progressive changes on the cestode tegument in worms incubated in PLS, papain & stem 
bromelain. The changes were in the form of blunting of the proglottid edges and a generalised eroded 
appearance apparent even at 10min post incubation albeit very superficial in nature (Fig 4.4 B,F&N). 
After 20min there was deeper erosion (Fig 4.4 C,G&O). After 60min post incubation the erosion 
became so extensive exposing the internal proglottid contents (Fig 4.4 D,H&P). Worms incubated in 
pineapple extract, however, showed different changes on the tegument albeit the presence of similar 
very superficial erosions was still apparent. At 10min post incubation there was formation of transverse 
wrinkling (Fig 4.4 J). At 20min post incubation there was only very superficial erosion and blunting of 
the proglottid edges (Fig 4.4 K). At 60 min post incubation apart from extensive transverse wrinklings 
and blunted proglottid edges there were also pockets which appeared to be fluid filled blebs at the 
wormÕs right flank (Fig 4.4 L). The worms incubated in HanksÕ saline, however, did not show any 
significant change on the tegument  surface even after 60min of incubation (Fig 4.4 R). When imaging 
was focused on the wormÕs scolex there was similar progressive erosion but this was comparatively less 
intense (Figs 4.5 B-D). 
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              0min                                   10min                                  20min                                   60min 
Fig 4.4 SEM images of adult H. diminuta in various CPs  
Adult H. diminuta incubated in various CPs in vitro. A-D; in PLS1500µM+1mM HC, E-H; in papain 
1500 µM+1mM HC, I-L; in pineapple extract 300µM+1mM HC, M-N; in stem bromelain 
2000µM+1mM HC,  Q-R; in HanksÕ saline. At specific time intervals worms were removed fixed in 
glutaraldehyde, stained in osmium tetraoxide, dehydrated in ethanol, gold coated and viewed under 
scanning electron microscope (see chapter 2). The concentration of active CP expressed in µM is the 
molar equivalent of the inhibitor E-64 used to block active CP in a titration assay (see chapter 2). Scale 
bars =100 µm. 
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              0min                                      10min                                    20min                                       60min 
Fig 4.5 SEM images of adult H. diminuta scolex in PLS 
Adult H. diminuta incubated in PLS in vitro focusing on the scolex only. A-D; in PLS 1500µM+1mM 
Hanks; E-F in HanksÕ saline. At specific time intervals worms were removed fixed in glutaraldehyde, 
stained in osmium tetraoxide, dehydrated in ethanol, gold coated and viewed under scanning electron 
microscope. Note the progressive erosion of the scolex tegument and the collapse of the globular shape 
by 60min while the scolex is perfectly preserved in HanksÕ saline even after 60min. The concentration 
of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to block active CP in a 
10µl volume in a titration assay (see chapter 2). Scale bars =10µm. 
 
4.2.4 Experiment 4 
 
Observation of CP mediated damage under transmission electron microscopy (TEM) 
 
4.2.4.1  Experimental design 
Following the results from Experiment 3, where tegumental damage was observed in worms incubated 
in CPs, it was felt important to also document the events occurring within the worm through cross 
sectional images captured by transmission electron micrography. Adult H. diminuta were obtained from 
infected male Wistar rats purchased from Charles River, UK. Worms were incubated in PLS 1000µM 
at 37¡C. At specific timely intervals, 1 worm was removed, fixed in glutaraldehyde, stained in osmium 
tetraoxide, embedded in plastic, ultrathin cross sections cut, stained in uranyl acetate and viewed under 
transmission electron microscope. 
 
4.2.4.2  Results 
There was formation of vacuoles at the subtegumental layer after 10min incubation in PLS (see Fig 
4.6B). It was also noted that the thin top layer coating the brush border had also disappeared (see Fig 
4.6B). After 20min there was increased formation of vacuoles and the brush border layer started to 
become irregular and less dense (Fig 4.6C). After 60min however, there were no more vacuoles seen in 
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the subtegumental layer and the brush border layer have become regular again but still devoid of the 
thin top layer (Fig 4.6D). The control worm incubated in HanksÕ saline still retains all the exact 
morphology seen earlier at 0min (Figs 4.6E&F). 
               0min                                    10min                                   20min                                        60min 
Fig 4.6 TEM images of adult H. diminuta in PLS  
Transmission electron micrograph images of adult H. diminuta incubated in PLS in vitro. A-D; in 
1000µM PLS, E-F; HanksÕ saline. At specific time intervals worms were removed fixed in 
glutaraldehyde, stained in osmium tetraoxide, embedded in plastic, ultra-thin cross sections cut, stained 
in uranyl acetate and lead citrate and viewed under transmission electron microscope. The 
concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10µl volume in a titration assay (see chapter 2). Scale bars = 2µm. 
 
4.2.5 Experiment 5 
 
The efficacy of various CPs against adult H. microstoma in vitro. 
 
4.2.5.1  Experimental design 
Following the promising results from Experiments 1-4 using the rat cestode H. diminuta it was also 
important to establish whether or not other cestode species are affected and to the same extent. 
Experiment 5 was a series of experiments assessing the efficacy of various CPs against the mouse 
cestode H. microstoma in vitro. H. microstoma were obtained from infected male BKW mice from B & 
K, UK and male C3H mice from Harlan, UK (see Chapter 2). Adult H. microstoma were transferred 
into various treatment wells (1 worm per well) containing CPs of varying concentrations of active 
enzymes as well as controls (3 replicates per treatment n=3) and incubated at 37¡C for 2hrs. During this 
period their motility was recorded every 15min using a semi objective scale of 0-5 (see Chapter 2). 
Data were analysed using SPSS software and IC50 values were generated using GraphPad Prism 5 
software. 
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4.2.5.2 Results 
In all CPs tested the motility of adult H. microstoma was reduced rapidly in the presence of higher 
concentrations of active CPs, but more gradually in the presence of moderate concentrations of active 
CPs (see Figs 4.7 A-D). Pineapple extract, PLS, papain and stem bromelain each caused a significant 
reduction in motility which in all cases was both time      ( F8,104 = 132.812  P<0.001; F6.883,96.365 = 
38.006  P<0.001; F5.811,69.734 = 79.233  P<0.001 and F8,112 = 38.426  P<0.001, respectively) and 
concentration ( F4,13 = 232.316  P<0.001; F6,14 = 95.017  P<0.001; F5,12 = 99.834  P<0.001 and F6,14 = 
132.113  P<0.001 , respectively ) dependant. However, motility was relatively preserved when worms 
were incubated in the presence of low concentrations of active CPs or in the control solutions of HanksÕ 
saline with or without cysteine and even in the presence of CP pre-treated with E-64 (see Fig 4.7 A-D). 
Although all CPs tested were efficacious, efficacy varied between the enzymes with pineapple extract 
being most efficacious at IC50 of 260µM and stem bromelain being the least efficacious with 1C50 
1451µM (see Fig 4.8 &Table 4.2). 
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Fig 4.7 Motility of adult H. microstoma in various CPs in vitro 
Motility of adult  H. microstoma  incubated in various CPs in vitro (A) pineapple extract (B) PLS (C) 
papain (D) stem bromelain. The concentration of active CP expressed in µM is the molar equivalent of 
the inhibitor E-64 used to block active CP in a titration assay (see chapter 2).Error bars represent the 
standard error of the mean (n=3). 
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Fig 4.8 Concentration-inhibition curves of the efficacy of various CPs against adult  H. microstoma in 
vitro. 
The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10µl volume in a titration assay (see chapter 2). Error bars represent the standard 
error of the mean (n=3). 
 
Table 4.2 IC50 values of various CPs against adult H. microstoma in vitro. 
CP IC50(µM)* 
Pineapple extract 260 
PLS 1107 
papain 1172 
Stem bromelain 1451 
* The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10µl volume in a titration assay (see chapter 2).  
 
4.2.6 Experiment 6 
 
Observation of CP mediated damage against H. microstoma in vitro. 
 
4.2.6.1  Experimental design 
Experiment 6 was an experiment to document visually the effects of CPs on H. microstoma in vitro 
through scanning electron microscopy. Adult H. microstoma were obtained from infected male C3H 
mice from Harlan, UK. Following the results from Experiment 3 where H. diminuta was incubated in 
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1500 µM which resulted in extensive tegumental erosions it was decided that in this experiment a lower 
dose would be used and hence worms were incubated in PLS 1000µM at 37¡C. At timely intervals, one 
worm was removed, fixed in glutaraldehyde, stained in osmium tetroxide, dehydrated in ethanol, 
critically point dried, gold coated and viewed under scanning electron microscopy. 
 
4.2.6.2 Results 
There were progressive changes seen on the tegumental surface starting from blunting of proglottids 
seen at 10min post incubation (see Fig 4.9B). At 20min a generalised superficial eroded appearance 
was apparent (see Fig 4.9C). At 60min there was marked generalised erosion and at certain point there 
was tegumental discontinuity and the outpouring of internal contents (Fig 4.9D). The worms incubated 
in HanksÕ saline however maintained the same appearance even after 60min with sharp proglottid edges 
and a smooth tegumental surface (see Fig 4.9E&F). 
                 0min                                    10min                                    20min                                      60min 
Fig 4.9 SEM images of adult H. microstoma in PLS 
Adult H. microstoma incubated in PLS 1000µM+1mM HC (A-D) and Hanks saline (E-F). At specific 
time intervals worms were removed fixed in glutaraldehyde, stained in osmium tetroxide, dehydrated in 
alcohol, gold coated and viewed under scanning electron microscope (see chapter 2). The concentration 
of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to block active CP in a 
10µl volume in a titration assay (see chapter 2). Scale bars represent 100µm. 
 
Effect of CPs against juvenile stages of cestodes 
 
4.2.7 Experiment 7 
 
The efficacy of various CPs against juvenile H. diminuta in vitro. 
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4.2.7.1  Experimental design 
Behnke et al. (2008) reported on the basis of unpublished results that juvenile free-living -stages of H. 
bakeri were not affected by CPs. Hence it was relevant here  to assess whether or not juvenile cestodes 
are affected by CPs. Experiment 7 was a series of experiments assessing the efficacy of various CPs 
against the juvenile artificially excysted H. diminuta in vitro. H. diminuta cysticercoids were obtained 
from infected T. confusum beetles maintained at the University of Nottingham. Dissected cysticercoids 
were artificially hatched following a protocol (Goodchild and Davis, 1972) (see Chapter 2 & Fig 
4.10A-D). Fully evaginated scoleces (1 worm per well) were then transferred into various treatment 
wells containing CPs of varying concentrations of active enzymes as well as controls (3 replicates per 
treatment n=3) and incubated at 37¡C for 2hrs. During this period their motility was recorded every 
15min using a semi objective scale of 0-3 (see Chapter 2). Data were analysed using SPSS software and 
IC50 values were generated using GraphPad Prism 5 software. 
 
Fig 4.10 Artificial excystation of cestodes in vitro 
The sequential process of artificial excystation of cysticercoids in vitro; H. diminuta (A-D); H. 
microstoma (E-I). (A&E) Freshly dissected cysticercoids from T. confusum incubated in HanksÕ saline. 
(B&F) cysticercoids incubated in acid-pepsin solution (C&H) cysticercods incubated in trypsin-bile 
solution with emerging scolex (D&I) Free scoleces. The concentration of active CP expressed in µM is 
the molar equivalent of the inhibitor E-64 used to block active CP in a 10µl volume in a titration assay 
(see chapter 2). Scale bars represent 61µm. 
 
4.2.7.2 Results 
In all CPs tested the motility of artificially excysted H. diminuta scoleces were rapidly reduced in the 
presence of higher concentrations of active CPs, but more gradually in the presence of moderate 
concentrations of active CPs (see Figs 4.11 A-D). Pineapple extract, PLS, papain and stem bromelain 
each caused a significant reduction in motility which in all cases was both time ( F5.54,55.402 = 28.139  
P<0.001; F8,128 = 42.996  P<0.001; F8,128 = 24.35  P<0.001 and F8,128 = 16.82  P<0.001, respectively ) 
and concentration ( F4,10 = 321.719  P<0.001; F7,16 = 111.516  P<0.001, F7,16 = 30.154  P<0.001 and 
F7,16 = 23.672  P<0.001, respectively) dependant. Motility, however, was relatively preserved when 
artificially excysted scoleces were incubated in the presence of low concentrations of active CPs or in 
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the control solutions of HanksÕ saline with or without cysteine and even in the presence of CP pre-
treated with E-64 (see Figs 4.11 A-D). Although all CPs tested were efficacious, efficacy varied with 
pineapple extract being most efficacious at IC50 of 63µM and stem bromelain being the least efficacious 
with 1C50 2843µM (see Fig 4.12 & Table 4.3). 
 
Fig 4.11Motility of juvenile H. diminuta in various CPs in vitro 
Motility of artificially excysted  H. diminuta  incubated in various CPs in vitro (A) pineapple extract 
(B) PLS (C) papain (D) stem bromelain. The concentration of active CP expressed in µM is the molar 
equivalent of the inhibitor E-64 used to block active CP in a 10µl volume in a titration assay (see 
chapter 2). Error bars represent the standard error of the mean (n=3). 
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Fig 4.12 Concentration-inhibition curves of the efficacy of various CPs against artificially excysted  H. 
diminuta in vitro.  
The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10µl volume in a titration assay (see chapter 2). Error bars represent the standard 
error of the mean (n=3). 
 
Table 4.3 IC50 values of various CPs against artificially excysted  H. diminuta scoleces in vitro. 
CP IC50(µM)* 
Pineapple extract 63 
PLS 1283 
papain 2727 
Stem bromelain 2843 
* The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10µl volume in a titration assay (see chapter 2).  
 
4.2.8 Experiment 8 
 
Observation of CP mediated damage against juvenile H. diminuta under light microscopy 
 
4.2.8.1  Experimental design 
Following the results from Experiment 7, Experiment 8 was designed to document visually the events 
taking place when artificially excysted H. diminuta scoleces are incubated in CPs. H. diminuta 
cysticercoids were obtained from infected T. confusum beetles maintained at the University of 
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Nottingham. Dissected cysticercoids were artificially hatched following the  protocol described by 
(Goodchild and Davis, 1972) (see Chapter 2 for full details & Figs 4.10A-D). Fully evaginated scoleces 
(1 worm per well) were then transferred into either a well containing PLS 1500µM+1mM HC, 
pineapple extract 300 µM+1mM HC, papain 1500µM+1mM HC, stem bromelain 2000µM+1mM HC 
or HanksÕ saline. At specific time intervals worms were photographed under light microscopy at a 
magnification of  x20. 
 
4.2.8.2 Results 
After 1 hour of incubation in active CPs, there were notable changes in worm morphology  with 
apparent ballooning of the distal end of worms incubated in PLS, papain and stem bromelain (see Figs 
4.13B,H & K). The worm incubated in pineapple extract however appeared to have shrunk and 
contracted (Fig 4.13E). After 2 hours the worm incubated in PLS appeared to be partially digested (see 
Fig 4.13C). The worm incubated in pineapple extract remained unchanged in the contracted state 
observed after 1hr (see Fig 4.13F). The worm incubated in papain appeared to develop shrinkage of the 
middle and caudal section (see Fig 4.13I). The worm incubated in stem bromelain appeared to develop 
another ballooning in the middle section (see Fig 4.13L). There were no significant changes in 
morphology seen in the worm incubated in HanksÕ saline (see Fig 4.11E) 
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                   0min                                                      60min                                                      120min 
Fig 4.13 Light microscopy images of juvenile H. diminuta in various CPs 
Artificially excysted H. diminuta scoleces incubated in PLS 1500µM+1mM HC (A-C), pineapple 
extract 300 µM+1 mM HC (D-F), papain 2000 µM+1mM HC (G-I), stem bromelain 2000 µM +1mM 
HC (J-L) and HanksÕ saline (M-N) in vitro. The concentration of active CP expressed in µM is the 
molar equivalent of the inhibitor E-64 used to block active CP in a 10 µl volume in a titration assay (see 
chapter 2). Scale bars = 61 µm. 
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4.2.9 Experiment 9 
 
The efficacy of various CPs against juvenile H. microstoma in vitro. 
 
4.2.9.1  Experimental design 
Experiment 9 was a series of experiments assessing the efficacy of various CPs against the juvenile 
artificially excysted H. microstoma in vitro. H. microstoma cysticercoids were ontained from infected 
T. confusum beetles maintained at the University of Nottingham. Dissected cysticercoids were 
artificially hatched following the protocol described in Chapter 2(Goodchild and Davis, 1972). Fully 
evaginated scoleces (1 worm per well) were then transferred into various treatment wells containing 
CPs of varying concentrations of active enzymes as well as controls (3 replicates per treatment n=3) 
and incubated at 37¡C for 2hrs. During this period their motility was recorded every 15min using a 
semi objective scale of 0-3 (see Chapter 2). Data were analysed using SPSS software and IC50 values 
were generated using GraphPad Prism 5 software. 
 
4.2.9.2 Results 
In all CPs tested the motility of artificially excysted H. microstoma scoleces were rapidly reduced in the 
presence of higher concentrations of active CPs, but more gradually in the presence of moderate 
concentrations of active CPs (see Figs 4.14 A-D). Pineapple extract, PLS, papain and stem bromelain 
each caused a significant reduction in motility which was both time ( F7.407,74.066 = 32.326  P<0.001;  
F7.88,126.086 = 38.692  P<0.001, F8,128 = 21.683  P<0.001 and  F8,128 = 20.896  P<0.001, respectively) and 
concentration ( F4,10 = 106.278  P<0.001; F7,16 = 180.025  P<0.001 ; ( F7,16 = 14.21  P<0.001and F7,16 = 
27.028  P<0.001, respectively) dependant. However, motility, was relatively preserved when artificially 
excysted scoleces were incubated in the presence of low concentrations of active CPs or in the control 
solutions of HanksÕ saline with or without cysteine and even in the presence of CP pre-treated with E-
64 (see Figs 4.14 A-D). Although all CPs tested were efficacious, efficacy varied with pineapple extract 
being most efficacious at IC50 of 74µM and stem bromelain being the least efficacious with 1C50 2339 
µM (see Fig 4.15 & Table 4.4). 
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Fig 4.14 Motility of juvenile H. microstoma in various CPs in vitro 
Motility of artificially excysted  H. microstoma  incubated in various CPs in vitro (A) pineapple extract 
(B) PLS (C) papain (D) stem bromelain. The concentration of active CP expressed in µM is the molar 
equivalent of the inhibitor E-64 used to block active CP in a 10µl volume in a titration assay (see 
chapter 2). Error bars represent the standard error of the mean (n=3). 
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Fig 4.15 Concentration-inhibition curves of the efficacy of various CPs against artificially excysted  H. 
microstoma in vitro.  
The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the standard 
error of the mean (n=3). 
 
Table 4.4 IC50 values of various CPs against artificially excysted  H. microstoma scoleces in vitro. 
CP IC50(µM)* 
Pineapple extract 74 
PLS 984 
papain 2264 
Stem bromelain 2339 
* The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a titration assay (see chapter 2).  
 
4.2.10 Experiment 10 
 
Observation of CP mediated damage against juvenile H. microstoma under light microscopy 
 
4.2.10.1 Experimental design  
Following the results from Experiment 9, Experiment 10 was designed to document visually the events 
taking place when artificially excysted H. microstoma scoleces are incubated in CPs. H. microstoma 
cysticercoids were obtained from infected T. confusum beetles maintained at the University of 
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Nottingham. Dissected cysticercoids were artificially hatched following the  protocol described in 
Chapter 2 (Goodchild and Davis, 1972). Fully evaginated scoleces (1 worm per well) were then 
transferred into either a well containing PLS 1500µM+1mM HC, pineapple extract 300 µM+1mM HC, 
papain 1500µM+1mM HC, stem bromelain 2000µM+1mM HC or HanksÕ saline. At specific time 
intervals worms were photographed under light microscopy at a magnification of x20. 
 
4.2.10.2  Results 
After 1 hour of incubation in active CPs, there were notable changes in worm morphology  with 
apparent shrinkage of worms incubated in PLS, papain and stem bromelain (see Figs 4.16B,H & K). 
The worm incubated in pineapple extract however appeared to be shortened and contracted (Fig 4.16E). 
After 2 hours the worm incubated in PLS appeared to be extensively digested (see Fig 4.16C). The 
worm incubated in pineapple extract appeared to remain similar in a shortened and contracted state 
similar to that observed at 1hr (see Fig 4.16F). The worm incubated in papain appeared to develop 
ballooning of its caudal section (see Fig 4.16I). The worm incubated in stem bromelain appeared to 
develop marked shrinkage of its middle and caudal section (see Fig 4.16L). There was no significant 
changes in morphology seen in the worm incubated in HanksÕ saline (see Fig 4.16N). 
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                0min                                                60min                                                   120min                  
Fig 4.16 Light microscopy images of juvenile H. microstoma in various CPs 
Artificially excysted H. microstoma scoleces incubated in PLS 1500µM+1mM HC (A-C), pineapple 
extract 300µM+1mM HC (D-F), papain 2000 µM+1mM HC (G-I), stem bromelain+1mM HC (J-L) and 
HanksÕ saline (M-N) in vitro. The concentration of active CP expressed in µM is the molar equivalent 
of the inhibitor E-64 used to block active CP in a 10 µl volume in a titration assay (see chapter 2). Scale 
bars = 61µm. 
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4.3 Discussion 
Although some preliminary reports of the in vitro effects of CPs against cestodes have been published 
(He et al., 1992; Stepek et al., 2007e) these were either very brief one-off experiments or the effects 
were never confirmed sufficiently thoroughly, as had been done  earlier for nematodes (Stepek et al., 
2005). As in nematodes (Stepek et al., 2005), a marked reduction in motility of cestodes exposed to 
CPs  was observed here and shown to be mediated by CPs, because worms incubated in CPs pre-treated 
with E-64 were not affected (Experiment 1). Moreover, the main effects of CP on worm motility were 
statistically significant while E-64 on its own or in combination with CPs did not reduce worm motility. 
Although CPs have been shown to affect various adult nematode species (Stepek et al., 2005; Stepek et 
al., 2006b, 2007b, e) they were not effective against the juvenile stages of H. bakeri (Behnke et al., 
2008) but did affect some juvenile plant nematode species (Stepek et al., 2007a). This suggests that the 
efficacy of CPs could be wider than previously thought and perhaps with further testing and 
improvements in drug formulation and delivery even nematode juvenile stages may eventually prove to 
be susceptible to better formulations of CPs. Data from this chapter have shown clearly that the efficacy 
of CPs are not limited to nematodes. CPs, whether naturally occurring like PLS and pineapple extract, 
or commercially available purified CPs such as papain and stem bromelain caused a significant 
reduction in motility leading to death of the worms in both rodent cestode models, and in each case 
irrespective of whether the worms were juveniles or adults. The reduction in motility on exposure to 
active CPs was also concentration dependant (Experiments 2,5,7&9) which is similar to the observation 
made on nematodes (Stepek et al., 2005).  
However, there was a striking difference between our observations on cestodes and earlier published 
reports on nematodes in that the reduction in motility mediated by CPs against cestodes were 
independent of the presence of the exogenous CP activator cysteine, whilst inclusion of cysteine was 
crucial in the case of all the nematodes studied to-date (Stepek et al., 2005). Cysteine acts as a reducing 
agent and the active site on CPs needs to be activated through reduction before the enzyme can digest 
its target molecules (Chapman et al., 1997). Therefore, a possible explanation for this difference 
between cestodes and nematodes,  the ability of CPs to still mediate damage to the tegument of cestodes 
independently of the presence of cysteine is perhaps because of the properties of the cestode tegument 
which differs fundamentally from the nematode cuticle in its structure and component composition. 
Perhaps through its excretory process, via the tegument, cestodes may be excreting some form of 
reducing agent that in turn activates CPs by donating electrons. 
Various CPs have been screened  for their efficacy  against H. bakeri (a convenient and sensitive rodent 
nematode model system) in vitro ranging from naturally occurring CPs like crude papaya latex, 
pineapple extract, kiwifruit extract and milkweed latex to purified commercially available CPs like 
ficin, papain, chymopapain and stem bromelain (Stepek et al., 2005). The efficacy of various CPs 
against H. bakeri varied considerably with the purified enzymes like papain and chymopapain ranking 
as the most efficacious compared to naturally occurring CPs such as crude papaya latex and pineapple 
extract, while kiwifruit extract was not efficacious at all (Stepek et al., 2005). An interesting aspect of 
the current results is that a different hierarchy of efficacy has been observed here for cestodes.  When 
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all the experiments in this chapter were compared it was shown clearly that irrespective of whether  
adult or juvenile stages were tested, the naturally occurring CPs such as those in pineapple extract and 
PLS were more efficacious than purified enzymes such as papain and stem bromelain. Commercially 
available purified enzymes are singular CPs while naturally occurring CPs contain a combination of 
more than one CP. For example papaya latex contains papain, chymopapain, glycyl endopeptidase and 
caricain while pineapple extract contains fruit bromelain, ananain and comosain. It is possible that the 
naturally occurring CPs work in synergy resulting in greater efficacy as compared to singular CPs 
working individually. A similar phenomenon was also observed in vivo when crude papaya latex was 
found to be more efficacious than papain in reducing H. bakeri burdens in mice (Stepek et al., 2007d). 
Kundu and Lyndem (2012) in screening the efficacy of several species of Cassia plant extracts against 
the poultry cestode R. tetragona observed that worms exposed to a combination of several species of 
cassia extracts resulted in greater efficacy and damage to the worms compared to singular species 
exposure. However, at present it is not fully understood as to why purified enzymes were more 
efficacious against H. bakeri in vitro compared to naturally occurring CPs. Perhaps it was the time 
point at which efficacy was determined by Stepek et al. (2005) who utilised  IC50 values derived at 
90min post incubation in CPs while in all my experiments I derived IC50 values at 30min post 
incubation because the longer the incubation time the more likely that other factors might be 
influencing the worms such as changes in the osmolarity of the incubation medium for example. Had I 
chosen a time point earlier than 30min, the effects might not have been so obvious between the 
different concentrations of active enzymes. It was evident in both rodent cestodes and in both adult and 
juvenile stages tested that pineapple extract was most efficacious (see tables 4.1-4.4) and this was 
followed by PLS, the purified enzyme papain and stem bromelain were the least efficacious (see tables 
4.1-4.4). It is quite obvious that there was a considerable gap between the efficacy of pineapple extract 
and the other enzymes tested although this was not reflected proportionately by the apparent damage 
inflicted upon the tegument. In fact, the effects of pineapple extract on the tegument were different both 
in appearance under SEM and perhaps also with respect to the mechanistic basis. There appeared to be 
no marked tegumental erosions (Figs 4.4 J-L) as was observed in worms incubated in other CPs such as 
PLS (Figs 4.4 B-D), papain (Figs 4.4F-H) and stem bromelain (Fig 4.4N-P). Firstly, the pineapple 
extract which was used in this chapter was not extracted using the more common method which is 
through precipitation by acetone or ammonium sulphate. This is because in pilot attempts, both 
extraction methods yielded low concentrations of active CPs (results not shown). Hence the extraction 
process was stopped short after juicing and concentrating the fruit (see Chapter 2) to get the maximum 
amount of active CPs (300µM in the neat stock).While this amended protocol resulted in greater yield 
of active CPs it did nevertheless result in a less purified extract possibly containing other components 
of pineapple fruit as for example, sugars and minerals.  
One particular component of interest is calcium as pineapples contain a high percentage of this element 
(Bartolom et al., 1995). Worms exposed to pineapple juice appeared contracted on light microscopy 
(results not shown) and showed blebs resembling the tegumental changes described in cestodes 
incubated in praziquantel (Becker et al., 1981) which is the treatment drug of choice in most 
platyhelminth infection (Mansour, 2002). Praziquantel is thought to affect platyhelminth tegument by 
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disrupting calcium channels allowing calcium influx causing muscle contraction (Tallima and El Ridi, 
2007b). Perhaps in similitude the CPs in pineapple extract may have also affected the tegument 
disrupting calcium channels allowing calcium influx evident by very superficial erosions appearing 
only after 20mins of incubation (Figs 4.4 K-L). This limited erosion is perhaps proportionate to the 
amount of active enzymes present in this particular pineapple extract stock used (300µM) because the 
extensive erosions seen in worms incubated in other CPs like PLS, papain and stem bromelain correlate 
to much higher concentrations of active CPs (5-7x more). This idea may be supported by the fact that 
purified stem bromelain which is also a CP from the pineapple plant exerted similar tegumental 
erosions comparable to PLS and papain without the contraction and other Ôpraziquantel- likeÕ changes. 
Therefore, it can be hypothesized that if one was able to perform a more efficient extraction, yielding 
pure pineapplefruit CPs, only at much higher concentrations of active CPs, the resultant effect on the 
worms may be comparable to the other CPs tested in this chapter. Since the high efficacy of pineapple 
extract in this case cannot be attributable to CPs alone, it is safer to exclude this particular CP variant 
from further tests like in vivo experiments. In fact this particular pineapple extract have been tested 
twice in vivo against H. bakeri in the mouse (a very sensitive system) and also against T. colubriformis 
and H. contortus in sheep (unpublished work) and in each case it failed to reduce worm burdens.  
Although the efficacy of different types of CPs against the same cestode varied, it did not differ 
substantially between the 2 different rodent cestodes tested in this chapter, whether adults or juvenile 
stages, and was comparable in both worms (Tables 4.1&4.2 for adult stage Tables 4.3&4.4 for juvenile 
stage) albeit with slightly more efficacy against H. diminuta . This came as a welcomed surprise since  
H. microstoma has been reported to be resistant to benzimidazoles (McCracken et al., 1992). Although 
there was no substantial difference in the efficacy of CPs between the two different rodent cestodes, 
there was however a difference in the efficacy of CPs against the equine cestode A. perfoliata (Chapter 
8) in which PLS was about 4x more efficacious. This was thought to be due to the relative shorter 
length of A. perfoliata.  
However, there was a difference seen between the results from the experiments with adult worms and 
the juvenile worms in that whilst the efficacy differed between naturally occurring CPs and purified 
CPs when adult worms were tested, despite the difference in efficacy the range was quite narrow (tabs 
4.1-4.2). For example, the IC50 values for PLS, papain and stem bromelain against adult H. microstoma 
were 1107, 1172 and 1451, respectively. In contrast when juvenile worms were tested the range of 
efficacy was much wider as for example 984, 2264 and 2339, respectively. There seemed to be a wider 
range of efficacy with purified CPs and naturally occuring CPs when tested against juvenile worms 
suggesting that the juvenile worms are more resistant to singular purified CPs but were comparably 
susceptible to naturally occurring CPs. This is perhaps because juvenile artificially excysted worms has 
not yet attained a strobila where most of the damage was seen to occur on adult worms. The adult worm 
scolex although affected by CPs (Figs 4.5 B-D) was comparatively less affected than its strobilar 
segments. This relative resistance of the scoleces to digestion by CP is in some ways reminiscent of the 
known resistance of tapeworm scoleces to immune attack. When worms are subjected to immune 
attack, they destrobilate (Befus and Featherston, 1974) and the scoleces alone survive until the adverse 
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conditions in the intestinal environment subside and the physiology returns to normal, when the 
surviving scoleces then proceed to re-grow a new strobila.   
In the case of resistance to CPs it is possible that there is a deficiency of CP target proteins in cestode 
scoleces, which are otherwise present in abundance on the strobila. This assumption, however, will 
need to be explored and verified by protein studies. This possible explanation may also be reinforced by 
the observation that damage in juvenile worms was more pronounced after 2hrs of incubation (Fig 4.13 
& 4.16) whereas extensive damage had already affected adult worm strobila even at 20min incubation 
in the same concentrations of active PLS (Figs 4.4 C). These observations are quite different from the 
observations seen with praziquantel which has a predilection for the neck region, while the strobila 
remains unaffected (Becker et al., 1981). Apart from this, the type of tegumental damage exerted by 
CPs is unique because it appears to erode the tegument hydrolysing certain proteins. This observation 
most certainly concurs with the observations made on nematodes where CPs digest the hard cuticle 
resulting in the bursting of internal contents due to high internal hydrostatic pressure (Behnke et al., 
2008). Most conventional cestocidals however appear to attack the tegument from the inside out. 
Praziquantel for example disrupts ion channels allowing permeability of elements causing blebbing, 
that finally bursts the worms (Mansour, 2002) which is also similar to the consequences of exposure to 
niclosamide (Kumchoo et al., 2007). Benzimidazoles also result in similar tegumental changes but in 
this case as a result of disruption of the microtubule dependant transport system (Schmidt, 1998b).   
The events observed cross-sectionally  within the tegument through TEM (Figs 4.6B-C) however, are 
quite similar to other cestocidals, as most have reported an increase in the formation of vacuoles and 
vesicles and disruption in the glycocalyx outer layer (Becker et al., 1981; Mansour, 2002; Schmidt, 
1998b). Schmidt (1998b) proposed that the vesicles may be transporting materials needed to synthesize 
and replenish the disrupted or lost glycocalyx layer. On a quick glance the appearance of tegument after 
60min post incubation in PLS (Fig 4.6D) appeared to contradict the extensive damage seen in SEMs. 
On careful consideration, however, the TEM studies were focusing on the outermost layer at a much 
smaller scale (2µm) since the tegument is almost like a cell membrane while most SEM studies were 
captured at a larger scale (100µm- 1mm). On closer inspection, despite the generalised normalised 
appearance due to the lack of multiple vesicles and vacuoles seen earlier (10min & 20min), the 
outermost glycocalyx layer coating the brush border appear to have disappeared when compared to the 
control image (Fig 4.6A).  This is perhaps suggestive that this particular image despite my attempt at 
capturing damage exactly where it may have occurred under light microscopy, represented a section of 
the tegument where rapid repair had taken place thus resulting in an otherwise comparatively 
normalized depiction.  
In summary, the results from the experiments described in this chapter indicate that CPs are indeed 
efficacious against cestodes in vitro by significantly reducing their motility leading to the death of the 
worms and the effects were indeed mediated by CPs. Unlike in nematodes CPs are able to exert their 
proteolytic activity against cestodes without the presence of exogenous cysteine. Despite the limited 
nature and the uncertainty surrounding published reports on CP efficacy against juvenile stages of 
helminths, CPs were indeed efficacious against juvenile cestodes. Naturally occurring CPs appeared to 
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be more efficacious than purified CPs. Efficacy also appeared to be dependant upon cestode size since 
there was no obvious difference in efficacy between the 2 rodent cestodes but CP was more efficacious 
against the smaller equine cestode A. perfoliata (Chapter 8). As in nematode cuticles, CPs appeared to 
digest the tegument giving rise to a generalised eroded appearance that was evident from SEM studies 
but which was quite different from the known modes of action of conventional cestocidals.  
  
72 
 
CHAPTER 5 
 
Assessment of the anthelmintic efficacy of cysteine proteinases against H. microstoma in vivo 
 
5.0  Summary  
H. microstoma is a natural parasite of house mice, and provides a convenient model system for the 
assessment of novel drugs for anthelmintic activity against cestodes.  The experiments described in this 
chapter indicate that treatment of mice infected with H. microstoma with PLS is only minimally 
efficacious. The effects seen on worm burdens and worm biomass were only minimally dose 
dependant, not permanent and the role of cysteine proteinases as the active principles in PLS was not 
confirmed by specific inhibition with E-64.Worm fecundity was not affected at all.  
 
5.1  Introduction 
The anthelmintic effects of cysteine proteinases (CPs) against nematodes in vivo have been successfully 
demonstrated in pigs (Satrija et al., 1994) mice (Satrija et al., 1995; Stepek et al., 2006b, 2007b, c) 
sheep (Buttle et al., 2011) and even chickens (Mursof and He, 1991). They also work effectively 
against the 3 major human nematode infections (Hansson et al., 1986). 
In comparison little is known about the effects of CPs on cestode infections. There is some 
evidence that CPs are detrimental to the survival of cestodes in in vitro maintained assays (He et al., 
1992; Stepek et al., 2007e), but data also indicate that this is not reflected in a reduction of parasite 
burdens when CPs are administered to infected hosts (de Amorin et al., 1999; He et al., 1992). Using 
lattices from the fig species of F. insipida and F. carica at 3-4mls/kg/day for 3 days, De Amorin et al. 
1999 failed to demonstrate  a significant reduction of parasites in albino mice infected with H. nana 
(also known as Vampirolepis nana, H. fraterna and Rodentolepis nana; 6.3-8.3%). However, the 
methodology described in this paper was unclear as the worm burdens were expressed as a percentage 
of the wet weight of proglottids found in faeces in relation to total faecal and intestinal proglottids on 
autopsy and dry weight was not assessed. Moreover, quantification of enzyme activity was not carried 
out, which raises the question of enzyme viability. Using young pineapple juice at doses between 0.4-
50%, He et al. (1992) also found no reduction in worm burdens in Swiss white mice infected with H. 
nana. However, the exact methodology applied in this Indonesian paper could not be ascertained as it is 
unavailable in the literature. To date, few results based on well designed in vivo trials have been 
published and whether CPs have in vivo activity against cestodes is still debatable. Nevertheless, it is 
very important to establish whether they are effective against cestodes in vivo, if potential drugs are to 
be taken forward to clinical trials and eventually are to be developed into useful therapeutic agents. 
Three rodent infective cestode model systems are maintained widely (H. microstoma, H. 
diminuta, and H. nana) and have been used extensively to study the biology and host-parasite 
relationships of cestodes (see table 5.1). In my project I have only used the first two species, largely due 
73 
 
to their availability locally, here at Nottingham University. The latter species (H. nana), despite being 
medically important, poses disadvantages in experimental set ups because it has a direct life cycle and 
hence in conventional animal houses there is always a high probability of cross and re-infection, and 
spread throughout the mouse colonies.  
Table 5.1. Similarities and differences between Hymenolepidids* 
Physical 
characteristics 
H.microstoma H.nana H.diminuta 
Length 8-50mm 25-40mm 20-60cm 
width 0.5-4mm 0.25-0.5mm 4mm 
Armed rostellum Yes Yes No 
Ova size ~85 µm ~40 x 50 µm ~70 µm 
Life cycle    
Requires 
intermediate host 
Yes No Yes 
Location in host Bile duct Small intestine 
(posterior section) 
Small intestine 
 
Prepatent period 16-17 days 14-16 days 19-20 days 
*adapted from Fox (2007) 
The first model is the bile duct dwelling mouse tapeworm H. microstoma. This species has 
attracted considerable interest during its classification history since it was first described by Dujardin in 
1845. Much of the confusion about this species is due to the ambiguous use of the generic component 
of its Latin name which has at various times changed from Taenia (Dujardin, 1845) to Rodentolepis 
(Spasskii, 1954) and the more recent Vampirolepis (Schmidt, 1986) . Despite the lack of consensus  and 
apparent plasticity of nomenclature, it is considered best to follow the latest proposal of  Cunningham 
and Olson (2010) who prefer the genus Hymenolepis (Blanchard, 1891) based upon commonality of 
usage, until a convincing molecular based phylogeny is generated. Therefore, the parasite is referred to 
as Hymenolepis microstoma throughout this thesis. 
While it is generally accepted that H. microstoma is specific to the mouse Mus musculus, some 
have reported successful infections in rats (Joyeux and Kobozieff, 1928) and there have also been 
reports of clinical cases (Macnish et al., 2003). However, other workers have reported failure to 
establish infections in rats (Dvorak et al., 1961; Goodall, 1972) and hamsters (Litchford, 1963). H. 
microstoma has an indirect life cycle in which arthropods such as flour beetles (e.g. Tribolium 
confusum) serve as intermediate hosts and autoinfection through eggs is not possible (Dvorak et al., 
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1961). However, experimental direct infections in congenitally athymic mice have been demonstrated 
(Andreassen et al., 2004).  Accidental ingestion of the arthropod host releases dormant cysticercoids 
which excyst in the duodenum and migrate to the bile duct within 4-5 days where they mature and start 
producing eggs 15-16 days post infection (De Rycke, 1966; Moss, 1971).  
The ease of maintaining this species in the laboratory and its practical advantage over H. nana 
makes it a preferable model even to H. diminuta which require costlier maintenance due to its host 
being the rat. Moreover, it is one of the four tapeworm species to have its complete genome 
characterised (Cunningham and Olson, 2010) . Despite all the advantages, it is somewhat challenging 
and intriguing to learn that with respect to anthelmintic susceptibility, H. microstoma has proven to be a 
resilient species. From juvenile cysticercoids in the flour beetle intermediate host (Evans et al., 1979) to 
bile duct dwelling adult worms, all have  shown resilience to benzimidazole based preparations 
(McCracken et al., 1992) compared to the highly susceptible H. diminuta (Coles, 1983) . Exact 
explanations remain elusive but one possibility may be that a large portion of the worm is protected 
from direct contact with drugs passing down the lumen of the intestine, because of its location  higher 
up in the bile duct (McCracken et al., 1992). 
 
Table 5.2. Growth of H.microstoma in M. musculus * 
Days 
p.i. 
Av. 
length(mm) 
Development and position in gut 
1-2 0.25-0.5 no external segmentation or genital system; worms localized in the first 10-20 
cm of the intestine 
3 1.58 some internal segmentation; appearance of genital system; worms localized in 
the first 10 cm of intestine 
4-5 3.4-3.85 external segmentation and male & female genital system discernable; worms 
localized in the bile duct 
6 5.85 testes in few segments 
7 9.15 testes mature 
8 13.5 early-mature to mature proglottids 
9-10 17-20.5 all proglottides mature 
11 27 disappearance of female glands; few pre-oncospheres 
12 36 pre-oncospheres, no hooks 
13 46.5 semi-gravid proglottides 
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14 62.5 near gravid proglottides 
15-16 94-129 gravid proglottides 
*adapted from (Cunningham and Olson 2010) 
 
At the moment, crude coprological methods such as the Macmaster and Kato-Katz are still the 
mainstay in most treatment efficacy monitoring. While these techniques have been shown to be robust 
and accurate in gastrointestinal nematodes (Levecke et al., 2011) it has continued to be  a problem in 
monitoring treatment efficacy in cestodes (Abbott and Barrett, 2008). The low sensitivity is thought to 
be due to the sporadic dispersion of gravid proglottides as well as the unequal distribution of eggs in the 
faecal mass (Nilsson et al., 1995). Lately, advanced methods such as immunological based detection 
have been shown to be more sensitive in detecting the horse tapeworm A. perfoliata infection (Skotarek 
et al., 2010). Ultimately, autopsy for the recovery of worms will provide an indication of treatment 
efficacy. Apart from worm counts, other autopsy indices such as worm biomass will in essence 
strengthen overall conclusions. Worm biomass assessment can either be done immediately after 
isolating worms from the host intestine (wet biomass) and/or also after removing worm fluid content by 
drying the worms (dry biomass). 
Having demonstrated in the results presented in Chapter 3 that H.microstoma is susceptible to CPs in 
vitro, here I present the results of experiments that aimed to assess whether CPs also have detectable 
activity against a natural cestode of mice in its normal host in vivo. 
 
5.2 Experimental design and results 
 
Effects of CPs on adult patent stage of H. microstoma in vivo 
 
5.2.1 Experiment 1  
 
A pilot assessment of the anthelmintic efficacy of crude papaya latex and papaya latex supernatant 
against H.microstoma in vivo 
 
5.2.1.1 Experimental design 
This experiment was designed to assess the effect of crude papaya latex (CPL) as used in earlier work 
(Stepek et al., 2005) and material from a new source (Enzymase, Brussels, Belgium) which is referred 
to as papaya latex supernatant (PLS; see Chapter 2, Materials and Methods for further details) as used 
76 
 
in all of my in vitro experiments. Fifteen mice were used in this experiment (see chapter 2). Mice were 
divided into 3 groups (n=5). Group 1 received CPL at 240nmols, group 2 received PLS at 240nmols 
while group 3 received water, all daily for 5 days from day 27 until day 31 post infection. On the day of 
treatment, mice were fasted for 4-5 hours as opposed to the original protocol described earlier for 6 
hours (Stepek et al., 2006b, 2007b, c) which was based on a clinical trial in Brazil (Hansson et al., 
1986). One mouse died from group 1 during the course of treatment and was excluded from analysis 
reducing group 1 sample size (n=4).The effectiveness of treatment was determined through faecal egg 
counts as well by autopsy and recovery of worms and assessment of their biomass.  
 
5.2.1.2 Results 
The faecal egg counts (Fig 5.1A) in neither the group receiving crude papaya latex nor the group 
receiving papaya latex supernatant showed any convincing reduction compared to the control group 
receiving water. Indeed arithmetically the mean values were higher than the control group following 
treatment. This difference in FEC between treatment groups was not statistically significant (rmGLM, 
between subjects test, F2,11=2.541 P=0.124) and there was no evidence of a divergence between 
treatment groups with time (within subjects test, time*treatment interaction F3.6,19.8=2.08 P=0.127). 
However, there was a significant difference in worm burdens (Fig 5.1B) between the treatment groups 
(Kruskal-Wallis test, χ22=7.65, P=0.022). As can be seen from Fig 5.1B, worm burdens appeared to be 
lower in the animals treated with PLS. Post hoc, comparison of worm burdens in group 2 (treated with 
PLS) with group 3(treated with water) indicated that there was a significant difference between the 
worm burdens in these two groups (Mann-Whitney U test, z=-2.495, P=0.013).  
 However, there were no significant differences observed in either of the two biomass assessments (Fig. 
5.1C). The mean wet biomass (Fig 5.1C) of both treatment groups did not show a difference as 
compared to the control and this was not statistically significant (Kruskal-Wallis test, χ22=0.771, 
P=0.68). The mean dry biomass (Fig 5.1C) of both treatment groups, however, did appear to differ 
numerically from the value of the control group although this was not statistically significant (Kruskal-
Wallis test, χ22=4.271, P=0.118). 
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Fig 5.1 Efficacy of papaya latex against H. microstoma in vivo 
Three indices used in assessing the effects of CPL and PLS on H. microstoma in vivo. (A) The log 
mean eggs per gram of faeces before (days 21-26) and during (days 27-31) treatment (arrows) of C3H 
mice infected with H. microstoma and treated with either CPL (n=4), PLS (n=5) or water (n=5). (B) 
The mean worm burden of C3H mice infected with H. microstoma and treated either with CPL 240 
nmols (n=4), PLS 240nmols (n=5) or water (n=5). (C) The mean biomass of H. microstoma in C3H 
mice treated either with CPL 240 nmols (n=4), PLS 240nmols (n=5) or water (n=5).  The amount of 
active CP expressed in nmols is the molar equivalent of the inhibitor E-64 used to block active CP in a 
10 µl volume in a titration assay (see chapter 2). Error bars represent the standard error of the mean. 
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5.2.2 Experiment 2  
 
Assessment of the anthelmintic efficacy of PLS against H.microstoma in vivo 
 
5.2.2.1 Experimental design 
This experiment was designed as a follow up from the pilot experiment, Experiment 1. Eighteen mice 
were used in this experiment (see chapter 2). To increase the likelihood of detecting a significant effect, 
the number of animals per group was increased from 5 to 9. Mice were divided into 2 groups. Each 
mouse in treatment group 1 received 0.2 ml dose of PLS at 240 nmols while group 2 received 0.2 ml 
water. Unlike in experiment 1 where mice were starved prior to oral dosing, all animal experiments 
conducted afterwards involves no fasting as it was found that fasting had no effect on treatment 
outcome (Luoga et al., 2011). All groups received daily treatment for 6 days starting from day 27 until 
day 32 post infection. The effectiveness of treatment was determined through faecal egg counts which 
were performed every other day from day 22 till 32 post infection as well as by autopsy for recovery of 
worms and assessment of their biomass.  
 
5.2.2.2 Results 
The faecal egg counts (Fig 5.2A) in the group receiving PLS did not show any convincing reduction 
compared to the control group receiving water. Indeed, as in the first experiment, arithmetically the 
mean values were higher than the control group following treatment. This difference in FEC between 
treatment groups was not statistically significant (rmGLM, between subjects test, F1,16=1.578 P=0.227) 
and there was no evidence of a divergence between treatment groups with time (within subjects test, 
time*treatment interaction F3.702,59.232=0.763 P=0.544). 
However, there were significant differences in worm burdens (Fig 5.2B) (Mann-Whitney U 
test, z=-2.789, P=0.005), wet biomass (Fig 5.2C) (Mann-Whitney U test, z=-2.518, P=0.012) and dry 
biomass (Fig 5.2C) (Mann-Whitney U test, z=-1.987, P=0.047) between the treated group and the 
control group. 
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Fig 5.2 Efficacy of PLS against H. microstoma in vivo 
The three indices used for assessing the effects of PLS on H. microstoma in vivo. (A) The log mean 
eggs per gram of faeces before (days 22-26) and during (days 28-32) treatment (arrows) of C3H mice 
infected with H. microstoma and treated with PLS (n=9) or water (n=9). (B) The mean worm burden of 
C3H mice infected with H. microstoma and treated with PLS 240nmols (n=9) or water (n=9). (C) The 
mean  biomass of H. microstoma in C3H mice treated with PLS 240nmols (n=9) or water (n=9). The 
amount of active CP expressed in nmols is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the standard error 
of the mean. 
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5.2.3 Experiment 3 
 
H. microstoma egg viability experiment 
 
5.2.3.1 Experimental design 
This experiment was planned as a follow-up to Experiments 1&2 where H. microstoma fecundity 
appeared to have been unaffected by in vivo PLS treatment. Two mice were used in this experiment 
(see chapter 2). The two mice were treated differently;  1 received 2 ml dose of PLS at 240 nmols and 
the other  received 2 ml dose of water. Unlike in experiments 1 & 2 where treatment was commenced 
much later (day 27 post infection) for better egg counts there was no need to wait egg production to 
reach itÕs peak hence treatment was started earlier (day 17) as H. microstoma would have reached the 
gravid proglottid stage by this time (Cunningham and Olson, 2010).  Both mice received daily 
treatment for 6 days starting from day 17 until day 22 post infection. On the 6
th
 day of treatment (day 
22), both mice were autopsied and their worms removed. Three worms were isolated from each of the 
two mice. From each worm, the distal most proglottid segments of  ̴ 1cm (longitudinal length) were cut 
and fed to a group of 3 previously starved T. confusum beetles, hence nine beetles were exposed to 
cestode eggs from each of the two treatments of the mouse hosts. From the same mice, their colons 
were dissected to recover any detached proglottid segments. Any detached proglottid segment found in 
each animal were fed to 3 more previously starved (5 days) T. confusum beetles. After indications that 
the fed segments have been consumed, regular beetle diet, consisting of a mixture of white and 
wholemeal flour, was added for conventional maintenance until after 30 day when all the beetles were 
dissected in HanksÕ saline to recover any developed cysticercoids. 
 
5.2.3.2 Results 
T. confusum beetles fed with the cut terminal proglottid segments from H. microstoma which had been 
treated in vivo with PLS were found to harbour intact cysticercoids (Table 5.3). In fact the mean 
number of cysticercoids recovered was comparable to that of the control group of beetles fed worms 
from mice which had been treated with water (Fig 2A). Beetles fed with detached proglottids segments 
recovered from the colon of treated mice also harboured intact cysticercoids (Table 2B) and the mean 
burden was comparable to that in the control beetle group fed with detached proglottids from mice 
treated with water (Fig 2B). 
 
Table 5.3 H. microstoma egg viability test 
The number of H. microstoma cysticercoids recovered from Tribolium beetles (n=9/ treatment group) 
fed with H. microstoma distal proglottid cut segments (from three worms) from each of two mice 
treated in vivo either with PLS or water 
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H. microstoma in 
vivo treatment 
Proglottid 
segment origin 
No of cysticercoids recovered 
Beetle1 Beetle 2 Beetle 3 
PLS Worm 1 0 1 0 
Worm 2 14 4 39 
Worm 3 1 30 10 
Water Worm 1 24 26 38 
Worm 2 0 0 0 
Worm 3 2 11 17 
 
 
Table 5.4 H. microstoma egg viability test 
The number of H. microstoma cysticercoids recovered from Tribolium beetles fed with detached H. 
microstoma proglottid segments from the colon of a mouse infected with H. microstoma and treated in 
vivo either with PLS (n=3) or water (n=3). 
H. microstoma in vivo 
treatment 
No of cysticercoids recovered 
Beetle 1 Beetle 2 Beetle 3 
PLS 6 7 0 
water 5 5 2 
 
 
Fig 5.3H. microstoma egg viability experiment 
 (A) Mean number of cysticercoids recovered from Tribolium beetles (n=9) fed with distal cut 
proglottid segments (n=3) from H. microstoma from C3H mice (n=2) treated in vivo either with PLS 
240nmols or water. (B) Mean number of cysticercoids recovered from Tribolium beetles (n=3) fed with 
colon found detached segments (n=3) from C3H mice (n=2) treated in vivo either with PLS 240nmols 
or water. The amount of active CP expressed in nmols is the molar equivalent of the inhibitor E-64 used 
to block active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent  the 
standard error of the mean. 
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5.2.4.1  Experimental design 
This experiment was a follow-up from Experiment 2 to confirm the effects demonstrated in the 
reduction in worm burden and biomass. Twenty mice were used in this experiment (see chapter 2). 
Although the previous Experiment 2 incorporated the use of a larger sample size n=9, this experiment 
was attempted using a smaller sample size n=5 because more groups were needed to factorially confirm 
the effect of PLS. Mice were divided into 4 groups. Each mouse in treatment group 1 received 0.2mls 
dose of PLS at 240 nmols. Group 2 received 0.2 ml dose of PLS at 240nmols + E-64 at 280 nmols. 
Group 3 received 0.2 ml dose of E-64 at 280 nmols and group 4 received 2 ml water. All groups 
received daily treatment for 6 days starting from day 17 until day 22 post infection. In this experiment, 
assessment of efficacy of treatment through faecal egg counts was not carried out due to the earlier 
results which had shown no differences between treated and control groups (Experiments 1 & 2). 
Therefore, worms were subjected to earlier treatment (day 17 post infection for the first dose of PLS, 
rather than day 27 post infection). Treatment effects were only assessed at autopsy through recovery of 
worms and assessment of their biomass. 
 
5.2.4.2 Results 
Arithmetically, there was only a 10-15% reduction in worm burdens when comparing mean values 
between the treated group and other control groups (Fig 3A). However, this was not statistically 
significant (Kruskal-Wallis test, χ22=6.97, P=0.73). Unexpectedly and surprisingly, in the wet biomass 
assessment, the mean values of the group treated with PLS was higher when compared to other control 
groups except for the group receiving PLS + E-64 which had the highest mean biomass (Fig 3B). This 
was also not statistically significant (Kruskal-Wallis test, χ22=3.263, P=0.353). In dry biomass 
assessment, there was a 15-40% reduction when comparing the mean values between the treated group 
and other control groups (Fig 3C). However, this was not statistically significant (Kruskal-Wallis test, 
χ22=4.077, P=0.253). The data were analyzed (Figures 3A, 3B and 3C) by 2-way ANOVA (treatment 
with PLS and/or E64) and the effect of PLS was not significant on worm burden (P= 0.384), wet 
biomass (P=0.202) or dry biomass (P=0.668). Interestingly, however, the main effect of E-64 was 
significant on worm burdens F(1,4)=7.2  P=0.016;(Mean for E-64 treated mice= 5 Mean for not 
treated=4.4 ) and dry biomass(P=0.049;Mean for E-64 treated mice= 0.10793 Mean for not 
treated=0.012276) but not on wet biomass (P=0.376).  
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Fig 5.4 Confirmation of the effects of PLS against H. microstoma in vivo 
(A) Mean worm burden (n=5) of C3H mice infected with H. microstoma and treated either with PLS 
240nmols, PLS 240nmols pre-treated with 280nmols E-64, E-64 280nmols or water. (B) Mean biomass 
(wet & dry) (n=5) of C3H mice infected with H. microstoma and treated either with PLS 240nmols, 
PLS 240nmols pre-treated with 280nmols E-64, E-64 280nmols or water. The amount of active CP 
expressed in nmols is the molar equivalent of the inhibitor E-64 used to block active CP in a 10 µl 
volume in a titration assay (see chapter 2). Error bars represent  the standard error of the mean. 
Treatment
M
ea
n
 w
o
rm
  
bu
rd
en
2
3
4
5
6
PLS
PLS+E-64
E-64
water
A
Treatment
M
ea
n
 b
io
m
as
s 
(g
ra
m
s)
0.0
0.1
0.2
0.3
0.4
PLS
PLS+E-64
E-64
water
wet biomass
dry biomass
B
84 
 
5.2.5 Experiment 5 
 
Observation of PLS mediated damage against H. microstoma in vivo. 
 
5.2.5.1  Experimental design 
This experiment was simply a further extension of Experiment 4 to graphically document the effects of 
PLS inflicted on H. microstoma in vivo. Four mice were used in this experiment (see chapter 2). Due to 
the non-analytical nature of the experiment only 1 mouse (n=1) per group was used to represent each of 
the 4 different treatment combinations. Mice were divided into 4 groups. Group 1 received 0.2mls dose 
of PLS at 240nmols. Group 2 received 0.2mls dose of PLS at 240nmols + E-64 at 280nmols. Group 3 
received 0.2mls dose of E-64 at 280nmols and group 4 received 0.2mls water. All the mice received 
daily treatment for 6 days starting from day 17 until day 22 post infection. The efficacy of treatment 
was assessed through the recovery of detached proglottids found in the large intestine downwards 
which were immediately fixed in glutaraldehyde and later dehydrated in ethanol, critical point dried and 
gold coated before finally being viewed under scanning electron microscopy for signs of any damage. 
 
5.2.13 Results 
The detached segment recovered from the PLS treated mouse appears to sustain treatment related 
damage albeit not extensive. On closer inspection (Fig 5.5A) there appears to be very superficial 
erosions which was not present in all the other segments (Figs 5.5B-D) found from other treatment 
combinations, all of which maintained their rather velvety appearance due to the intact brush border 
layer of the tegument. 
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Fig 5.5 SEM images of the effects of PLS against H. microstoma in vivo 
SEM images of detached proglottid segments of H. microstoma recovered from the colons of infected 
mice treated with (A) PLS 240 nmols (B) PLS 240 nmols pre-treated with 280 nmols E-64 (C) E-64 
280 nmols (D) water. Note the superficial erosions in (A) and the otherwise velvety appearance in other 
segments. The amount of active CP expressed in nmols is the molar equivalent of the inhibitor E-64 
used to block active CP in a 10 µl volume in a titration assay (see chapter 2).  
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5.2.6 Experiment 6 
 
Assessment of dose-dependency of PLS treatment against H. microstoma in vivo 
 
5.2.6.1  Experimental design 
 
This experiment was carried out to assess whether or not the reduction in worm burdens and biomass 
effects demonstrated by PLS against H. microstoma in Experiment 2 was dose- dependant. Twenty 
mice were used in this experiment (see chapter 2). Compared to previous Experiments 1 & 2 which 
sought to observe significance between treatments, this experiment was a correlational study between 
PLS dose and worm autopsy indices. Therefore, a smaller sample size n=3 was thought to be generally 
sufficient for each level of treatment. Mice were divided into 7 groups of different doses of PLS. This 
experiment was also executed simultaneously with Experiment 3 in which mice from the group 
receiving water were incorporated as group 1 (0 nmols dose) in this experiment n=5 and mice receiving 
240 nmols of PLS n=5 were incorporated as group 5. Group 2 n=3 received 30 nmols of PLS, group 3 
n=3 received 120 nmols, group 4 n=3 received 180 nmols, group 6 n=3 received 360 nmols and group 
7 n=3 received 480 nmols. All groups received treatment daily for 6 days starting from day 17 until day 
22 post infection. Treatment effects were assessed through worm count and biomass assessment at 
autopsy. 
 
5.2.6.2 Results 
Autopsy revealed a weak but significant negative correlation between PLS dose and worm burden (R=-
0.397 n=25 P=0.049) (Fig 5.6A). There was also a weak negative correlation between PLS dose and 
dry biomass which was not significant (R=-0.265 n=25 P=0.201) (Fig 5.6B). The wet biomass in 
contrast showed a weak positive trend with increasing doses of PLS but this was not significant as well 
(R=0.206 n=25 P=0.323) (Fig 5.6B). 
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Fig 5.6 PLS dose dependency against H. microstoma in vivo 
Three indices used to assess the relationship between PLS dose and H. microstoma in vivo. (A) The 
correlational trend between increasing PLS dose and worm burden.(B) The correlational trend between 
increasing PLS dose and biomass. All groups were of the same sample size (n=3) except groups 1 and 
5 (n=5). For statistical analyses see text. The line of best fit is provided to guide the eye. The amount of 
active CP expressed in nmols is the molar equivalent of the inhibitor E-64 used to block active CP in a 
10 µl volume in a titration assay (see chapter 2).  
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5.2.7 Experiment 7 
 
Assessment of H. microstoma recovery in vivo post PLS treatment 
 
5.2.7.1 Experimental design 
This experiment was designed to assess whether or not H. microstoma have the ability to recover in 
vivo post PLS treatment since tapeworms have been shown to repair themselves quickly after sustaining 
damage (Befus and Threadgold, 1975). Twenty mice were used for this experiment (see chapter 2). The 
mice were divided into 4 groups with 5 mice per group. Group 1 received 0.2 ml PLS at 240 nmols, 
group 2 received 0.2 ml water, group 3 received 2 ml PLS at 240 nmols and group 4 received 0.2 mls 
water. All groups received daily treatment for 6 days from day 17 until day 22 post infection. Groups 1 
& 2 were sacrificed immediately at the end of the treatment week (day 22 post infection) while groups 
3 & 4 were left to continue without treatment for another week until day 28 of infection. The 
effectiveness of treatment was determined through autopsy for recovery of worms and assessment of 
their biomass on days 22 and 28 post infection. 
 
5.2.7.2 Results 
Among all three indices studied there were obvious reductions among worms in treated mice compared 
with those among the controls irrespective of autopsy time. However, there were appreciative increases 
in worm burden and biomass when animals were autopsied later on day 28. Data were further explored 
using 2-way GLM to assess the main effects of time and treatment and also the interaction between the 
two variables.  
The effect of treatment on worm burden was not significant F1,16 = 2.4 P=0.141 (although treated mice 
had 17.4% fewer worms than controls after treatment and 8.7% fewer worms than controls when 
autopsied 1 week later ) and neither was the effect of time on worm burden F1,16 = 0.267 P=0.613. 
There was no significant interaction between time and treatment on worm burden F1,16 = 0.267  
P=0.613.  
The effect of treatment on wet biomass, however, was close to significance F1,16 = 3.514 P=0.079 and 
the percentage reduction in wet biomass was 24.2% post treatmnet and 16.6% when autopsied 1 week 
later. Surprisingly, the effect of time was also significant F1,16 = 4.596  P=0.048, wet biomass values 
being higher in both treated and control mice on day 28 compared with day 22. However, the 
interaction of treatment and time was not significant F1,16 = 0.023  P=0.881.  
The effect of treatment on dry biomass was significant F1,16 = 6.268 P=0.024. The effect of time was 
also significant F1,16 = 4.681 P=0.046. Again, perhaps surprisingly, there was no significant interaction 
between time and treatment F1,16 = 0.086 P=0.773. 
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Fig 5.7 H. microstoma recovery post PLS treatment 
!(A) The mean worm burden of C3H mice infected with H. microstoma immediately after 6 days 
treatment of either 240nmols of PLS or water (n=5) and 1 week after withholding treatment (n=5). (B) 
The mean biomass of H. microstoma in C3H mice immediately after 6 days treatment of either 
240nmols of PLS or water (n=5) and 1 week after withholding treatment (n=5). The amount of active 
CP expressed in nmols is the molar equivalent of the inhibitor E-64 used to block active CP in a 10 µl 
volume in a titration assay (see chapter 2). Error bars represent  the standard error of the mean. 
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Effects of CPs on prepatent stages of H. microstoma in vivo 
 
5.2.8 Experiment 8  
 
Assessment of the anthelmintic efficacy of PLS against H. microstoma during the migratory phase in 
vivo 
 
5.2.8.1 Experimental design 
This experiment was designed to test the hypotheses that young and still migrating H. microstoma 
which are present in the lumen of the intestine  for 3-4 days before entering the bile duct, and therefore 
should be fully exposed to luminal CP after treatment, are more susceptible to CP than the adult worms 
as shown in earlier experiments. Eighteen mice were used in this experiment (see chapter 2). To 
increase the likelihood of a significant effect, the number of animals per group was increased from 5 to 
9. Mice were divided into 2 groups. Each mouse in treatment group 1 received 0.2mls dose of PLS at 
240 nmols daily for 5 days starting from day 2 until day 6 post infection, while mice in the control 
group 2 received 0.2mls water. Because 6 day old worms will be too small to recover, the experiment 
was extended until day 14 post infection by which time the worms have attained a reasonable and more 
easily quantifiable size. The effectiveness of treatment was determined through autopsy for recovery of 
worms and assessment of their biomass.  
 
5.2.8.2 Results 
Autopsy revealed significant effects of treatment on worm burden and biomass in the treated group as 
compared to the control group. There was a significant difference seen in worm burdens (Fig 5A) 
(Mann-Whitney U test, z=-2.147, P=0.032), in the wet biomass (Fig 5B) (Mann-Whitney U test, z=-
3.311, P=0.001) as well as in the dry biomass (Fig 5C) (Mann-Whitney U test, z=-2.474, P=0.013) 
between the treated group and the control group. 
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Fig 5.8 PLS effects on migratory stages of H. microstoma 
The autopsy indices used to assess the effects of PLS on the migratory phase H. microstoma in vivo. 
(A) The mean worm burden of C3H mice infected with H. microstoma and treated with PLS 240 nmols 
(n=9) or water (n=9). (B) The mean  biomass of H. microstoma in C3H mice treated with PLS 240 
nmols (n=9) or water (n=9). The amount of active CP expressed in nmols is the molar equivalent of the 
inhibitor E-64 used to block active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars 
represent  the standard error of the mean. 
 
5.3 Discussion 
The experiments described in this chapter are the very first to test the effects of papaya latex on the 
cestode H. microstoma, there being no reports in the literature on assessment of CP on this species in 
laboratory trials.  In Experiments 1 and 2 in which faecal egg counts were employed as a measure for 
assessment of treatment efficacy, the results showed no reduction in mean EPG in treated groups as 
compared to the controls, despite the reductions in worm burden and biomass. This was somewhat 
surprising because as much as 90% reduction has been seen in faecal egg counts of nematodes such as 
H. bakeri treated with papaya latex (Stepek et al., 2007c). There are several possible explanations. 
treatment
M
ea
n
 w
o
rm
  
bu
rd
en
0
1
2
3
4
5
PLS 240nmols
water
A
treatment
m
ea
n
 b
io
m
as
s 
(g
ra
m
s)
0.00
0.05
0.10
0.15
0.20
PLS 240nmols
water
wet biomass
                        dry biomass
B
92 
 
Firstly, it has to be emphasized that H. microstoma is a bile duct dwelling worm with only parts of its 
strobila exposed in the intestinal lumen.  Since the administered CPs are primarily, going to be passing 
down the intestinal lumen, the scolex and neck regions are not likely to be exposed to high 
concentrations of the CPs. Hence the areas of major contact between CPs and the cestode are going to 
be in the terminal proglottids. In a short term administration protocol such as this, damage to these 
terminal proglottids, may well be reflected in loss of weight of these terminal, gravid proglottids, by 
their premature loss from the strobila, but also in liberation of the eggs that had formed in the 
developing and mature proglottids. The actual generation of eggs, however, may be protected from the 
effects of CP by their location in the bile duct.  
Direct exposure of the surface of parasites to CPs appears to be a very important factor in this potential 
novel drug as CPs are poorly absorbed systemically. This was evident in the case of the sheep nematode 
T. colubriformis which tunnels deep inside the intestinal mucosa during developmental stage whose 
fecundity was not affected by papaya latex treatment whereas another  sheep nematode H. contortus 
whose life cycle is entirely luminal succumbed (Buttle et al., 2011). Even if it appears that treatment 
with CPs did not affect FEC this does not conclusively establish that fecundity is not affected. Firstly, 
the faecal egg count is probably a poor indicator of the worm burdens in tapeworm infections as evident 
also by the wide error bars of the mean EPG values before treatment, suggesting high variability of 
eggs found in faeces (Figs 5.1A & 5.2A).  These may be explained by the sporadic discharge of gravid 
segments as well as their unequal distribution in the faecal mass (Nilsson et al., 1995). This is 
especially the case with the horse tapeworm A.perfoliata where coprological detection of infection is 
unreliable due to low sensitivity (Abbott and Barrett, 2008) and in this system it has been reported that 
there is no correlation between tapeworm burden and egg detection (Meana et al., 1998; Proudman and 
Edwards, 1992).  
Nevertheless, even though there were many eggs in the faeces of infected mice post treatment, it was 
possible that the eggs had experienced more subtle harmful effects limiting their capacity to develop 
normally after exposure to CPs. It was then imperative to ascertain whether fecundity was affected 
despite no reduction in egg counts through an egg viability test (Experiment 3). Disappointingly, H. 
microstoma eggs were not affected at all because intact H. microstoma cysticercoids were recovered 
from Tribolium beetles fed with either cut terminal proglottid segments or detached proglottid segments 
recovered from the colons of  mice infected with H. microstoma and treated with PLS. PLS did not 
appear to have had any effect on H. microstoma fecundity when administered to infected mice.  A 
similar result, with unaffected fecundity, was also observed in PLS treated rats infected with H. 
diminuta (Chapter 7).  
Structurally, cestode eggs have a thicker outer shell compared to trichostrongyloid nematode eggs such 
as those of H. bakeri, but not those of Trichuris and Ascaris species. This robust egg shell is required 
because of the need for the eggs to survive under harsh external environmental conditions before 
continuing its life cycle in an intermediate host. 
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While it can be concluded that the arithmetic mean worm counts were reduced numerically in all the 
experiments reported here (1, 2, 4,7&8), there was considerable variation in the degree of reduction, 
ranging from 9% (Experiment 3) to 50% (Experiment 1) and not all were statistically significant 
especially in experiments utilising smaller sample sizes. A confirmatory experiment with E-64 also 
failed to demonstrate any significant main effects of PLS treatment relative to the other control 
treatments (Experiment 4). Interestingly, the dose of PLS was found to be significantly negatively 
correlated with worm burden (Experiment 6), suggesting that fewer worms survived treatment when the 
dose was high. This dose-dependent reduction in worm numbers may suggest that despite the location 
of the scoleces in the bile duct, they were in fact not well protected from the effects of treatment with 
PLS. However, the recovery of tiny scoleces is never 100% accurate and there remains the possibility 
that as a result of the stress on the strobila from the CPs, the worms had destrobilated and their scoleces 
still persisted somewhere in the intestine without having been detected at autopsy and post-mortem 
examination. Indeed in Experiment 7 mice autopsied later, in fact a week  after the completion of 
treatment harboured more and bigger worms compared to those autopsied immediately after treatment. 
However, this effect had no connection with treatment as the interaction of treatment and time was not 
significant. This suggests that the reductions seen in earlier experiments were temporary and that H. 
microstoma do re-grow post treatment. In comparison, H. diminuta in a similar experiment but 
receiving a higher dose of PLS (Chapter 7) were smaller.  
When recovered worms were subjected to biomass assessments, there were notable inconsistencies 
especially in wet biomass assessments and instead of finding reductions, in some cases the arithmetic 
mean worm biomasses were higher than those of the control untreated groups of mice (Experiment 1 
and 4). Even more counter intuitively, in one instance the PLS dose was found to be positively 
correlated with wet biomass (Experiment 6). This could be due to several factors. Firstly, the process of 
removing excess fluid that surrounds and coats the worms is never 100% reliable using filter paper. 
This is why a second biomass assessment is made when worms are completely dry after removal of all 
fluid content by drying the worms in an oven. Secondly, cestodes being different in structure from 
nematodes and lacking a tough cuticle might be susceptible to fluid influx due to dysfunctional 
membrane transport systems from damaged or dead proglottids, thereby resulting in unexpected 
biomass values. This possibility is further strengthened when it is considered that all the mean dry 
biomass assessments showed an arithmetic reduction compared to the control groups, with the 
percentage reductions ranging from 16%(Experiment 4) to 59%(Experiment 1). Despite this consistent 
reduction trend, statistical analyses were inconsistent and could not be confirmed with E-64 treatment 
(Experiment 4) especially in experiments using small sample sizes (Experiment 1 and 4). This goes in 
tandem with the relationship with PLS dose which showed a negative correlation with dry biomass but 
was not statistically significant. Therefore, despite consistent arithmetic reductions of treatment group 
mean values and negative correlations, the wide variation in data distribution and hence non-significant 
outcomes of statistical analyses can only mean that papaya latex is only minimally efficacious against 
H. microstoma in vivo. This was also depicted graphically in Experiment 5 where the detached 
proglottid segments found from the mouse treated with PLS showed only a minimal effect on the 
tegument compared to the more profound damage observed in H. diminuta (Chapter 7). 
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One proposed explanation  for the relatively weak effect of PLS on this worm is that the H. microstoma 
scolex which resides high in the bile duct is largely protected against the effects of CP (McCracken et 
al., 1992). This prompted Experiment 8 in which young and still migrating worms, fully exposed in the 
intestinal lumen, would be subjected to CP treatment. However, if this was true, one might have 
expected a marked reduction in all autopsy indices but in actual fact, the reductions seen were minimal 
(Experiment 8). Secondly, the IC50 value needed for in vitro experiments (Chapter 4) were 
comparatively much higher than in nematodes (Stepek et al., 2005) immediately imposing limitation on 
the dose that can be ethically given to the treated animals. Thirdly, CPs become inactivated to a large 
extent when they pass through the stomach leaving less active enzyme available to affect worms in the 
intestine (Huet et al., 2006). This has been shown before when mice infected with the stomach dwelling 
P. muricola experienced loss of worms during treatment with  CPs only when the acid environment was 
neutralised by antacids (Stepek et al., 2007b). Finally, it may be possible that H. microstoma, having 
evolved to withstand the constant insult from pancreatic enzymes, may well have developed enzymic 
inhibitors that may non-specifically inhibit CPs resulting in temporary inhibition. 
This result however, is in agreement with previous studies in which H. microstoma was found to be 
resilient to anthelmintics such as benzimidazoles when compared to the considerably more susceptible 
H. diminuta (McCracken et al., 1992). Even at the larval stage, H. microstoma was resistant to 
benzimidazole based preparations (Evans et al., 1979; Evans et al., 1980). To the best of my 
knowledge, only praziquantel has been shown to be efficacious against H. microstoma (Thomas and 
Gonnert, 1977). This is because, praziquantel affects worms by inducing contractions  though 
increasing the influx of calcium (Mehlhorn et al., 1981), and thereby rendering paralysis in the worms 
and making them vulnerable to removal from the gut by peristalsis.   
A more intriguing observation was when worms were treated with CPs blocked with E-64 (Experiment 
3), because unexpectedly they were even larger than the controls. This might be due to exaggerated 
proglottid regeneration after an initial insult. The null hypothesis to this experiment was there would be 
no difference between worms treated with E-64 deactivated  papaya latex and controls. It was not 
expected that worms receiving deactivated papaya latex would be bigger than the untreated controls. 
One possibility is that there may be a role of other components of papaya latex such as mucolytic 
enzymes and alkaloids in this effect (Mezhlumyan et al., 2003) . The cestode tegument, unlike the 
robust nematode cuticle is simply a surface extension of parenchymal cells comprising an epithelium 
(Smyth, 1998) that is both a barrier against the environment as well as a dynamic absorptive surface 
where various nutrients are absorbed through ionic pumps and endocytosis.  It is plausible that other 
components of papaya latex may play a role in blocking or competitively binding themselves to 
transport molecules and ionic channel gates allowing osmotic diffusion of external contents into the 
worm.  
While none of the experiments described in this chapter saw treatment related animal casualties nor 
poor weight gain (results not shown) nevertheless it has been observed that some mice (during pilot 
experiments) do develop toxicity to PLS doses much higher than the ones described in this thesis and 
hence I have limited the maximum dose to be 240nmols per day. Symptoms include poor appetite and 
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weight loss perhaps secondary to events happening in the gut. Autopsy performed on these mice 
revealed abdominal distension and gaseous intestinal swelling. While the exact pathophysiology is not 
clearly understood it needs to be emphasized that none of these symptoms were seen in rats receiving 
10x the dose (2.4µmols) albeit proportionate to the dose per kilo body weight ratio. Also worth 
mentionaing that oral dosing of PLS in sheeps was similarly sound and safe (Buttle et al., 2011). Hence 
these possible side effects although needs to be kept in mind but should never hinder the progress of 
developing CPs further into useful novel anthelmintics. 
In summary, CPs do indeed affect H. microstoma in vivo albeit minimally and temporarily. Given the 
high efficacy of PLS observed against nematode models and the better efficacy against H. diminuta, H. 
microstoma is not a sensitive enough model system for screening novel compounds for potential 
anthelmintic activity. Hence there is a need to explore other model systems. Had it been possible to 
administer higher doses of PLS to mice the effects might have been comparable to those seen in H. 
diminuta (Chapter 8). Nonetheless, the results indicate that perhaps with better formulation and 
improvement in delivery of CPs, these natural plant products may be developed further into useful 
anthelmintics for humans and our livestock. 
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CHAPTER 6 
 
Assessment of the anthelmintic efficacy of cysteine proteinases against H.diminuta in mice in vivo 
 
6.0 Summary  
H. diminuta is naturally expelled from the mouse host about 10-12 days post infection but has been 
shown to survive the immunologically mediated response when treated with immunosuppressant drugs. 
Apart from utilising model systems in their permissive host to which the parasites are well adjusted, 
utilisation of unstable systems, such as H.diminuta in the non-permissive mouse host before the worms 
are expelled, may enable identification of anthelmintic activity more readily by tipping the balance in 
favour of worm loss.  Moreover, this less stable system (compared to H. diminuta in its normal rat host) 
could be further exploited by blocking immunologically mediated expulsion from the mouse host by 
treatment with steroid immunosuppressants. The experiments described in this chapter indicate that 
treatment of mice infected with H. diminuta with papaya latex is efficacious, resulting in marked 
reductions in the worm burden and biomass, far more potent effects than those seen in permissive hosts. 
However, these effects were only minimally dose dependant and specific inhibition by E-64 only 
confirmed the role of cysteine proteinase as the active principles in papaya latex affecting worm growth 
but not worm elimination. The role of the immune system in contributing towards the potent effect is 
highly plausible when immunosuppression failed to achieve comparable potency. 
 
6.1 Introduction 
H. diminuta is a natural parasite of the rat but this cestode can establish in mice and can grow for a 
limited period of time before being immunologically expelled about 10-12 days post infection (Hopkins 
et al., 1972a). However, expulsion is greatly delayed in young hosts with immature immunity in which 
the worms can also grow much bigger than in adult mice (Befus and Featherston, 1974; Pike and 
Chappell, 1981) or during pregnancy and lactation when the host undergoes natural 
immunosuppression (Selby and Wakelin, 1975). Concurrent infections with nematodes (Courtney and 
Forrester, 1973) and protozoans (Machnicka and Choromanski, 1980) have been shown also to delay 
expulsion because of interference by the co-infecting species with host immunity, thereby facilitating 
longer survival of H. diminuta. This led to attempts of artificial induction of immunosuppression 
through corticosteroids, graft rejection agents like antithymocyte serum as well as cytotoxic drugs such 
as methotrexate (Hopkins et al., 1972b), all of which were found to prolong H. diminuta infections in 
mice. Conversely, if the murine host has experienced infection earlier, and has acquired immunity, the 
worms are rejected earlier and do not grow as large as in primary infections (Hopkins et al., 1972a). 
While the key kinetics underlying worm expulsion have been described (Webb et al., 2007), the 
complexity of the immune response is still not fully understood (McKay, 2010). Immunologically 
mediated tegumental damage was also evident with the observation of dark areas (DA) on the tegument 
of H. diminuta grown in mice by Befus and Threadgold (1975) and the demonstration of leucocyte 
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adherence to the tegument with subsequent macrophage mediated phagocytosis of microtriches 
(Andreassen et al., 1990), of which both workers suggested complement mediated damage.  
The main reason behind utilising the same cestode species (H. diminuta) but in a non-
permissive host is to assess the suitability of this particular combination as a screen for anthelmintic 
activity, with the objective of finding a more sensitive in vivo assay system for detecting anthelmintic 
activity than that reflected in the permissive host. Cestodes such as H. diminuta are well adapted to 
their primary definitive hosts in which they can survive for years. One hypothesis explaining how they 
survive is that they can repair damage to their surface quickly, much more readily than nematodes for 
example. In a non-permissive host the parasites survive initially and are able to repair damage to their 
surface (Andreassen and Hoole, 1989) but as the host response intensifies the balance swings in favour 
of the host, and the parasites are eventually expelled. It is possible that cestodes repair surface damage 
induced by CP and other agents that target their surface. Therefore,  in this chapter I explore the 
suitability of using the H. diminuta-mouse model to detect CP mediated anthelmintic activity with the 
expectation that H. diminuta should be easier to expel from this non-permissive host, than from its 
primary definitive host, in which its ability to repair damage is likely to be more efficient. My 
hypothesis is that because this is a non-permissive system, and relatively unstable, it should be easier to 
contribute to the immunological/physiological stresses that the worms are experiencing when growing 
in mice, and CPs should therefore be more effective than in the rat host, tipping the balance in favour of 
reduced growth and earlier expulsion of worms. In any case the results will provide an interesting 
comparison with the results seen in the permissive host (H. diminuta in rats) and in the other permissive 
model-system (H. microstoma in mice) that I describe in Chapters 5 and 7. This will show how robust 
the efficacy of CPs is in affecting cestodes in different host combinations and under different 
circumstances. In turn, the results will enable assessment of  the usefulness of CPs as a possible novel 
anthelmintic, because the broader the spectrum of activity the greater their appeal and likely acceptance 
by potential consumers in the farming, veterinary and medical professions (Behnke et al., 2008). 
 
6.2 Experimental design and results 
 
6.2.1 Experiment 1 
 
Assessment of H.diminuta survival in the non-permissive mouse host 
 
6.2.1.1  Experimental design 
Thirty mice were used in this experiment (see chapter 2). Mice were allocated randomly to 6 groups 
with 5 mice in each group. 1 group (5 mice) was sacrificed each day starting from day 7 till day 12 post 
infection to ascertain worm burdens.  
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6.2.1.2 Results 
In the experiment, the mean worm burden ranged steadily between 2.8 and 3 in mice killed on days 7 to 
9 post infection before plummeting to 0.4 and 0.8 from days 10 to 11 post infection. There were no 
worms found on day 12 post infection (Fig 6.1). 
 
Fig 6.1 H. diminuta in the non-permissive host lifespan 
The lifespan of H.diminuta in the non-permissive C3H mouse host expressed as mean worm burden per 
day post infection (n=5). Each point represents 5 mice killed on the same day. The mean worm burden 
was drastically reduced between days 10-12 post infection. Error bars represent the standard error of the 
mean. 
 
6.2.2 Experiment 2 
 
Assessement of the anthelmintic efficacy of PLS against H. diminuta in the non-permissive mice host in 
vivo. 
 
6.2.2.1  Experimental design 
This experiment was designed to test the hypothesis that H. diminuta in the non-permissive host is 
susceptible to the effects of CPs. Twenty mice were used in this experiment (see chapter 2). Mice were 
divided into 2 groups of n=10. Following the result from experiment 1, the duration and timing for 
autopsy in this experiment was chosen so as to not coincide with the phase of spontaneous 
immunologically mediated expulsion. Each mouse in treatment group 1 received 240nmol PLS (0.2mls) 
daily for 6 days starting from day 4 until day 9 post infection while the control group (group 2) received 
the same volume in water. Unlike experiments using mature worms that include assessment of 
fecundity through faecal egg counts, the effectiveness of treatment was determined through autopsy for 
recovery of worms and assessment of their biomass on day 9 post infection.  
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6.2.2.2 Results 
Autopsy revealed a dramatic reduction of almost 80% in worm burden and biomass of the treated group 
as compared to controls (Fig 6.2A-B). These were all highly significant differences seen in worm 
burden (Fig 6.2A) (Mann-Whitney U test, z=-3.872, P<0.001), wet biomass (Mann-Whitney U test, z=-
3.794, P<0.001) as well as dry biomass (Fig 6.2B) (Mann-Whitney U test, z=-3.492, P<0.001) as 
compared to the controls. 
 
Fig 6.2 PLS efficacy against H. diminuta in the non-permissive host in vivo 
(A) The mean worm burden of C3H mice infected with H. diminuta and treated with PLS 240nmols 
(n=10) or water (n=10). (B) The mean worm biomass of C3H mice infected with H. diminuta and 
treated with PLS 240nmols (n=10) or water (n=10).  There was a highly significant difference observed 
between all autopsy indices as compared to the control group. For statistical analyses see text. The 
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amount of active CP expressed in nmols is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the standard error 
of the mean. 
6.2.3 Experiment 3 
 
Confirmation of the effects of PLS against H. diminuta in the non-permissive host in vivo 
 
6.2.3.1  Experimental design  
This experiment was a follow-up from experiment 2 to confirm the effects demonstrated in the 
reduction in worm burden and biomass. Twenty mice were used in this experiment (see chapter 2). 
Although the previous Experiment 2 incorporated the use of a larger sample size n=10, this experiment 
was attempted using a smaller sample size n=5 because more groups were needed to factorially confirm 
the effect of PLS. Mice were divided into 4 groups. Each mouse in treatment group 1 received 0.2mls 
dose of PLS at 240 nmol. Group 2 received 0.2 ml dose of PLS at 240 nmols + E-64 at 280 nmols. 
Group 3 received 0.2mls dose of E-64 at 280 nmols and group 4 received 0.2 ml water. All groups 
received daily treatment for 6 days starting from day 4 until day 9 post infection. The effectiveness of 
treatment was determined through autopsy for recovery of worms and assessment of their biomass on 
day 9 post infection.  
 
6.2.3.2 Results 
Arithmetically, there was only minimal reduction (18%) in worm burden when comparing mean values 
between the treated group receiving PLS (mean=3.6) and the control group receiving water (mean=4.4) 
(Fig 6.3A). In fact, the group receiving E-64 only (mean=3.4) had the fewest worms (Fig 6.3A). 
However, this was not statistically significant (Kruskal-Wallis test, χ22=2.427, P=0.489). Surprisingly, 
in the wet biomass assessment, the treated group (mean=0.00444) had a 60% reduction of mean 
biomass compared to the control group (mean=0.01112) (Fig 6.3B). Also unexpectedly were the 61% 
and 43% reductions in mean biomass in the groups treated with PLS+E-64 (mean=0.00432) and E-64 
only (mean= 0.00636) respectively when compared to the control group, although statistically there was 
no significance, P being just marginally the wrong side of the cut off (Kruskal-Wallis test, χ22=7.15, 
P=0.067). Similarly, the dry biomass assessment, saw a more pronounced reduction of 78% between 
the treated group and the group receiving water (Fig 6.3B) which was  statistically significant (Kruskal-
Wallis test, χ22=9.11, P=0.028). In assessing the main effects of PLS, data were analyzed by 2-way 
ANOVA (treatment with PLS and/or E64) and the effect of PLS was significant on both biomass 
assessments (wet biomass P=0.014 dry biomass P=0.003) but not on worm burden P=0.682. Despite 
the reduction seen in biomass as compared to the group receiving water, the effects of E-64 or PLS pre-
treated with E-64 were not significant in any of the indices.  
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Fig 6.3  Confirmation of the effects of PLS against H. diminuta in the non-permissive host in vivo 
The various autopsy indices used to measure the effects of PLS against H. diminuta in the non-
permissive mouse host. (A) The mean worm burden of C3H mice infected with H. diminuta and treated 
either with PLS 240nmols (n=5), PLS 240nmols pre-treated  with E-64 280nmols (n=5), E-64 
280nmols (n=5) or water (n=5). (B) The mean  biomass of H. diminuta in C3H mice treated either with 
PLS 240nmols (n=5), PLS 240nmols pre-treated with E-64 280nmols (n=5), E-64 280 nmols (n=5) or 
water. PLS appears to only minimally affect worm burden but other treatments seemed to be equally 
affected if not more. PLS appear s to have a substantial effect on worm biomass but this was also true 
with the group receiving PLS pre-treated with E64. The group receiving E-64 only also appears to be 
affected as compared to the controls. For statistical analyses see text. The amount of active CP 
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expressed in nmols is the molar equivalent of the inhibitor E-64 used to block active CP in a 10 µl 
volume in a titration assay (see chapter 2). Error bars represent the standard error of the mean. 
6.2.4  Experiment 4 
 
Observation of PLS mediated damage against H. diminuta in the non-permissive host in vivo. 
 
6.2.4.1  Experimental design 
This experiment was simply a further extension of Experiment 3 to graphically document the effects of 
PLS inflicted on H. diminuta in the non-permissive mouse in vivo. Four mice were used in this 
experiment (see chapter 2). Due to the non- analytical nature of the experiment only 1 mouse (n=1) per 
group was used to represent each of the 4 different treatment combinations. Mice were divided into 4 
groups. Group 1 received 0.2mls dose of PLS at 240nmols. Group 2 received 0.2mls dose of PLS at 
240nmols + E-64 at 280nmols. Group 3 received 0.2mls dose of E-64 at 280nmols and group 4 
received 0.2mls water. All mice received daily treatment for 6 days starting from day 17 until day 22 
post infection. The efficacy of treatment was assessed through the recovery of detached proglottid 
segments found in the large intestine downwards which were immediately fixed in glutaraldehyde and 
later dehydrated, critical point dried and gold coated before finally being viewed under scanning 
electron microscopy for signs of any damage. 
 
6.2.4.2  Results 
Generally the detached proglottid segments recovered were longer in terms of number of proglottids per 
detached segment as compared to similar experiments using H. diminuta in the rat host or even H. 
microstoma in mouse. All segments recovered irrespective of the treatment received in vivo appears to 
have developed widespread wrinkling which was not seen in similar experiments with H. diminuta in 
the rat host or even H. microstoma in mice. On top of this unusal wrinkling the proglottid segment 
recovered from the mouse treated with PLS 240nmols appears to also sustain extensive tegumental 
damage in the form of tegumental erosions and digestion. 
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Fig 6.4 SEM images of the effects of PLS against H. diminuta in the non-permissive host in vivo 
SEM images of detached proglottid segments of H. diminuta recovered from the colons of infected 
C3H mice treated with (A) PLS 240 nmols (B) PLS 240 nmols  pre-treated with 280nmols  E-64 (C) E-
64 280 nmols (D) water. Note the extensive treatment related damage in the H. diminuta proglottid 
segment recovered from the mouse treated with treated with PLS 240 nmols which was not present in 
the other control segments. Note also the widespread wrinkling in all H. diminuta proglottid segments 
recovered irrespective of their treatment in vivo. The amount of active CP expressed in nmols is the 
molar equivalent of the inhibitor E-64 used to block active CP in a 10 µl volume in a titration assay (see 
chapter 2).  
 
6.2.5 Experiment 5 
 
Assessment of dose-dependency of PLS treatment against H. diminuta in the non-permissive host in 
vivo 
 
6.2.5.1  Experimental design 
This experiment was carried out to assess whether or not the reduction in worm burdens and biomass 
effects demonstrated by PLS against H. diminuta in Experiment 2 is dose-dependant. Twenty two mice 
were used in this experiment (see chapter 2). Compared to previous Experiments 2 and 3 which sought 
to observe significance between treatments, this experiment was a correlation study between PLS dose 
A B
C D
104 
 
and worm autopsy indices. Therefore, a smaller sample size n=3 was thought to be generally sufficient. 
Mice were divided into 6 groups of different doses of PLS. This experiment was also executed 
simultaneously with Experiment 3 in which mice from the group receiving water were incorporated as 
group 1 (0nmols dose) in this experiment (n=5) and mice receiving 240nmols of PLS (n=5) were 
incorporated as group 5. Group 2 (n=3) received 30nmols of PLS, group 3 (n=3) received 120nmols, 
group 4 (n=3) received 180nmols and group (6 n=3) received 360nmols. All groups received daily 
treatment for 6 days starting from day 4 until day 9 post infection. Treatment effects were assessed 
through worm counts and biomass assessments at autopsy on day 9 post infection. 
 
6.2.5.2 Results 
Autopsy revealed a weak negative correlation between PLS dose and worm burden (R
2
=0.006, n=22, 
P=0.615) (Figure 6.5A). Although not statistically significant, there were indications of a weak 
negative relationship between dose of PLS and worm biomass (wet biomass R
2
=0.0758, n=22, 
P=0.194) (Figure 6.5B) and PLS dose especially dry biomass which is just outside of significance 
(R
2
=0.1468, n=22, P=0.063) (Figure 6.6C).  
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Fig 6.5 Dose dependency of PLS against H. diminuta in the non-permissive host in vivo 
The various indices demonstrating the relationship between PLS dose and H. diminuta in the non- 
permissive mouse host. (A) The correlational trend between increasing PLS dose and worm burden.(B) 
The correlational trend between increasing PLS dose and worm biomass. All groups were of the same 
sample size (n=3) except groups 1 and 5 (n=5). For statistical analysis see text. The line of best fit is 
provided to guide the eye. The amount of active CP expressed in nmols is the molar equivalent of the 
inhibitor E-64 used to block active CP in a 10 µl volume in a titration assay (see chapter 2).  
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6.2.6 Experiment 6 
 
Assessment of survival of H. diminuta in the immunosuppressed non-permissive mice host 
 
6.2.6.1  Experimental design 
Twenty mice were used in this experiment (see chapter 2). Mice were randomly divided into 5 groups 
of 5 mice in each group and the sixth group consisted of only 3 mice. Each mouse received 5 H. 
diminuta cysticercoids on day 0 of infection through oral gavage. Each mouse was injected with 0.1ml 
(1mg/ml) dexamethasone (Voren 
TM 
Boehringer-Ingelheim, UK) subcutaneously every other day 
starting from day 1 post infection until respective day of culling. All mice were given oxytetracycline 
hydrochloride (Terramycin, Pfizer Ltd) in their drinking water at a concentration of 3g/litre) for the 
duration of the experiment (Behnke et al., 1980). One group (5 mice) was sacrificed every other day 
starting from day 8 until day 12 post infection and then every 4 days until day 20 post infection to 
ascertain worm burdens. The sixth group (3 mice) was left until day 32 post infection before autopsy.  
 
6.2.6.2 Results 
Unlike in Experiment 1, the mean worm burden was almost preserved and ranged steadily between 4.4 
and 5 until the end of the experiment at day 32 post infection (Fig 6.6A). The mean biomass climbed 
almost exponentially from day 8 before reaching a plateau from day 16 post infection (Fig 6.6B). 
However, at day 32, the mean worm biomass was reduced to almost 40% from their peak size despite 
retaining worm count (Fig 6.6B). 
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Fig 6.6  H.diminuta lifespan in the immunosuppressed non-permissive host 
The lifespan of H.diminuta in the non-permissive immunosuppressed C3H mice host expressed as (A) 
mean worm burden per day post infection (n=5). (B) Mean worm biomass per day post infection (n=5). 
Each point represent 5 mice killed on same day except the last point which consisted of 3 mice. The 
mean worm burden was preserved until the end of experiment with only the mean worm biomass 
reduced from their peak mass at the end of the experiment. Error bars represent the standard error of the 
mean. 
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6.2.7 Experiment 7 
 
Assessment of the efficacy of PLS against H. diminuta in the immunosuppressed non- permissive host 
 
6.2.7.1  Experimental design 
Following the success of Experiment 6 in which H. diminuta was able to be survive for longer than 
normal avoiding the usual immunologically mediated expulsion by immune suppression, this 
experiment was designed to determine whether the marked effects of PLS treatment on H. diminuta in 
the non-permissive host was partly immunologically mediated. The hypothesis is that when the immune 
system is suppressed, the PLS effects will not be as marked. Twenty mice were used in this experiment 
(see chapter 2). Each mouse was injected with 0.1ml (1mg/ml) dexamethasone (Voren 
TM 
Boehringer-
Ingelheim, UK) subcutaneously every other day starting from day 1 post infection until the end of 
experiment on day 16 post infection. All mice were given oxytetracycline hydrochloride (Terramycin, 
Pfizer Ltd) in their drinking water at a concentration of 3g/litre) for the duration of the experiment 
(Behnke et al., 1980). Mice were divided into 2 groups (n=10). Each mouse in treatment group 1 
received 0.2 ml doses of PLS at 240nmols daily for 6 days starting from day 11 until day 16 post 
infection while the control group (group 2) received 0.2mls dose of water. The effectiveness of 
treatment was determined through autopsy for recovery of worms and assessment of their biomass on 
day 16 post infection. 
 
6.2.7.2 Results 
Autopsy revealed a less dramatic reduction of a mere 23% in worm burden (Fig 6.7A) and about 45% 
reduction in biomass of the treated group as compared to controls (treated group mean wet 
biomass=0.91 grams, control group mean wet biomass=1.60 grams; treated group mean dry 
biomass=0.21 grams, control group mean dry biomass=0.39 grams ) (Fig 6.7B). These were all highly 
significant differences seen in worm burden  (Mann-Whitney U test, z=-2.746, P=0.006) and biomass 
(wet biomass Mann-Whitney U test, z=-3.25, P=0.001;dry biomass Mann-Whitney U test, z=-3.25, 
P=0.001) as compared to the controls. 
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Fig 6.7 PLS efficacy against H. diminuta in the immunosuppressed non-permissive host in vivo 
(A) The mean worm burden of immunosuppressed C3H mice infected with H. diminuta and treated 
with PLS 240nmols (n=10) or water (n=10). (B) The mean biomass of H. diminuta in 
immunosuppressed C3H mice treated with PLS 240nmols (n=10) or water (n=10). There a highly 
significant difference observed between all autopsy indices as compared to the control group. For 
statistical analyses see text. The amount of active CP expressed in nmols is the molar equivalent of the 
inhibitor E-64 used to block active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars 
represent the standard error of the mean. 
 
6.3 Discussion 
Before embarking on definitive experiments in assessing PLS efficacy, explorative worm survival 
experiments were needed to ascertain the time course in which one can work with H. diminuta as it is 
known to be spontaneously expelled from the mouse host between days 10-12 post infection (Hopkins 
et al., 1972a). Experiment 1 confirmed the observation of Hopkins et al. (1972a) which clearly limits 
anybody wishing to work with H. diminuta in mice to only 10 days post infection. However, the mean 
worm burden, before expulsion in this experiment (days 7 to 9 post infection) was somewhat lower than 
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expected (2.8-3) when considering that each mouse was infected with 5 cysticercoids. This was perhaps 
disappointing and it is not known why establishment of worms was so low in this experiment, since in 
H. diminuta infections in rodents given an inoculum of 5 cysticercoids normally yield 4-5 worms in 
each animal.  Nevertheless, the results concurred with earlier work and are consistent with knowledge 
that H. diminuta in the non-permissive host undergoes expulsion from days 10-12 post infection until 
all the worms are eventually lost by the end of weeks 2-3 of infection (Hopkins et al., 1972a). Because 
the expulsion of H. diminuta in the non-permissive host is immunologically mediated (Hopkins et al., 
1972a; Persaud et al., 2007), Hopkins et al. (1972b) were able to prolong worm survival by induction 
of immunosuppression. Experiment 5 was designed to confirm this phenomenon ahead of further trials. 
Preliminary experiments (results not shown) using identical equivalent doses of dexamethasone instead 
of the original cortisone used by Hopkins et al. (1972b) failed to preserve worms beyond the normal 
survival window before spontaneous expulsion. It was only after several experiments utilising higher 
(>2 X the original dose) equivalent doses of corticosteroids that I was able to preserve H. diminuta 
from being expelled. Surprisingly, the preservation of H. diminuta in the non- permissive host was 
achieved up to 32 days post infection which is 12 days longer than the original experiment by Hopkins 
et al. (1972b). It is also important to note that despite the acquired longevity worm biomass was 
reduced over time suggesting an adaptation to limited resources often referred to as the crowding effect 
(Read, 1951). However, this particular group, which was left to endure for longer, had a smaller sample 
size n=3 because the original aim of the experiment was just to repeat that of Hopkins et al. (1972b)  
and to terminate the experiment on day 20 post infection. However, there were no losses and the 3 
additional mice that had been included to compensate for possible losses were killed eventually on day 
32. Hopkins et al. (1972b) however were only able to preserve the worms at the expense of substantial 
host loss (about 20% from the original sample size) which may be due to the administration of steroids 
through intramuscular injections and not providing antibiotics during periods of immunosuppression,  
the latter factor being rectified in their subsequent work. Surprisingly, in this experiment, using a 
different corticosteroidal variant injected subcutaneously rather than intramuscularly and at a higher 
dose than used by Hopkins et al. (1972b), the treatment managed to achieve preservation without 
experiencing any host casualties. Perhaps, newer generations of corticosteroids have less adverse 
effects than the earlier versions (Degreef, 1999). Nevertheless, all this has enabled me to work with H. 
diminuta for longer beyond its spontaneous expulsion window.  
 Unlike H. diminuta in its definitive rat host which was moderately affected by PLS (Chapter 7) 
and even H. microstoma which was only minimally affected (Chapter 5), H. diminuta in the non-
permissive host proved to be the most sensitive model for assessing the anthelmintic efficacy of PLS in 
cestodes. Here, there were dramatic reductions in worm burden and biomass of almost 80% when H. 
diminuta was grown in the non-permissive mouse host and treated with PLS (Experiment 2). This may 
be explained by a two pronged attack on the worm namely PLS and the immune system. Either PLS 
(Chapter 7) or the immune system (Befus and Threadgold, 1975) has been shown to affect H. diminuta 
on their own thereby making them an unforgiving menace when both work in tandem. However, these 
effects need to be factorially confirmed using E-64 as a specific inhibitor for CP so that the effects seen 
are indeed the main effects of PLS. Despite a much varied response in arithmetical reductions (worm 
111 
 
burden 18%, wet biomass 60% and dry biomass 78%) as compared to the controls, this experiment 
(Experiment 3) confirmed that PLS do indeed affect the ability of the worm to repair itself after PLS 
treatment as non-parametric testing revealed that worm biomass was close to (wet biomass) and 
significantly different (dry biomass) in the PLS treated group. Furthermore, 2-way ANOVA was 
significant for the effect of PLS but not for E-64 or when the interaction between both (pls see text for 
statistical analysis). PLS treatment however cannot be said to be responsible for worm loss as the worm 
burden was not significantly different when differences between groups were tested by non- parametric 
tests or by 2-way ANOVA. It is also important to note in all confirmatory experiments (experiment 3 
here; also in chapters 5 & 7) a smaller sample size n=5 was used due to logistical and practical 
considerations. This might explain the variability seen between the confirmatory experiments and the 
definitive experiments using a larger sample size n=10. This result is indeed identical to that in Chapter 
7 where PLS was confirmed to affect worm size but not worm counts. What is not identical though is 
that worms receiving PLS pre-treated with E-64 or worms receiving E-64 only were also reduced in 
size when compared to the group receiving water alone. However, despite their magnitude, these were 
not statistically significant differences. In Chapter 5 & 7 where perhaps an exaggerated response of 
repair was seen in groups receiving PLS pre-treated with E-64, the results suggested that because PLS 
was being competitively inhibited other components of PLS like mucolytic enzymes and alkaloids 
(Mezhlumyan et al., 2003) might still be at large diffusing through the tegument. Unlike in natural 
permissive hosts where cestodes are able to repair damage quickly (Befus and Threadgold, 1975), H. 
diminuta in the non-permissive mouse host is constantly being attacked by the immune system and 
hence is most likely unable to repair itself as efficiently as it does in its normal rat host and therefore 
appears to be affected proportionately. This was also true when worms in the group receiving E-64 only 
also appeared to be affected compared to the controls receiving water. What is striking is that all 3 
different treatments appeared to affect H. diminuta in a proportionate manner not seen in similar 
confirmatory experiment of H. diminuta in the rat host where all other treatment groups had values that 
were indistinguishable from those of the controls receiving water. SEM images of recovered detached 
proglottid segments (experiment 4) may perhaps consolidate these earlier observations and postulations. 
Firstly It was noted that all the detached proglottid segments were longer in terms of number proglottids 
per detached segment found compared to the detached segments found in similar experiments in 
chapter 5 (H. microstoma in mouse) & 7 (H. diminuta in rats). This may be explained by perhaps due to 
the attacking immunity the worms were releasing their proglottids at a faster rate and hence longer 
groups of proglottids detached. Secondly all proglottid segments irrespective of treatment received in 
vivo exhibit widespread wrinkling which was also never seen in similar experiments in chapters 5 & 7. 
This phenomenon is again perhaps as a result of immune system attack. Thirdly the proglottid segment 
recovered from the mouse treated with PLS appeared to have sustained extensive and substantial 
damage unlike in similar experiment of H. diminuta in the rat host where the damage sustained was less 
severe (chapter 7). This could perhaps be explained by the combinative onslaught from both the 
immune system and PLS attacking the tegument. Having confirmed the effects of PLS, it was then 
found through Experiment 5, that the effects of PLS on worm size and numbers were not dose 
dependant. The experiment revealed variable but consistently negative but insignificant correlations 
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between PLS dose and worm indices (Fig 6.5). This again is in keeping with the results seen when H. 
diminuta in its natural rat host. To finally conclude this hypothesis, PLS should be administered to this 
model system in a situation in which the immune system will not be able to play its role. Following the 
success of preservation of worms through immunosuppresion (Experiment 6), the final Experiment 7 
revealed a less marked reduction profile ranging from 23%-47% (Fig 6.7) compared to Experiment 2 
(80%-90%) but nevertheless still statistically significant reduction. This supports the idea that the 
earlier marked effects seen were the consequence of a combined assault from both PLS and a fully 
functional immune system. In summary, all the results are sufficient to support my hypothesis that in 
exploiting this non-permissive, unstable system, the anthelmintic efficacy of CPs was greatly enhanced. 
Clearly the complex immunological mechanism that facilitates the expulsion of H. diminuta in 
the non-permissive host, has generated an environment in which additional stresses on the worms, such 
as those imposed by the enzyme activity of PLS attacking the wormÕs surface, tip the balance in favour 
of expulsion and prevent the growth of larger worms. Apart from worm expulsion kinetics (Webb et al., 
2007), immunologically mediated tegumental damage has been observed (Andreassen et al., 1990; 
Befus and Threadgold, 1975) On the other hand, in the permissive host, where such immune reactions 
do not occur, or are expressed less vigorously, the effects of PLS on worm burdens and biomass, as a 
result of the anthelmintic activity of CPs, are less marked because the worms presumably can cope 
better with the ensuing damage to their surface and can repair it sufficiently to avoid expulsion. 
Cestodes are known to be able to repair damage to their tegument rapidly, within hours in some cases in 
vitro (Befus and Threadgold, 1975) but given the simultaneous onslaught of both the immune system 
and the administered PLS, they were clearly overwhelmed.  
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CHAPTER 7 
 
Assessment of the anthelmintic efficacy of cysteine proteinases against H.diminuta in vivo in rats 
 
7.0 Summary  
H. diminuta is a natural parasite of the common brown rat Rattus norvegicus, and provides a convenient 
model system for the assessment of the anthelmintic activity of novel drugs against cestodes. In contrast 
to earlier reports, the experiments described in this chapter indicated that treatment of rats infected with 
H. diminuta with papaya latex was efficacious, albeit moderately, resulting in a significant, but 
relatively small, reduction in worm burden and biomass. However, these effects were only partially 
dose dependant although specific inhibition by E-64 confirmed the role of cysteine proteinase as the 
active principles in papaya latex affecting worm growth but not worm elimination. However, over a 
longer duration than explored in the earlier experiments worm loss was magnified but the effects on 
worm growth were not enhanced. Worm fecundity was not affected at all.  
 
7.1 Introduction 
The anthelmintic effects of cysteine proteinases (CPs) against nematodes in vivo have been successfully 
demonstrated in mice (Satrija et al., 1995; Stepek et al., 2006b, 2007b, c), pigs (Satrija et al., 1994), 
sheeps (Buttle et al., 2011), chickens (Mursof and He, 1991) and there is evidence from trials in 
humans infected with the three major intestinal species that CPs also work effectively against human 
infectious intestinal nematodes (Hansson et al., 1986). 
In comparison, little is known about the effects of CPs on cestode infections. There is some 
evidence that CPs are detrimental to the survival of cestodes in in vitro maintained assays (He et al., 
1992; Stepek et al., 2007e); Chapter 3 this thesis), but some published data also indicate that this is not 
reflected in a reduction of parasite burdens when CPs are administered to infected hosts (de Amorin et 
al., 1999; He et al., 1992). Using lattices from the fig species of F. insipida and F. carica at 3-
4mls/kg/day for 3 days, De Amorin et al. 1999 failed to demonstrate a significant reduction of parasites 
in albino mice infected with H. nana (6.3-8.3%). However, the methodology described in this paper 
was unclear as worm burden was expressed as a percentage of the wet weight of proglottids found in 
faeces in relation to total faecal and intestinal proglottids on autopsy and no dry weight assessment was 
carried out. Moreover, the authors did not quantify active molar enzyme activity which raises the 
question of enzyme viability. Using young pineapple juice at doses between 0.4-50%, He et al. 1992 
also found no reduction in worm burden in Swiss white mice infected with H. nana. One pertinent issue 
with respect to this model system is that H. nana is a rather unusual cestode in that it can develop 
directly in rodent hosts without the involvement of intermediate hosts and infections can be augmented 
by autoinfection (Smyth, 1998), thereby making assessment of parasite burdens difficult and unreliable 
in relation to the originally administered eggs or cysticercoids. Moreover, the exact methodology 
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applied in this Indonesian paper could not be ascertained as copies of the paper are unavailable through 
library resources in the UK, and cannot be downloaded via the internet. To date, few results based on 
well designed in vivo trials with tapeworms have been published and whether CPs have in vivo activity 
against cestodes is still debatable. Nevertheless, it is very important to establish whether they are 
effective against cestodes in vivo, if potential drugs are to be taken forward to clinical trials and 
eventually are to be developed into useful therapeutic agents. 
Two rodent infective cestode model systems are maintained widely and have been used 
extensively to study the biology and host-parasite relationships of cestodes. The first of these, H. 
microstoma, was discussed in Chapter 5. The second model is the intestinal lumen dwelling rat 
tapeworm H. diminuta. Despite being a natural parasite of  rats (Abu Madi et al., 2001), these 
tapeworms can also grow temporarily in mice before they are expelled usually 10-12 days post 
infection by host immunity (Hopkins et al., 1972a). However, they have been shown to survive 
rejection in the immunocompromised host (Hopkins et al., 1972b). H. diminuta has an indirect life 
cycle in which arthropods such as flour beetles (e.g. Tribolium confusum) serve as intermediate hosts 
(Fox, 2007). Accidental ingestion of the arthropod host releases dormant cysticercoids which excyst in 
the duodenum of the vertebrate host and migrate and mature in the small intestine. Unlike H. 
microstoma which possesses hooks as organs of attachment, H. diminuta is only equipped with an 
unarmed rostellum, so the parasite cannot embed deeply into the intestinal mucosa, but is attached only 
by its suckers. This attachment is temporary because the worms can detach easily enabling movement 
and reattachment at new sites within the intestine (Smyth, 1998). The weak attachment of this species, 
suggests that it may be a sensitive model in which to assess the host-protective effects of anthelmintics 
such as the CPs being evaluated in this project.  In this context also, H. diminuta exhibits a complex 
pattern of migratory behaviour. There is a circadian pattern of migration of which there is anterior 
migration from 12am to 6am and a posterior migration during the period of 12pm to 6pm (Tanaka and 
MacInnis, 1975). Various stimuli were thought to influence migration including availability of ingesta 
in the stomach (Read and Kilejian, 1969), nutrition (Dunkley and Mettrick, 1977) and even pH of 
intestinal contents (Mettrick, 1971). Finally it was concluded that the actual stimulus affecting 
migration was intestinal contraction as the worms move anteriorly against peristalsis during active 
feeding to avoid expulsion (Sukhdeo, 1992b). 
Having demonstrated in the results presented in Chapter 4 that H. diminuta is susceptible to 
CPs in vitro, here I present the results of experiments that aimed to assess whether CPs also have 
detectable activity against a natural cestode of rats in its normal host in vivo. The hypothesis tested was 
that H. diminuta is susceptible to the anthelmintic activity of CPs when developing in its normal rat 
host. 
 
7.2 Experimental design and results 
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7.2.1 Experiment 1 
 
Assessment of the anthelmintic efficacy of papaya latex supernatant (PLS) against H.diminuta in vivo. 
 
7.2.1.1 Experimental design 
This experiment was designed to assess the effect of PLS against H. diminuta in vivo. Twenty rats were 
used in this experiment (see chapter 2). Rats were divided into 2 groups. Group 1 received PLS at 2.4 
µmols and group 2 received water. The effectiveness of treatment was determined through faecal egg 
counts as well as by autopsy for recovery of worms and assessment of their biomass. Each rat in group 
1 received a 2 ml dose of PLS containing 2.4 µmols of active CPs while each rat in group 2 received a 2 
ml dose of water. Faecal egg counts were carried out on days 21
st
, 23
rd 
, 25
th 
,28
th
, 30
th
 and 32
nd
 post 
infection. Treatment was administered once daily starting from days 27
th
 until 32
nd
. 1 rat from the 
treatment group died during the course of treatment and was not included in the results analysis. 
 
7.2.1.2 Results 
The faecal egg counts (Fig 7.1A) in the treatment group receiving PLS did not show any convincing 
reduction compared to the control group receiving water. Indeed arithmetically, the mean values were 
higher than the control group following treatment. This difference in FEC between treatment groups 
was not statistically significant (rmGLM, between subjects test, F1,17=2.772 P=0.114) and there was no 
evidence of a divergence between treatment groups with time (within subjects test, time*treatment 
interaction F4.415,75.056=2.371 P=0.054). 
However, there were significant differences in worm burden (Fig 7.1B) (Mann-Whitney U 
test, z=-2.936, P=0.003) and biomass (Fig 7.1C) ( wet biomass, Mann-Whitney U test, z=-2.351, 
P=0.011;  dry biomass, Mann-Whitney U test, z=-2.694, P=0.007) assessments between the treated 
group and the control group. 
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Fig. 7.1. Efficacy of PLS against H. diminuta in vivo 
The various indices demonstrating the effects of PLS on H. diminuta in vivo. (A) The mean eggs per 
gram of faeces before (days 21-25) and during (days 27-32) treatment of Wistar rats infected with H. 
diminuta and treated with PLS 2.4 µmols (n=9) or water (n=10). There was no significant difference 
observed in faecal egg counts between treatment groups, nor a significant time*treatment interaction. 
For statistical analyses see text. Error bars represent the standard error of the log mean. (B) The mean 
worm burden of Wistar rats infected with H. diminuta and treated with PLS 2.4 µmols  (n=9) or water 
(n=10). (C) The mean biomass of H. diminuta in Wistar rats treated with PLS 2.4 µmols (n=9) or water 
(n=10). There were significant differences observed in all three autopsy indices between the treated 
group as compared to the control group. For statistical analyses see text. The amount of active CP 
expressed in µmols is the molar equivalent of the inhibitor E-64 used to block active CP in a 10 µl 
volume in a titration assay (see chapter 2). Error bars represent the standard error of the mean. 
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7.2.2 Experiment 2 
 
H. diminuta egg viability experiment 
 
7.2.2.1  Experimental design 
This experiment was planned as a follow-up to Experiment 1 where H. diminuta fecundity appeared to 
have been unaffected by in vivo PLS treatment. Two rats were used in this experiment (see chapter 2). 
The two rats were treated differently;  1 received 2 ml dose of PLS at 2.4 µmols and the other  received 
2mls dose of water. Both rats received daily treatment for 6 days starting from day 17 until day 22 post 
infection. On the 6
th
 day of treatment (day 22), both rats were autopsied and their worms removed. 
Three worms were isolated from each of the two rats. From each worm, the distal most proglottid 
segments of  ̴ 1cm (longitudinal length) were cut and fed to a group of 3 previously starved T. confusum 
beetles, hence nine beetles were exposed to cestode eggs from each of the two treatments of the rat 
hosts. From the same rats, their colons were dissected to recover any detached proglottid segments. Any 
detached proglottid segment found in each animal were fed to 3 more previously starved (5 days) T. 
confusum beetles. After indications that the fed segments have been consumed, regular beetle diet 
consisting of mixture of white and wholemeal flour were added for regular maintenance until after 30 
days when all the beetles were dissected in HanksÕ saline to recover any developed cysticercoids. 
 
7.2.2.2 Results 
T. confusum beetles fed with the cut terminal proglottid segments from H. diminuta which had been 
treated in vivo with PLS were found to harbour intact cysticercoids (Table 7.1A). In fact the mean 
number of cysticercoids recovered was comparable to that of the control group of beetles fed worms 
from rats which had been treated with water (Fig 7.2A). Beetles fed with detached proglottid segments 
recovered from the colon of treated rats also harboured intact cysticercoids (Table 7.1B) and the mean 
burden was comparable to that in the control beetle group fed with detached proglottid segments from 
rats treated with water (Fig 7.2B). 
Table 7.1 H. diminuta egg viability test 
Number of H. diminuta cysticercoids recovered from Tribolium beetles (n=9/ treatment group) fed with 
H. diminuta distal proglottid cut segments (from three worms) from each of two rats treated in vivo  
either with PLS or water 
H. diminuta in 
vivo treatment 
Proglottid 
segment origin 
No of cysticercoids recovered 
Beetle1 Beetle 2 Beetle 3 
PLS Worm 1 10 15 15 
Worm 2 14 11 13 
Worm 3 0 4 0 
Water Worm 1 4 6 7 
Worm 2 12 20 6 
Worm 3 9 14 18 
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Table 7.2 H. diminuta egg viability test 
Number of H. diminuta cysticercoids recovered from Tribolium beetles fed with detached H. diminuta 
proglottid segments from the colon of  Wistar rats infected with H. diminuta and treated in vivo either 
with PLS (n=3) or water (n=3). 
H. diminuta in vivo 
treatment 
No of cysticercoids recovered 
Beetle 1 Beetle 2 Beetle 3 
PLS 2 0 0 
water 0 3 1 
 
 
 
 
Fig 7.2 H. diminuta egg viability experiment 
(A) Mean number of cysticercoids recovered from Tribolium beetles (n=9) fed with distal cut 
proglottid segments (n=3) from H. diminuta from rats (n=2) treated in vivo either with PLS 2.4 µmols 
or water. (B) Mean number of cysticercoids recovered from Tribolium beetles (n=3) fed with colon 
found detached segments (n=3) from Wistar rats (n=2) treated in vivo either with PLS 2.4 µmols or 
water. The amount of active CP expressed in µmols is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the standard 
error of the mean. 
 
7.2.3 Experiment 3 
 
Confirmation of the effects of PLS against H.diminuta in vivo 
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7.2.3.1 Experimental design 
This experiment was a follow-up from Experiment 1 to confirm the effects demonstrated in the 
reduction in worm burden and biomass. Twenty rats were used in this experiment (see chapter 2). 
Although the previous Experiment 1 incorporated the use of a larger sample size n=10, this experiment 
was attempted using a smaller sample size n=5 because more groups were needed to factorially confirm 
the effect of PLS. Each rat was infected with 5 cysticercoids of H. diminuta  on day 0 by oral gavage. 
Rats were divided into 4 groups. Each rat in treatment group 1 received 2 ml dose of PLS at 2.4 µmols. 
Group 2 received 2 ml dose of PLS at 2.4 µmols + E-64 at 2.8 µmols. Group 3 received 2 ml dose of E-
64 at 2.8 µmols and group 4 received 2 ml water. All groups received daily treatment for 6 days starting 
from day 17 until day 22 post infection. In this experiment, assessment of efficacy of treatment through 
faecal egg counts was not carried out due to the earlier results which showed no differences between 
treated and control groups (Experiment 1). Therefore, worms were subjected to earlier treatment (day 
17 post infection for the first dose of PLS, rather than day 27 post infection). Treatment effects were 
only assessed at autopsy through the recovery of worms and assessment of their biomass on day 22 post 
infection. 
 
7.2.3.2 Results 
Arithmetically, there was only minimal reduction (17%) in worm burden when comparing mean values 
between the treated group receiving PLS (mean=3.8) and the control group receiving water (mean=4.6) 
(Fig 7.3A). However, this was not statistically significant (Kruskal-Wallis test, χ22=4.138, P=0.247). 
Biomass assessments however revealed more profound reductions. In the wet biomass assessment, the 
treated group (mean=1.5989grams) had a 38% reduction of mean biomass compared to the control 
group (mean=2.5857grams) (Fig 7.2B) which was statistically significant (Kruskal-Wallis test, 
χ22=10.166, P=0.017). Also noted were increments rather than comparable mean values seen in the 
other control groups like the group receiving PLS+E64 (mean=2.8612grams) and the group receiving 
E64 only (mean=2.6917grams) which were 11% and 4% greater respectively as compared to the group 
receiving water (mean=2.5857grams)(Fig 7.3B). Similarly, the dry biomass assessment saw a 
comparable reduction of 41% between the treated group (mean=0.4452grams) and the group receiving 
water (mean=0.7529grams) (Fig 7.2B) which was also statistically significant (Kruskal-Wallis test, 
χ22=8.806, P=0.032). As expected, a similar pattern of increment was also seen in the other control 
groups i.e. the group receiving PLS+E64 and the group receiving E-64 only which were 3.9% and 4.5% 
greater respectively. In assessing the main effects of PLS, data were analyzed by 2-way GLM 
(treatment with PLS and/or E-64) and the effect of PLS did not significantly affect worm burden 
(P=0.176) but was generally significant in affecting worm biomass (wet biomass P=0.068, dry biomass 
P=0.021). Surprisingly, the effects of E-64 was also found to significantly affect the increment rather 
than reduction in worm biomass (wet biomass P=0.005, dry biomass P=0.008) but not worm burden 
(P=0.176). Importantly the interaction between the main effects of PLS and E-64 was found significant 
in affecting worm biomass (wet biomass P=0.014, dry biomass P=0.024) but not worm burden 
(P=0.176). In other words E-64 had a different consequence depending on whether the rats were treated 
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with PLS or not. In PLS treated rats E-64 ablated the loss of weight completely but in non-PLS treated 
rats there was a margin increase in worm biomass. 
 
Fig 7.3 Confirmation of the effects of PLS against H. diminuta  in vivo 
The various autopsy indices used to measure the effects of PLS against H. diminuta in vivo. (A) The 
mean worm burden of Wistar rats infected with H. diminuta and treated either with PLS 2.4 µmols 
(n=5), PLS 2.4 µmols  pre-treated  with E-64 2.8 µmols (n=5), E-64 2.8 µmols (n=5) or water (n=5). 
(B) The mean biomass of H. diminuta in Wistar rats treated either with PLS 2.4µmols (n=5), PLS 2.4 
µmols pre-incubated with E-64 2.8 µmols (n=5), E-64 2.8 µmols (n=5) or water. PLS appeared to only 
minimally affect worm burdens whilst moderately affecting worm biomass. Other treatments such as E-
64 or when PLS was pre-treated with E-64 did not affect worm burden but surprisingly resulted in a 
slight increase in worm biomass when compared to the controls. For statistical analyses see text. The 
amount of active CP expressed in µmols is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the standard error 
of the mean. 
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7.2.4 Experiment 4 
 
Observation of PLS mediated damage against H. diminuta in vivo. 
 
7.2.4.1 Experimental design 
This experiment was simply a further extension of Experiment 3 to graphically document the effects of 
PLS inflicted on H. diminuta in vivo. Four rats were used in this experiment (see chapter 2). Due to the 
non- analytical nature of the experiment only 1 rat (n=1) per group was used to represent each of the 4 
different treatment combinations. Rats were divided into 4 groups. Group 1 received 2mls dose of PLS 
at 2.4 µmols. Group 2 received 2mls dose of PLS at 2.4 µmols + E-64 at 2.8 µmols. Group 3 received 2 
ml dose of E-64 at 2.8 µmols and group 4 received 2 ml water. All rats received daily treatment for 6 
days starting from day 17 until day 22 post infection. The efficacy of treatment was assessed through 
the recovery of detached proglottid segments found in the large intestine downwards which were 
immediately fixed in glutaraldehyde and later dehydrated, critical point dried and gold coated before 
finally being viewed under scanning electron microscopy for signs of any damage. 
 
7.2.4.2 Results 
H. diminuta proglottid segments recovered from the rat treated with PLS 2.4µmols appeared to sustain 
treatment related damage as the damage observed was substantial, uneven and located not at the 
proglottidÕs anatomical point of attachment exposing H. diminuta eggs (Fig 7.4A). The segments 
recovered from control rats treated with either PLS 2.4µmols pre-treated with E-64 2.8µmols, E-64 
2.8µmols or water did not show similar damage apart from the minimal, clean and sharp tegumental 
breaks or cracks which may be mechanical in origin (Figs 7.4 B-D). 
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Fig 7.4 SEM images of the effects of PLS against H. diminuta in vivo 
SEM images of detached proglottid segments of H. diminuta recovered from the colons of infected 
Wistar rats treated with (A) PLS 2.4 µmols (B) PLS 2.4 µmols  pre-treated with 2.8 µmols  E-64 (C) E-
64 2.8 µmols (D) water. Note the extensive uneven damage (arrows) in (A) exposing H. diminuta eggs 
seen at the lateral aspect of the segment which is not the point of attachment. Note the otherwise 
minimal, clean and sharp breaks or cracks in other segments  (B-D) which may be mechanical in origin. 
The amount of active CP expressed in µmols is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10 µl volume in a titration assay (see chapter 2).  
 
7.2.5 Experiment 5 
 
Assessment of the dose-dependency of H. diminuta in vivo in rats. 
 
7.2.5.1 Experimental design 
This experiment was carried out to assess whether or not the reduction in worm burdens and biomass 
observed following treatment of infected rats with PLS against H. diminuta in Experiment 1 is dose-
dependant. Sixteen rats were used in this experiment (see chapter 2). This experiment was a 
correlational study between the dose of PLS and worm autopsy indices. Therefore, a smaller sample 
A B
C D
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size n=3 was thought to be generally sufficient for each level of treatment. Rats were divided into 4 
groups each receiving different doses of PLS. This experiment was also executed simultaneously with 
Experiment 3 in which rats from the group receiving water were incorporated as group 1 (0 nmols dose) 
in this experiment (n=5) and rats receiving 2400nmols of PLS n=5 were incorporated as group 4. 
Group 2 (n=3) received 60 nmols of PLS, group 3 (n=3) received 240nmols. All groups received daily 
treatment for 6 days starting from day 17 until day 22 post infection. Treatment effects were only 
assessed through worm counts and biomass assessments at autopsy on day 22 post infection. 
 
7.2.5.2 Results 
Autopsy revealed no correlation between PLS dose and worm burden (R=0.001, n=16, P=1) (Figure 
7.5A).  Reassuringly, there was a significant negative correlation between worm biomass and PLS dose 
in assessment of dry biomass (R=-0.531, n=16, P=0.034) (Figure 5B). The wet biomass had a weak 
negative correlation with PLS dose but this was not significant (R=-0.186, n=16, P=0.49) (Figure 5B).  
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Fig 7.5 Dose-dependency of PLS against H. diminuta in vivo 
The various indices demonstrating the relationship between PLS dose and H. diminuta in vivo. (A) The 
correlational trend between increasing PLS dose and worm burden. (B) The correlational trend between 
increasing PLS dose and worm biomass. All groups were of the same sample size (n=3) except groups 
1 and 4 (n=5). For statistical analyses see text. The line of best fit is provided to guide the eye. The 
amount of active CP expressed in nmols is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10 µl volume in a titration assay (see chapter 2).  
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7.2.6 Experiment 6 
Assessment of H. diminuta recovery in vivo post PLS treatment 
 
7.2.6.1 Experimental design 
This experiment was designed to assess whether or not H. diminuta have the ability to recover in vivo 
post PLS treatment since tapeworms have been shown to repair themselves quickly after sustaining 
damage (Befus and Threadgold, 1975). Twenty rats were used in this experiment (see chapter 2). The 
rats were divided into 4 groups with 5 rats per group (n=5). Group 1 received 2mls PLS at 2.4µmols, 
group 2 received 2mls water, group 3 received 2mls PLS at 2.4µmols and group 4 received 2mls water. 
All groups received daily treatment for 6 days from day 17 until day 22 post infection. Groups 1 & 2 
were sacrificed immediately at the end of the treatment week (day 22 post infection) while groups 3 & 
4 were left to continue without treatment for another week until day 28 of infection. 1 rat in group 3 
died during the course of treatment and was excluded from the results reducing the number of sample in 
group 3 (n=4). The effectiveness of treatment was determined through autopsy for recovery of worms 
and assessment of their biomass on days 22 and 28 post infection. 
 
7.2.6.2 Results 
The first autopsy which was immediately after completing 6 days of treatment revealed a modest 
profile of reduction compared to the reductions seen in Experiment 1 and  3. In fact there was no 
arithmetical reduction seen in worm burden (Fig 7.6A) but there was 6-18% reduction seen in biomass 
(Fig 7.6B). Interestingly, the second autopsy which was conducted 1 week after withholding treatment 
revealed a more profound profile of reductions compared to 1
st
 round of autopsy with all indices 
showing an increase in arithmetical reductions ranging from 12-22%. Data were further explored using 
2-way GLM to assess the main effects of time and treatment and also the interaction between the two 
variables. The effect of treatment on worm burden was not significant F1,15=3.151 P=0.096 and neither 
was the effect of time on worm burden F1,15=0.014 P=0.907. There was no significant interaction 
between time and treatment on worm burden F1,15=3.151 P=0.096. The effect of treatment on wet 
biomass, however, was close to significance F1,15=3.386 P=0.086. Surprisingly, the effect of time was 
also significant F1,15=6.663 P=0.021, wet biomass values being lower on day 28 compared with day 22 
in both groups. However, surprisingly the interaction of treatment and time was not significant 
F1,15=1.25 P=0.281 despite the greater discrepancy between mean values of treated and control rats on 
day 28 compared with day 22. The effect of treatment on dry biomass was significant F1,15=7.682 
P=0.014, the values in PLS treated rats being lower on both occasions, while the effect of time was just 
outside of significance F1,15=4.143 P=0.06. Again, perhaps surprisingly, there was no significant 
interaction between time and treatment F1,15=0.261 P=0.617. 
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Fig 7.6 H. diminuta recovery post PLS treatment 
 (A) The mean worm burden of Wistar rats infected with H. diminuta immediately after 6 days 
treatment of either PLS 2.4 µmols (n=5) or water (n=5) and 1 week after withholding treatment of PLS 
2.4 µmols (n=4) or water (n=5). (B) The mean biomass of H. diminuta in Wistar rats immediately after 
6 days treatment of either PLS 2.4 µmols (n=5) or water (n=5) and 1 week after withholding treatment 
of PLS 2.4 µmols (n=4) or water (n=5). The amount of active CP expressed in µmols is the molar 
equivalent of the inhibitor E-64 used to block active CP in a 10 µl volume in a titration assay (see 
chapter 2). Error bars represent the standard error of the mean. 
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7.3 Discussion 
Following the disappointing results from using the H. microstoma model (Chapter 5) this chapter was 
designed to test the efficacy of CPs in a different model system, H. diminuta, in its natural host, the rat. 
With this model, I intended to explore the consequences of treatment with CPs for an entirely intestinal 
lumen dwelling tapeworm as opposed to H. microstoma which attaches in the bile duct and employs 
hooks to aid attachment to host tissues. The latter species, attaching in the common bile duct, might 
escape contact with CP especially in the sensitive neck region and the scolex itself.  
Disappointingly, the faecal egg count results (Fig 7.1A) showed no reduction in the treated group as 
compared to the control. Despite the worms being fully exposed to the CPs because the worm is lumen 
dwelling, the dose still failed to show any reduction in faecal egg counts.   Clearly, tapeworms cannot 
be compared directly to nematodes which once affected by CPs, usually die, exploding soon afterwards, 
resulting in the cessation of egg output which is then clearly reflected within 24h in a reduction of 
faecal egg counts. 
 It was then imperative to ascertain whether fecundity was still affected despite no reduction in egg 
counts by egg viability test (Experiment 2). Disappointingly, H. diminuta eggs were not affected at all 
because intact H. diminuta cysticercoids were recovered from Tribolium beetles fed with either cut 
terminal proglottid segments or detached proglottid segments recovered from the colon of rats infected 
with H. diminuta and treated with PLS. The difference in mean cysticercoids recovered between 
Tribolium beetles fed with cut terminal proglottid segments and recovered detached proglottid segments 
was perhaps due to their size where the cut proglottides were around 10mm in longitudinal length 
whereby the colon recovered detached segments were around 1-2mm.Unlike the benzimidazoles which 
were able to affect the development of H. diminuta larval stages (Evans and Novak, 1976) PLS does 
not appear to have any effect on H. diminuta fecundity when administered to infected rats. However, 
the experiment by (Evans and Novak, 1976) was an in vitro experiment in which infected Tribolium 
beetles were fed flour infused with benzimidazole drugs, whereas in the current work I tested the 
viability of eggs shed in vivo by infected rats. Structurally, cestode eggs have a thicker outer shell 
compared to trichostrongyloid nematode eggs such as those of H. bakeri, but not those of Trichuris and 
Ascaris species. This robust egg shell is required because of the need for the eggs to survive in harsh 
external environmental conditions before continuing its life cycle in an intermediate host. Perhaps, the 
egg shell does not contain similar protein targets found in the tegument and nematode cuticle which are 
susceptible to PLS attack. Similar findings of unaffected fecundity were also observed in H. 
microstoma (chapter 5). 
Contrary to the unaffected fecundity, autopsy indices revealed a different perspective on the efficacy of 
PLS against H. diminuta in vivo. The pilot experiment (Experiment 1) revealed a moderate (46%-54%) 
but significant reduction profile. This came as a surprise since H. microstoma was only minimally 
affected (Chapter 5). In the non-permissive host however, a more marked effect was seen on H. 
diminuta (Chapter 6) possibly as a result of a compound attack from PLS as well as the immune 
system. However, these effects need to be confirmed using E-64 as a specific inhibitor for CP so that  
we can indeed be certain that of the cysteine proteinases in PLS are the active principles. Despite a 
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much varied response in arithmetical reductions (worm burden 17%, wet biomass 38% and dry biomass 
41%) as compared to the controls this experiment (Experiment 3) confirmed that PLS cannot be said to 
be responsible for worm loss but does indeed affect the ability of the worm to repair itself after PLS 
treatment, as non-parametric testing revealed that worm biomass was significantly different (both wet 
& dry biomass) from the other control groups. Not surprisingly, both groups either receiving E-64 alone 
or PLS which had been pre-incubated with E-64, saw an increase in biomass (4-10%) compared to the 
group receiving water. This finding is comparable to similar observations from experiments conducted 
with H. microstoma which were thought to be due to an exaggerated response of repair following the 
perturbation of other components in PLS (since PLS being competitively inhibited) such as the 
mucolytic enzymes and alkaloids that PLS is known to contain  (Mezhlumyan et al., 2003). These 
might still be at large diffusing through the tegument. Even E-64 alone might still be diffusing through 
the tegument causing disturbance and the exaggerated repair. This postulation was strengthened by the 
fact that the main effects of E-64 was significant in a 2-way GLM. Therefore, PLS can possibly be said 
to affect the ability of H. diminuta to repair itself but not to the extent of expelling the damaged worms. 
SEM images of found detached proglottid segments from the colon following treatment perhaps 
provide further evidence of PLS efficacy. While the control segments were either intact or possibly 
sustained mechanical damage (Fig 7.4B-D), the segment found in the colon of the PLS treated animal 
appeared to have sustained more extensive, treatment-related damage (Fig 7.4A) which was uneven in 
appearance across the sampled proglottids. However, the possibly damaged appearance was not as 
extensive as that seen earlier in the in vitro experiment images (Chapter 4). One possible explanation 
could be due to the remarkable ability for repair in cestodes (Befus and Threadgold, 1975). 
In evaluating these effects further it was also imperative to ascertain whether or not the effects were 
dose dependant (Experiment 5.). As expected, worm burden has no correlation with increasing PLS 
dose (Fig 7.5A). Worm dry biomass however showed the expected negative correlation (Fig 7.5B) with 
increasing PLS dose although wet biomass had only a weak correlation (Fig 7.5B) but nevertheless still 
in the expected direction. Having seen all the effects of PLS on H. diminuta in vivo after completing 
treatment it was also important to see whether or not these effects are permanent or temporary since 
cestodes have been shown to be able to repair damage very quickly (Befus and Threadgold, 1975). The 
reduction in worm burden especially required validation because there remained the possibility that 
what might have been interpreted initially as worm loss was in actuality generated by destrobilated 
scoleces persisting somewhere in the intestine and later regrowing to the original size as mature worms 
when the danger from local CPs had been swept away by peristalsis. Destrobilated scoleces have been 
shown to regrow even when transplanted into another host (Hopkins et al., 1972a). Experiment 6 
revealed that arithmetically time does have an effect on worm loss because there was an overall 15% 
loss of worm burden when the assessment was conducted a week later than immediately after treatment. 
However, this proved not to be statistically significant indicating that actually worms are not lost over 
this short period of time in PLS treated animals. The interaction of time and treatment on worm burden 
was close to but not significant (P=0.096), and this reflected the slight drop in numbers in treated rats 
and the slight gain in mean worm burden in the control rats over time but the values are very small and 
whether they have a biological basis is not clear. It is possible that PLS is indeed responsible for some 
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loss of  H. diminuta worms in vivo possibly through a synergistic interaction with the immune system 
whereby weak and vulnerable worms post PLS damage might not be able to continue to evade the host 
immunity as well as normal patent and healthy worm.  Even in its natural rat host, H. diminuta has been 
shown to be rejected immunologically over a long time frame (Andreassen and Hopkins, 1980).  
The effects on worm burdens differ from those on worm size  as reflected in biomass where dry 
biomass was significantly reduced and mean wet biomass also fell with time although not significantly. 
Interestingly a fall in mean dry and wet biomass was also evident in control rats although not 
significantly in the case of dry biomass since the main effect of time and the interaction between time 
and treatment were not significant. In the case of wet biomass, however, the change over time (Fig 
7.6B) alone was significant indicating that worms did get smaller over time in the experiment 
regardless of treatment and this might possibly be explained by interworm competition for resources as 
described by Read (1951) who coined the crowding effect. 
Another observation worth mentioning is the occurrence casualties during experiment. In experiments 1 
& 6, 1 rat from each experiment died during the course of treatment. Unlike some mice, rats were not 
affected at all by PLS treatment and this was reflected by no weight loss during a typical 6-days 
treatment course (results not shown). Casualties happened almost immediately during oral gavage as a 
result of slight inaccuracy in animal handling technique where the animal may have experienced gastro-
oesophageal reflux and part of the PLS may find its way into the animalÕs lungs killing it 
instantaneously.  
 The results from this chapter provide the first convincing evidence showing that this 
tapeworm, H. diminuta, is affected by CPs in vivo albeit just moderately and this contrasts with 
previous reports based on experiments with other species of rodent cestodes (de Amorin et al., 1999; He 
et al., 1992). The results offer the possibility that with further refinement, CPs may be developed into 
broad spectrum anthelmintics that remove nematodes from their hosts and have significant effects also 
on any concurrently resident tapeworms. 
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CHAPTER 8 
 
Assessment of the anthelmintic efficacy of PLS against the equine cestode A. perfoliata in vitro. 
 
8.0 Summary  
Papaya latex has been demonstrated to be efficacious against murine (Satrija et al., 1995; Satrija, 2001; 
Stepek et al., 2006b, 2007b, c), porcine (Satrija et al., 1994), ovine (Buttle et al., 2011), canine (Stepek 
et al., 2007e) and even helminths of chicken (Mursof and He, 1991). The experiments described in this 
chapter indicate that CPs are also efficacious against the equine cestode A. perfoliata by causing a 
significant reduction in motility leading to death of the worms. This is the first evidence for 
anthelmintic efficacy of CPs in an equine helminth, providing further evidence that the spectrum of 
activity of CP is not restricted to nematodes and supporting the idea that they can be developed into 
useful broad-spectrum anthelmintics.. 
 
8.1 Introduction 
Horses are animals of economic importance (Huffman and Guidry, 1979), as working animals in some 
countries, for the provision of meat and especially in the racing and leisure industries in more affluent 
parts of the world.  Maintaining their health is therefore crucial. Gastrointestinal helminths are a major 
cause of morbidity in the livestock industry including horses (Matthews et al., 2004; Nieuwhof and 
Bishop, 2005)  in which nematodes such as Parascaris, the  strongyloids and the cyasthostomins  are 
central to the problem, with pathological effects that can be severe enough to cause marked distress to 
the animals. Infection with the equine cestode A. perfoliata has recently been recognized as a 
significant  cause of  morbidity in horses (Proudman and Trees, 1999).  Intestinal problems may range 
from mild colic (Proudman et al., 1998) to necrosis (Rodriguez-Bertos et al., 1999) and there has even 
been a report of a fatal case of caecal rupture (Ryu et al., 2001). 
Control of GI helminths is principally by chemotherapy (Behnke et al., 2008), and not 
surprisingly with the wide scale usage and over use of anthelmintics resistance has arisen among equine 
nematodes just as in those of cattle and sheep. Anthelmintic resistance among horse worms is a serious 
problem of some economic significance (Kaplan, 2002, 2004). Despite the lack of any reports of 
resistance among horse tapeworms, the issue should not be taken lightly especially in the wake of 
development of praziquantel resistance in other platyhelminths (Ismail et al., 1999) 
Alternatives to conventional chemotherapy based on synthetic products should be explored in 
the wake of promising developments of plant based anthelmintics such as the  CPs (Behnke et al., 
2008). CPs have been shown to work against various helminths ranging from murine (Stepek et al., 
2007c) to ovine (Buttle et al., 2011), and recent work shows that they are also effective against 
tapeworms (Stepek et al., 2007e) and See Chapter 4 and 6. 
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 In earlier chapters, I explored the effects of CPs both in in vitro and in vivo against rodent 
tapeworms which are useful laboratory models, but are not of economic significance. In this chapter I 
present data assessing the efficacy of papaya latex against the equine cestode A. perfoliata which is an 
important pathogen of horses and which is not easy to treat with conventional anthelmintics (Matthews 
et al., 2004).  
 
8.2 Experimental design and results 
 
8.2.1  Experiment 1 
 
The efficacy of PLS against adult A. perfoliata in vitro. 
 
8.2.1.1  Experimental design 
Adult horse tapeworms, A. perfoliata, were sourced from TurnerÕs abbatoir, Cheshire (see chapter 2). 
Worms were incubated in different combinations of treatments of either PLS with and without the 
activator cysteine (on a range of concentration of active CP), PLS pre-treated with E-64 and the control 
treatments of HanksÕ saline with and without cysteine. 
 
Fig 8.1 A. perfoliata in horse caecal fluid transferred from the flask. 
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8.2.1.2 Results 
Arithmetically, it was evident that worm motility quickly decreased in the groups incubated in higher 
concentrations of PLS activity (1000µM- 3000µM). Motility decreased steadily in the groups  
incubated in intermediate concentrations of PLS activity (30µM- 300µM). On the contrary motility was 
relatively maintained until the end of experiment at 120min in worms incubated in low concentration of 
PLS activity (10µM), PLS priorly treated with E-64, HanksÕ saline with or without 1mM cysteine. The 
motility reducing effects of PLS against A. perfoliata were both time (F8,112=87.631 P<0.001) and 
concentration (F 6, 14=245.924 P<0.001) dependant.  
 
Fig 8.2 Motility of adult A. perfoliata in PLS in vitro 
Motility of adult  A.perfoliata  incubated in varying concentrations of active PLS in vitro. The 
concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the standard error 
of the mean n=3. 
 
 
Table 8.1 IC50 values of PLS efficacy against various cestodes. 
 
 
 
 
*Data derived from chapter 4 
** The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10 µl volume in a titration assay (see chapter 2).  
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Fig 8.3 Concentration-inhibition curves of PLS activity against various cestodes at 30 minutes post 
incubation.  
Note the greater efficacy of PLS against A. perfoliata with IC50 values of almost 4x less than murine 
cestodes. The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 
used to block active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the 
standard error of the mean n=3. 
 
8.2.2 Experiment 2 
 
The observation of CP mediated damage against A. perfoliata under SEM 
 
8.2.2.1  Experimental design 
Experiment 2 was conducted simultaneouly alongside Experiment 1. Worms from the same stock used 
in Experiment 1 were incubated into either PLS 1000µM+1mM HC or HanksÕ saline. At timely 
intervals of 10min, 20min and 60min, 1 worm was removed and fixed in glutaraldehyde, dehydrated in 
alcohol, critical point dried and gold coated before finally being viewed under SEM. 
 
8.2.2.2 Results 
Worms incubated in PLS showed marked generalised erosions as early as 10min (Fig 8.4B). After 
20min of incubation in PLS and the progressive erosion was made more apparent and the tegument 
appears to undergo ÔexfoliationÕ (Figs 8.4 C). After 60min of incubation in PLS the tegument was 
severely damaged and appears chapped and flaky. 
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              0min                                      10min                                       20min                                   60min                
Fig 8.4  SEM images of A. perfoliata in PLS  
A. perfoliata incubated in  PLS 1000 µM+1 mM HC  in vitro (A) at 0 min (B) at 10 min (C) at 20 min 
(D) at 60 min. A. perfoliata incubated in HanksÕ saline (E) at 0min (F) at 60min. Note the progressive 
damage to the tegument in worms incubated in PLS and intact worms incubated in HanksÕ saline. The 
concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to block 
active CP in a 10 µl volume in a titration assay (see chapter 2).  
 
8.2.3 Experiment 3 
 
The efficacy of various CPs against A. perfoliata in vitro 
 
8.2.3.1  Experimental design 
Experiment 3 was designed as an extension of experiment 1 to observe the efficacy of other types of 
CPs against A. perfoliata. Adult  A. perfoliata, were sourced from Lawrence J. PotterÕs abbatoir, 
Somerset (see chapter 2). Worms were incubated in different combinations of treatments of either CP 
with and without the activator cysteine (on a range of concentration of active CPs), CP pre-treated with 
E-64 and the control treatments of HanksÕ saline with and without cysteine (3 replicates per treatment 
n=3). 
 
8.2.3.2 Results 
In all CPs tested the motility of adult A. perfoliata was rapidly reduced in the presence of higher 
concentrations of active CPs, but more gradually in the presence of moderate concentrations of active 
CPs (see Figs 8.5 A-C). Pineapple extract caused a significant reduction in motility which was both 
time ( F8,80 = 82.897  P<0.001 )  and concentration ( F4,10 = 136.908  P<0.001 ) dependant. Papain 
caused a significant reduction in motility which was both time ( F8,96 = 94.168  P<0.001 ) and 
concentration ( F5,12 = 76.546  P<0.001 ) dependant. Stem bromelain caused a significant reduction in 
A B C D
E F
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motility which was both time ( F8,96 = 55.798  P<0.001 ) and concentration ( F5,12 = 32.816  P<0.001 ) 
dependant. Motility however was relatively preserved when worms were incubated in the presence of 
low concentrations of active CPs or in the control solutions of HanksÕ saline with or without cysteine 
and also in the presence of CP pre-treated with E-64 (see Fig 8.5 A-C). Although all CPs tested were 
efficacious, efficacy varied between the enzymes with pineapple extract being most efficacious at IC50 
of 74µM and stem bromelain being the least efficacious with 1C50 of 834µM (tab 8.2). 
 
Fig 8.5 Motility of adult A. perfoliata in various CPs in vitro 
Motility of adult  A. perfoliata  incubated in various CPs in vitro (A) pineapple extract (B) papain (C) 
stem bromelain. , CP without cysteine (concentration equivalent to the highest concentration in 
particular  experiment); , 1000µM+1mM HanksÕ cysteine;  , 300µM+1mM HanksÕ cysteine; , 
100µM+1mM HanksÕ cysteine; , 30µM+1mM HanksÕ cysteine;  , 10µM+1mM HanksÕ cysteine;  
; CP pre-treated with E-64 (active CP concentration equivalent to the highest concentration in 
particular CP experiment); , 1mM HanksÕ cysteine; , HanksÕ saline. The concentration of active CP 
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expressed in µM is the molar equivalent of the inhibitor E-64 used to block active CP in a 10 µl volume 
in a titration assay (see chapter 2). Error bars represent the standard error of the mean n=3. 
 
Fig 8.6 Concentration-inhibition curves of various CPs against A. perfoliata in vitro at 30 minutes post 
incubation.  
The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10 µl volume in a titration assay (see chapter 2). Error bars represent the standard 
error of the mean n=3. 
 
Table 8.2 IC50 values of various CPs against A. perfoliata in vitro. 
 
 
 
 
* The concentration of active CP expressed in µM is the molar equivalent of the inhibitor E-64 used to 
block active CP in a 10 µl volume in a titration assay (see chapter 2).  
 
8.3 Discussion 
One of the important aspects in developing novel classes of anthelmintic is the need for them 
to show broad spectrum of activity against helminths and even parasites of other taxonomic groups, 
such as the protozoa, because the broader the spectrum against pathogens the better the chances of 
acceptance by users (Behnke et al., 2008). Papaya latex has been demonstrated to be efficacious against 
murine (Stepek et al., 2007c), porcine (Satrija et al., 1994), ovine (Buttle et al., 2011) canine (Stepek et 
al., 2007e) and even helminths of chicken (Mursof and He, 1991). It has also been demonstrated to 
affect juvenile stages of plant parasitic nematodes (Stepek et al., 2007a). These observations suggest a 
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broad spectrum of activity and hence a promising prospect for CPs in conventional therapy. Moreover, 
in this thesis, evidence has been presented showing an even wider spectrum of activity than that already 
in the public domain, namely on rodent cestodes both in vitro and in vivo.  
The experiments reported in this chapter showed  a marked effect of CPs on an equine cestode, 
A. perfoliata, in vitro by significantly reducing its motility and finally causing death of the worms (see 
Figs 8.2 & 8.5). The reduction in motility was both time and dose dependant but independant of the 
presence of cysteine, similarly to the earlier reported observations on both rodent cestodes (see Chapter 
4) but differing from the effects on nematodes which are dependant upon the presence of cysteine 
(Stepek et al., 2005). The most likely explanation of this is perhaps through its excretory process via the 
tegument that cestodes produce a reducing agent that in turn activates CPs.  
Equally surprising was the finding that CPs appeared to be more efficacious against A. 
perfoliata than it was against other rodent cestodes (see Fig. 8.3) with IC50 values of 3-4 times lower 
than for rodent cestodes (see table 8.1). This greater sensitivity of A. perfoliata to CPs may be 
explained by the relative diminutive length of A. perfoliata size which ranged between 2-5cm compared 
to 14 day-old adult H. diminuta used earlier for in vitro experiments (chapter 4) which were are almost 
15cm long. Thus exposed surface area may have been factor, but it may also be possible that the 
tegument itself is different from that of rodent cestodes in terms of its constituent proteins, as a result of 
the different diets and consequently physiological conditions in the intestines of horses compared to 
rodents. Efficacy also differed between different types of CPs (see Fig 8.6 and Table 8.2) with naturally 
occurring CPs like pineapple extract and PLS being more efficacious than singular purified CPs like 
papain and stem bromelain which is a similar observation in rodent cestodes (chapter 4). 
It has been shown that CPs damage the tegument of murine cestodes possibly by hydrolysing 
particular proteins that make up the tegument resulting in generalised tegumental digestion. 
Consequently, at weakened points CPs eventually cause breaches of tegumental integrity and the 
subsequent release of internal contents. In this chapter, based on SEM observations, PLS has been 
shown to damage the tegument of A. perfoliata (see Fig. 8.4)  in much the same manner,  beginning 
with superficial generalised erosion of the surface of the tegument (Fig 8.4B) and with time, a much 
deeper and widespread generalised destruction (Fig 8.4D).  Visually the images documenting damage 
to the surface of rodent cestodes (chapter 4) and those in this chapter to A. perfoliata were 
indistinguishable in terms of the sequence and extent of the changes that were observed. This is quite 
different from conventional cestocidals such as praziquantel which causes contraction in platyhelminths 
(Becker et al., 1980; Mehlhorn et al., 1981) or benzimidazoles which interferes with β-tubulin synthesis 
resulting in blebbing of the tegument (Schmidt, 1998a). 
The results from the work described in this chapter constitute the first evidence of CP affecting 
an equine helminth and in turn provide an interesting possibility for the development of CP based 
anthelmintic for cestodes of horses, which are known to be a significant risk factor in equine health 
(Proudman et al., 1998). This prospect is particularly compelling for a number of reasons. Firstly, the 
greater efficacy of PLS against A. perfoliata, compared to rodent cestodes, demonstrated here, must be 
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a positive feature. Secondly, CPs have been shown to accumulate in the hindgut region, where A. 
perfoliata resides, for longer periods of time (see chapter 3) , than in more proximal regions and this is 
another positive feature since it should ensure prolonged and more intense exposure to CPs for 
tapeworms dwelling in this region of the gut. Lastly, it has also been demonstrated that large animals 
such as small ruminants, including sheep (Buttle et al., 2011), required less drug per kilo body weight 
than small animals like mice (Stepek et al., 2007c), thus minimising or perhaps even eliminating the 
problem of toxicity. More importantly, the results provided further evidence that the spectrum of 
activity of CP is not restricted to nematodes, supporting the idea that they can be developed into useful 
broad-spectrum anthelmintics. 
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CHAPTER 9 
  
General discussion and conclusion 
 
9.0  Summary 
This chapter provides an overall view of all the work conducted during my research programme, 
highlighting key observations from the various chapters of this thesis. I refer to some of the challenges I 
experienced and identify areas for improvement and further work. Thus it is important throughout to 
refer to the individual chapters for additional, specific and detailed information on the experiments that 
were conducted and to which I refer here. 
 
9.1  General discussion 
Gastrointestinal (GI) helminths pose a significant threat to the livestock industry (Nieuwhof and 
Bishop, 2005) and are a recognized cause of global morbidity in humans (Chan, 1997b). Control relies 
principally on chemotherapy (Behnke et al., 2008) but in the case of nematodes is rapidly losing 
efficacy through widespread development and spread of resistance to conventional anthelmintics 
(Kaplan, 2004) and hence the urgent need for novel classes of anthelmintics. Extracts from papaya latex 
have been shown to be effective against nematodes from various hosts in vitro (Stepek et al., 2005; 
Stepek et al., 2006b, 2007b) and in vivo (Buttle et al., 2011; Stepek et al., 2006b, 2007b, d) and their 
effects were confirmed to be mediated by CPs (Stepek et al., 2005).  Preliminary evidence has 
suggested that plant derived CPs may affect also other classes of helminths including cestodes (He et 
al., 1992; Stepek et al., 2007e). In developing novel classes of anthelmintics it is important to establish 
the breadth of their spectrum of activity because the broader the spectrum the better their chances of 
acceptance by the end users (Behnke et al., 2008). This project was initiated to establish systematically 
whether CPs are able to affect cestodes, causing damage sufficient to prevent the worms from surviving 
in their hosts. 
One of the main problems in developing natural products and introducing them into 
conventional therapy is standardization of their active principles (Behnke et al., 2008). This is because 
variation may exist between different varieties or even between different stages of development of the 
same fruit (Vines and Oberbacher, 1963). Therefore, rather than using crude papaya latex which is 
unrefined and collected from multiple sources we chose to use a more standardized form of papaya 
latex from Enzymase (Brussels, Belgium) which was sourced from the a single plantation and was 
subjected to strict and standardized purification processes. Another key aspect in manipulating enzymes 
is preserving the amount of active enzymes because enzymes are incapable of exerting their biological 
effects on target molecules unless activated. PLS was the result of several further refinement processes 
including centrifugation and dialysis in which loss of enzyme activity was kept to a minimum.  
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Since PLS was used throughout the thesis, it was therefore important to address 
questions/concerns that might be raised by the insightful and critical reader/referee. An obvious concern 
is enzyme stability under the working conditions in the laboratory, i.e.- how stable is PLS during 
storage or during incubation of in vitro assays ?. In Chapter 3 we investigated the thermostability of 
PLS under various conditions within the context of the thesis. Under storage we observed that PLS was 
stable at lower temperatures where it remained active for up to 1 year. This was not unexpected, since 
proteins in general are known to undergo denaturation at higher temperatures (Somero, 1995). 
However, it was also noted that freezing affected the active component of PLSto some degree but this 
amounted to no more than 20% loss of enzyme activity and no further deterioration was observed. This 
loss of enzyme activity may be explained by cold denaturation. Unlike heat denaturation which is 
clearly correlated with temperature (Somero, 1995) the mechanism of protein inactivation by cold 
denaturation is multifaceted with much damage attributed to crystallisation of water through physical 
and chemical changes (Arakawa et al., 2001). Given that freezing affects PLS to some degree, one 
would naturally expect that repeated freeze-thawing will inactivate or at least reduce the amount of 
active enzymes even further as was shown by Cao et al. (2003). However, surprisingly, PLS was fairly 
stable throughout repeated freeze-thaw cycles of up to 5x. This may be due to the fact that PLS is not a 
singular purified enzyme but rather a partially refined enzyme complex which actually contains many 
components other than proteases some of which may protect the proteases physically and also 
contribute to the stability of CP as excipients.  
The next important question to address was how stable is PLS under the typical in vitro 
motility assay conditions employed here and reassuringly, although perhaps initially counter intuitively 
given the temperature,  PLS was observed to be stable during the whole 2hrs of incubation at 37¡C 
under exactly typical in vitro motility assay conditions.  Notwithstanding,  papaya latex has been shown 
by others to resist temperatures of up to 60¡ (Chaiwut, 2007) before denaturation takes effect. 
Furthermore, the inclusion of cysteine in all CP assays should act as an excipient adding further 
stabilisation effects.   
Apart from investigating PLS thermostability it was also important to investigate how PLS 
behaves in the animal model itself,  because to date the anthelmintic properties of papaya latex have 
been reported only for oral treatment with the crude latex (Stepek et al., 2007b). It was observed that 
PLS activity declined by 75% within 60min in the stomach before steadily rising in the colon and the 
lower part of the small intestine. Similar observations were also made in the rat model confirming at 
least that active PLS was still detectable in the large intestines of both rodent model systems used in the 
experiments reported in this thesis, despite the published concerns about inactivation of orally 
administered CPs by stomach acid (Huet et al., 2006). 
Having demonstrated that the CPs used were active, it was important next to address the key 
hypothesis on which this work depended, namely that in addition to being potent anthelmintics for 
nematode infections, CPs are effective also against cestodes. Although there have been preliminary 
reports of the in vitro effects of CPs against cestodes (He et al., 1992; Stepek et al., 2007e) these were 
either very brief one-off experiments or the effects were never confirmed in sufficient detail and to a 
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degree comparable to the work undertaken with nematodes (Stepek et al., 2005). I started by 
conducting preliminary experiments, based largely on the work of Stepek et al. (2007e) and noted 
similar observations. Extending these findings necessitated confirmation that the reduction in motility 
was indeed mediated by CPs. In Chapter 4 I demonstrated in a factorial experiment that worms 
incubated in PLS pre-treated with E-64 remained motile until the end of the experiment while worms 
incubated in the same amount of active CPs but not pre-treated with E-64 succumbed to the enzymes. 
This was confirmed statistically when the main effect of CP was shown to differ significantly from the 
other treatments that were included in these assays. Having confirmed that the motility reduction effects 
were mediated by CPs I proceeded to test a range of CPs on a range of concentrations. CPs, whether 
naturally occurring like PLS and pineapple extract or commercially available purified CPs like papain 
and stem bromelain, caused a significant reduction in motility leading to the death of the worms in both 
rodent cestode models. However, there was a striking difference between our observations on cestodes 
and earlier published reports on nematodes in that the reduction in motility mediated by CPs against 
cestodes were independent of the presence of the exogenous CP activator cysteine, whilst inclusion of 
cysteine was crucial in the case of all the nematodes studied to-date (Stepek et al., 2005). Cysteine acts 
as a reducing agent and the active site on CPs needs to be activated through reduction before the 
enzyme can digest its target molecules (Chapman et al., 1997). Therefore, a possible explanation for 
this difference between cestodes and nematodes,  the ability of CPs to still mediate damage to the 
tegument of cestodes independently of the presence of cysteine is perhaps because of the properties of 
the cestode tegument which differs fundamentally from the nematode cuticle in its structure and 
component composition. Perhaps through its excretory process through the tegument results in some 
form of reducing agent which in turn activates the CPs. The reduction in motility was also enzyme 
concentration dependant as has been reported for nematodes (Stepek et al., 2005).   
Although CPs have been shown to affect various intestinal dwelling adult nematode species 
(Stepek et al., 2005; Stepek et al., 2006b, 2007b, e) they were not effective against the juvenile stages 
of H. bakeri (Behnke et al., 2008) but did affect some juvenile plant nematode species (Stepek et al., 
2007a). So the question is raised as to whether the juvenile stages of cestodes are also susceptible to 
CPs. Using an artificial excystation protocol (Goodchild and Davis, 1972) I made similar observations  
on the juvenile artificially excysted scoleces of both rodent cestodes, to those seen on adult worms, in a 
range of CPs and in a range of concentrations of active CPs.  
Another pertinent question was whether CPs from different plant sources differ to any 
significant degree in their efficacy against cestodes. It was observed that naturally occurring CPs such 
those found in pineapple extract and PLS were more efficacious than singular purified CPs. 
Commercially available purified enzymes are singular CPs while naturally occurring CPs contain a 
combination of more than one CP.  For example, papaya latex contains papain, chymopapain, glycyl 
endopeptidase and caricain while pineapple extract contains fruit bromelain, ananain and comosain. It 
is possible that naturally occurring CPs work in synergy resulting in greater efficacy as compared to 
singular CPs working individually. Similar phenomenon have also been observed in vivo when crude 
papaya latex was found to be more efficacious than papain in reducing H. bakeri burdens in mice 
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(Stepek et al., 2007d). Kundu and Lyndem (2012) in screening the efficacy of several species of Cassia 
plant extracts against the poultry cestode R. tetragona observed that worms exposed to a combination 
of several species of cassia extracts resulted in greater efficacy and damage to the worms compared to 
singular species exposure.  
It was interesting to note that juvenile artificially excysted scoleces were relatively more 
resistant to singular purified CPs than they were to naturally occurring CPs. This might suggest that the 
scolex which has not yet developed a strobila, where most damage occurs, is perhaps more resistant to 
CPs. This could be because of a lack of suitable target proteins in the tegument associated with the 
scolex, compared with that covering the strobila. This relative scolex resistance is also reminiscent of 
the scolex resistance towards immune system attack where destrobilated scolex is able to regrow. CP 
efficacy also did not differ substantiallybetween the 2 species of rodent cestodes albeit CP was slightly 
more efficacious against H. diminuta. This contradicted the literature since H. microstoma has been 
shown to be resistant to anthelmintics (McCracken et al., 1992).  However, there was a difference in the 
efficacy of CPs between the rodent cestodes and the equine cestode A. perfoliata which was explored in 
Chapter 8. PLS was four times more efficacious against A. perfoliata compared with its effect against 
rodent cestodes. This was perhaps due  to the apparent size discrepancy between the 2 species in which 
A. perfoliata is a mere 3-5 cm in length, while 14day old H. diminutas used throughout the thesis reach 
15 cm.  
While the motility assays provided strong evidence that CPs do indeed affect cestodes, the 
next important question to address was how? One way to answer this question was by careful 
observation of changes to the surface of the worms during incubation in CPs and quantification of any 
resulting damage. It was observed that in both rodent cestodes the appearance of damage was similar 
with generalised tegumental erosions mainly affecting the strobila. In lower concentrations the erosion 
was not marked, but rather superficial and at certain points there was tegumental discontinuity with the 
release of internal contents mainly eggs from gravid proglottid. In higher concentration of active CPs 
the damage was marked and extensive with deep erosions and an exfoliative appearance. However, 
despite being incubated in the same high concentration of active CP, the scoleces and the neck regions 
did not appear to sustain similarly extensive damage but rather lighter more superficial tegumental 
erosions. This might be suggestive again of a relative resistance of the scolex region as compared to the 
strobila, as proposed above, perhaps due to different CP protein target composition. This observation is 
quite different from the observations seen with praziquantel which has a predilection for the neck 
region while the strobila remains unaffected (Becker et al., 1981).  
This mechanism of erosive damage is almost comparable to the events seen with nematodes 
(Behnke et al., 2008) differing only because nematodes are enclosed within a tough cuticle with high 
hydrostatic pressure. Thus, a slight breach in the cuticle literally results in an explosion of the internal 
contents of nematodes. Cestodes, however, are only limited by the thin plasma membrane like 
tegument, hence damage is rather progressive than sudden. This is a stark contrast to conventional 
therapies like praziquantel (Becker et al., 1981), niclosamide (Kumchoo et al., 2007) and even 
benzimidazoles (Schmidt, 1998b) whose effects appear to be mediated by a different mechanism 
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affecting the tegument. Rather than attacking the tegument from outside they appear to kill cestodes 
from the inside out, initially by diffusing within the tegument and then weakening the tegument from 
within (Mansour, 2002). The events observed in cross-sections of the tegument, however, are quite 
similar to those reported for other cestocidals.  Most reports include an increase in the formation of 
vacuoles and vesicles and disruption in the glycocalyx outer layer (Becker et al., 1981; Mansour, 2002; 
Schmidt, 1998b). Schmidt (1998b) proposed that the vesicles may be transporting materials needed to 
synthesize and replenish the disrupted or lost glycocalyx layer, which tapeworms are known to be able 
to do most efficiently (Befus and Threadgold, 1975). So in part some of the resistance to CP attack 
observed in this work, may be explicable by rapid turnover and repair of damaged sections of the 
tegument. It may be that only in high concentrations of CPs is the balance between sustained damage 
and repair swung in favour of treatment. Hence the worms experience irreparable damage 
incapacitating them to such a degree that they cannot sustain their location in the hosts intestine and are 
driven out by peristalsis.. 
 Since CPs were shown to affect cestodes in vitro and the effects were confirmed to be 
mediated by CPs, it was important next to answer the ultimate question as to whether CPs actually 
affect cestodes in vivo. In the past many natural compounds and products have been purported to 
possess anthelmintic efficacy as indicated by their effects on parasites in vitro but most have not lived 
up to their reputation when tested in vivo (Behnke et al., 2008). For example, He et al. (1992) found 
that young pineapple juice affected H. nana in vitro but not in vivo. Similarly fig latex has been shown 
to be ineffective at reducing H. nana worm burdens (de Amorin et al., 1999). My investigations, 
however ,surprisingly revealed that PLS was indeed efficacious against cestodes in vivo. Efficacy, 
however, varied between the cestode species tested and also depended on the index of efficacy gauged. 
In most of my experiments I used several indices to gauge CP treatment efficacy in vivo and this 
included a non invasive index such as faecal egg counts, as well as autopsy dependent indices including 
worm counts, worm biomass both wet and dry. I started with assessing whether or not CPs have any 
effect on worm fecundity by quantifying faecal egg counts. Disappointingly, in both rodent models 
faecal egg counts were not affected at all. The faecal egg count results showed no reduction in the 
treated group as compared to the control in either rodent cestodes. I initially started with H. microstoma 
(Chapter 5) before repeating a similar regimen on H. diminuta (Chapter 7). The initial impression 
following the disappointing results from H. microstoma was that the egg production centre in the neck 
region might have been spared from the exposure to CPs due to its location in the bile duct or perhaps 
also the dose administered may have been too small (240nmols in mice). However, this notion was 
proved wrong because H. diminuta  despite being fully exposed to CP onslaught, because it is an 
entirely lumen dwelling cestode, and being administered with a dose 10x higher (2.4µmols) still 
showed no reduction in faecal egg counts (Chapter 7).  Clearly, tapeworms cannot be compared directly 
to nematodes which once affected by CPs, usually die, exploding soon afterwards with resultant 
cessation of egg output that is then clearly reflected within 24h in a reduction of faecal egg counts.  
 Nevertheless, there was still a possibility that despite no overall reduction in egg counts the 
eggs exposed to CPs in the hostÕs gut might not be viable anymore. It was then imperative to ascertain 
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whether fecundity was still affected despite no reduction in egg counts by an egg viability test. 
Disappointingly, again in both models eggs were not affected at all because intact cysticercoids were 
recovered from Tribolium beetles fed with either cut terminal proglottid segments or detached 
proglottid segments recovered from the colon of rodent hosts treated with PLS. Unlike the 
benzimidazoles which were able to affect the development of H. diminuta larval stages (Evans and 
Novak, 1976) PLS does not appear to have any effect on either rodent cestodeÕs fecundity when 
administered to infected rats. Perhaps the eggs are protected within their thick outer shell which fail to 
express target proteins. Structurally, cestode eggs have a thicker outer shell compared to 
trichostrongyloid nematode eggs such as those of H. bakeri, but not those of Trichuris and Ascaris 
species, both of which have tough egg shells to enable the larvae within to develop to the infective 
stage within the eggs in the external environment, as in cestodes. This robust egg shell is required 
because of the need for the eggs to survive in the harsh external environmental conditions before 
continuing its life cycle in an intermediate host. On the basis of my results I can conclude that CPs do 
not affect egg viability or adult cestode fecundity in vivo.  
Assessment of fecundity, however, is not a definitive marker of efficacy of treatment because 
the final indicator will always be the autopsy indices. Unlike in nematodes where autopsy indices can 
only be assessed through worm counts, in the case of cestodes treatment efficacy can also be assessed 
through worm biomass because a small worm compared to the controls is an indicator that it is under 
stress and might be expelled eventually either by the treatment or with the assistance of host immunity. 
Surprisingly, despite the unaffected fecundity both rodent models appeared to be affected by PLS albeit 
differing in the level of efficacy. PLS was only minimally efficacious against H. microstoma (Chapter 
5). Depending on the exact circumstances of each experiment, there were varying levels of reduction in 
worm burdens and biomass and these were generally not significant, depending to some extent on the 
sample size utilised, with larger samples just touching a significant level of reduction. The reductions 
were also not dose dependant and could not be said to be mediated by CPs because the main effects of 
CPs were not significant in a factorial experiment. Although it is easy to explain this relative resistance 
of H. microstoma, compared to H. diminuta ,which was more susceptible by referring to the literature in 
which H. microstoma is generally accepted to be resistant also to conventional anthelmintics (Evans et 
al., 1979; McCracken et al., 1992), there are other factors that need to be considered as well. Firstly the 
efficacy of CPs against H. microstoma in vitro was quite comparable to that of H. diminuta (Chapter 4). 
Secondly, the dose that was being administered to mice was 10x lower than the dose administered to 
rats. Thirdly the mechanistic basis by which CPs inflict damage upon cestodes appeared to be different 
compared to other conventional anthelmintics (Chapter 3). Therefore, I would like to suggest that if the 
mousee model system were able to be administered with at least a similar dose to that administered to 
H. diminuta infected rats, it might be possible to observe higher efficacy, perhaps similar between the 2 
species.  
Moving on to the next model system PLS was generally moderately efficacious against H. 
diminuta in vivo resulting in a significant, but relatively small, reduction in worm burdens and biomass. 
These effects were only partially dose dependant and specific inhibition by E-64 only confirmed the 
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role of cysteine proteinase as the active principles in papaya latex,  affecting worm growth and hence 
size but not potent enough to cause worm expulsion.  
Having observed these effects it was also important to determine whether these effects were 
permanent or temporary. In both models I attempted an experiment in which one group was killed 
immediately after completing the usual treatment regime whilst another group was killed and autopsied 
one week later. In H. microstoma there was no difference in worm count when worms were left to 
survive post treatment but in H. diminuta the worm elimination effects was magnified.  The effects on 
worm growth, however, were not enhanced in either model. Perhaps the discrepancy between the 2 
species was again due to the different doses applied but also it can be postulated that the surviving 
treated worms may not be able to withstand immunological attack to a degree comparable to that they 
show normally when they are fit and not threatened by anthelminics. It is possible that the longer term 
effects of treatment were mediated by a second phase of attack by the host system on already weakened 
worms, resulting in the worms succumbing eventually, given sufficient time. 
One of the main limitations that I believe limited the efficacy of treatment with CPs on 
naturally growing adult worms in their normal hosts, was the concentration of anthelmintic,  the exact 
dose that could be administered to the rodent hosts, without evident side effects and due consideration 
for animal welfare. While, because of the side effects observed at the higher dose levels,  there was no 
possibility for increasing the dose further, there is another model that could be and was exploited to 
demonstrate the host-protective effects of CPs in vivo. H. diminuta is known to survive in the mouse 
host temporarily before being immunologically expelled (Hopkins et al., 1972a). The mouse is a non-
permissive host because H. diminuta cannot grow to maturity in normal fully immunocompetent 
animals. If this window period, before expulsion, could be exploited, I would expect to see an enhanced 
CP effect because the parasite is in a non-permissive host in which there may be some physiological 
incompatibility and in which the worms are also subject to an effective immunological attack that may 
show synergism with the damaging consequences of exposure to CPs. Indeed, as predicted, PLS 
treatment of mice infected with H. diminuta resulted in marked significant reductions in all autopsy 
indices (Chapter 6). To extend these observations invoking an essential complementary role for the 
immune system,  the primary hypothesis was modified invoking a compound effect partly mediated by 
the immune system. To test this idea, it was predicted that the effects would not be as marked when the 
immune system is suppressed. Indeed in the next experiment (Chapter 6) I demonstrated that when the 
immune system was suppressed by corticosteroids the effect of PLS at reducing worm burdens and 
biomass were less marked. The results from this chapter (Chapter 6) provide an interesting comparison 
between the effects seen in the permissive host model where efficacy against H. diminuta was 
moderate. It may also suggest that in terms of targeting tapeworm infections, CPs may be immunology 
dependant drugs, just as is thought to be the case in praziquantel and schistosomes (Hrckova and 
Velebny, 1997; Hrckova et al., 1998). This idea however needs to be further explored , exploiting mice 
with genetically knocked out immune systems, rather than those treated with a  wide spectrum 
immusuppressive and anti-inflammary agent such as the corticosteroids employed here. 
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Having demonstrated systematically that CPs do indeed have potent effects on rodent cestodes 
it was worth extending the main research question concerning the degree to which CPs show a broad  
spectrum of activity by including another host-parasite system of the same class but of a different host 
and one with considerable economic importance. Horse tapeworm infections have recently been 
recognized as a significant cause of morbidity in horses (Proudman et al., 1998) and horses are animals 
of economic importance. Resistance to conventional anthelmintic is also a recognized problem in the 
horse industry (Matthews et al., 2004). If I could show that CPs also affect equine cestodes then there 
will be a real prospect for the development of CPs into novel classes of anthelmintic for horses. 
However, this approach had some limitations and was restricted to in vitro experiments as a license to 
conduct animal experiments involving horses was not available to me. To my surprise, not only was the 
horse cestode A. perfoliata susceptible to CPs, but the CPs were also observed to be many times more 
effiacacious in vitro compared to their effects against rodent cestodes (Chapter 8). Therefore, not only 
did this chapter (Chapter 8) extended the spectrum of activity to another cestode species, it also opened 
up a new chapter of opportunity for the development of CPs into a novel anthemintic for horses. Firstly, 
due to CPs being more efficacious at lower concentration in vitro and secondly because A. perfoliata 
resides in the ileo-caecal junction, it is probably exposed to prolonged exposure to CPs because 
experiments in rodents have shown clearly that CPs accumulate and reside for much longer in the 
hindgut segment compared with more anterior regions of the intestine(Chapter 3).  
Lastly, with regards to CP side effects, although it has been observed in mice receiving PLS 
doses higher than the doses described in this thesis similar observations were not observed in rats 
receiving similar dose per kilo body weight. In fact oral dosing of papaya latex in sheep was sound and 
safe (Buttle et al., 2011). With regards to these side effects, although needs to be noted, it should never 
hinder the progress of developing CPs into useful novel anthelmintics. 
Overall, although CPs appear to affect cestodes the efficacy is relatively less when compared 
to its efficacy against nematodes (Stepek et al., 2007c). It is even smaller when compared to the very 
high efficacy of conventional cestocidals like praziquantel (Thomas and Gonnert, 1977). Therefore it is 
not possible to immediately develop CPs into useful primary cestocidals at the moment. However with 
further refinement in formulation and delivery may perhaps improve CP efficacy as primary 
cestocidals. At the moment it does however fulfil the role of a broadspectrum anthelmintic primarily for 
nematodes with concurrent effects against cestodes. 
 
9.2  Conclusion 
Contrary to preliminary negative reports on CP efficacy against cestodes, in my thesis I have clearly 
demonstrated that CPs do indeed affect the rodent cestodes H. microstoma and H. diminuta in vitro and 
in vivo. Naturally occurring CPs were more efficacious than commercially available singular purified 
CPs. Efficacy was also enhanced by the synergistic effects of the immune system demonstrated in the 
non-permissive host. Moreover, efficacy was extended to include the equine cestode A. perfoliata in 
vitro. The results offer an interesting possibility that with further refinement, CPs may be developed 
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into broad spectrum anthelmintics that remove nematodes from their hosts and have significant effects 
also on any concurrently resident tapeworms. Novel anthelmintics are desperately needed at the current 
time to counter the onset of resistance to the synthetic anthelmintics that are used widely, and I hope 
sincerely that the experiments that I have reported here provide a baseline for the further exploration 
and development of CPs for the treatment of tapeworm infections of man and our domestic animals. 
  
148 
 
REFERENCES 
Abbott, J.B., Barrett, E.J., 2008. The problem of diagnosing tapeworm infections in horses. Equine Vet 
J 40, 5-6. 
Abu-Madi, M.A., Behnke, J.M., Prabhaker, K.S., Al-Ibrahim, R., Lewis, J.W., 2009. Intestinal 
helminths of feral cat populations from urban and suburban districts of Qatar. Vet Parasitol. 
Alarcon, F., 2006. [Neurocysticercosis: its aetiopathogenesis, clinical manifestations, diagnosis and 
treatment]. Rev Neurol 43 Suppl 1, S93-100. 
Albonico, M., Bickle, Q., Ramsan, M., Montresor, A., Savioli, L., Taylor, M., 2003. Efficacy of 
mebendazole and levamisole alone or in combination against intestinal nematode infections 
after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ 81, 343-
352. 
Aleksic-Shihabi, A., Vidolin, E.P., 2008. Cystic echinococcosis of the heart and brain: a case report. 
Acta Med Okayama 62, 341-344. 
Alvarez-Sanchez, M.A., Perez Garcia, J., Bartley, D., Jackson, F., Rojo-Vazquez, F.A., 2005. The 
larval feeding inhibition assay for the diagnosis of nematode anthelmintic resistance. Exp 
Parasitol 110, 56-61. 
Andreassen, J., Hoole, D., 1989. Repair of Hymenolepis diminuta after complement-mediated damage. 
Parasitology 99 Pt 3, 437-443. 
Andreassen, J., Hoole, D., Befus, D., 1990. Complement-mediated leucocyte adherence to newly 
excysted and 4-day-old Hymenolepis diminuta. Int J Parasitol 20, 905-911. 
Andreassen, J., Hopkins, C.A., 1980. Immunologically mediated rejection of Hymenolepis diminuta by 
its normal host, the rat. J Parasitol 66, 898-903. 
Andreassen, J., Ito, A., Ito, M., Nakao, M., Nakaya, K., 2004. Hymenolepis microstoma: direct life 
cycle in immunodeficient mice. J Helminthol 78, 1-5. 
Antolova, D., Reiterova, K., Miterpakova, M., Dinkel, A., Dubinsky, P., 2009. The first finding of 
Echinococcus multilocularis in dogs in Slovakia: an emerging risk for spreading of infection. 
Zoonoses Public Health 56, 53-58. 
Arakawa, T., Prestrelski, S.J., Kenney, W.C., Carpenter, J.F., 2001. Factors affecting short-term and 
long-term stabilities of proteins. Advanced drug delivery reviews 46, 307-326. 
Arizono, N., Yamada, M., Nakamura-Uchiyama, F., Ohnishi, K., 2009. Diphyllobothriasis associated 
with eating raw pacific salmon. Emerg Infect Dis 15, 866-870. 
Bal, N., Kocer, N.E., Arpaci, R., Ezer, A., Kayaselcuk, F., 2008. Uncommon locations of hydatid cyst. 
Saudi Med J 29, 1004-1008. 
Bartolom, A.P., Ruprez, P., Fster, C., 1995. Pineapple fruit: morphological characteristics, chemical 
composition and sensory analysis of red Spanish and Smooth Cayenne cultivars. Food 
Chemistry 53, 75-79. 
Becker, B., Mehlhorn, H., Andrews, P., Thomas, H., 1980. Scanning and transmission electron 
microscope studies on the efficacy of praziquantel on&lt;i&gt;Hymenolepis nana (Cestoda) in 
vitro. Parasitology Research 61, 121-133. 
Becker, B., Mehlhorn, H., Andrews, P., Thomas, H., 1981. Ultrastructural investigations on the effect 
of praziquantel on the tegument of five species of cestodes. Parasitology research 64, 257-269. 
Befus, A.D., Featherston, D.W., 1974. Delayed rejection of single Hymenolepis diminuta in primary 
infections of young mice. Parasitology 69, 77-85. 
Befus, A.D., Threadgold, L.T., 1975. Possible immunological damage to the tegument of Hymenolepis 
diminuta in mice and rats. Parasitology 71, 525-534. 
Behnke, J.M., Buttle, D.J., Stepek, G., Lowe, A., Duce, I.R., 2008. Developing novel anthelmintics 
from plant cysteine proteinases. Parasit Vectors 1, 29. 
Behnke, J.M., Parish, H.A., 1979. Expulsion of Nematospiroides dubius from the intestine of mice 
treated with immune serum. Parasite Immunol 1, 13-26. 
Behnke, J.M., Parish, H.A., Hagan, P., 1980. The effect of gamma irradiation on Nematospiroides 
dubius. Factors affecting the survival of worms in a primary infection in mice. J Helminthol 
54, 173-182. 
Benifla, M., Barrelly, R., Shelef, I., El-On, J., Cohen, A., Cagnano, E., 2007. Huge hemispheric 
intraparenchymal cyst caused by Taenia multiceps in a child. Case report. J Neurosurg 107, 
511-514. 
Benner, C., ., H.C., Snchez-Serrano, L.P., Budke, C.M., Carmena, D., 2010. Analysis of the economic 
impact of cystic echinococcosis in Spain. Bulletin of the World Health Organization 88, 49-57. 
Bennett, J.L., Pax, R.A., 1986. Micromotility meter: an instrument designed to evaluate the action of 
drugs on motility of larval and adult nematodes. Parasitology 93 ( Pt 2), 341-346. 
Berger, J., Asenjo, C.F., 1939. Anthelmintic Activity of Fresh Pineapple Juice. Science 90, 299-300. 
149 
 
Berger, J., Asenjo, C.F., 1940. Anthelmintic Activity of Crystalline Papain. Science 91, 387-388. 
Blanchard, R. 1891. Histoire zoologique et mdicale des tniads du genre Hymenolepis Weinland 
(Paris, Socit d'ditions scientifiques), p. 112. 
Bolton, S., 2007. Assessment of the anthelmintic efficacy of natural plant cystein proteinases against 
the rodent cestode, Hymenolepis diminuta. BSc. thesis. University of Nottingham  
Bordon, L.M., 1992. Intestinal obstruction due to Taenia saginata infection: a case report. J Trop Med 
Hyg 95, 352-353. 
Borthakur, S.K., Das, M.R., 2006. Incidence of monieziosis in cattle and buffalo calves of Guwahati. 
Journal of veterinary parasitology 20. 
Budke, C.M., Deplazes, P., Torgerson, P.R., 2006. Global socioeconomic impact of cystic 
echinococcosis. Emerg Infect Dis 12, 296-303. 
Budke, C.M., White, A.C., Jr., Garcia, H.H., 2009. Zoonotic larval cestode infections: neglected, 
neglected tropical diseases? PLoS Negl Trop Dis 3, e319. 
Buttle, D.J., Behnke, J.M., Bartley, Y., Elsheikha, H.M., Bartley, D.J., Garnett, M.C., Donnan, A.A., 
Jackson, F., Lowe, A., Duce, I.R., 2011. Oral dosing with papaya latex is an effective 
anthelmintic treatment for sheep infected with Haemonchus contortus. Parasit Vectors 4, 36. 
Cabaret, J., Geerts, S., Madeline, M., Ballandonne, C., Barbier, D., 2002. The use of urban sewage 
sludge on pastures: the cysticercosis threat. Vet Res 33, 575-597. 
Cabrera, P.A., Irabedra, P., Orlando, D., Rista, L., Haran, G., Vinals, G., Blanco, M.T., Alvarez, M., 
Elola, S., Morosoli, D., Morana, A., Bondad, M., Sambran, Y., Heinzen, T., Chans, L., 
Pineyro, L., Perez, D., Pereyra, I., 2003. National prevalence of larval echinococcosis in sheep 
in slaughtering plants Ovis aries as an indicator in control programmes in Uruguay. Acta Trop 
85, 281-285. 
Cao, E., Chen, Y., Cui, Z., Foster, P.R., 2003. Effect of freezing and thawing rates on denaturation of 
proteins in aqueous solutions. Biotechnology and bioengineering 82, 684-690. 
Castanares-Zapatero, D., Laterre, P.F., 2009. Ruptured hydatid cyst in a patient with shock. 
Hepatobiliary Pancreat Dis Int 8, 638-639. 
Chai, J.Y., Darwin Murrell, K., Lymbery, A.J., 2005. Fish-borne parasitic zoonoses: status and issues. 
Int J Parasitol 35, 1233-1254. 
Chaiwut, P., Nitsawang, S., Shank, L., Kanasawud, P., 2007. A Comparative Study on Properties and 
Proteolytic Components of Papaya Peel and Latex Proteases. Chiang Mai J. Sci. 34, 109-118. 
Chan, M.S., 1997a. The global burden of intestinal nematode infections--fifty years on. Parasitol Today 
13, 438-443. 
Chan, M.S., 1997b. The global burden of intestinal nematode infections Ñ Fifty years on. Parasitology 
Today 13, 438-443. 
Chapman, H.A., Riese, R.J., Shi, G.P., 1997. Emerging roles for cysteine proteases in human biology. 
Annual review of physiology 59, 63-88. 
Cinto, P.O., Souza, A.L.R., Lima, A.C., Chaud, M.V., Gremio, M.P.D., 2009. LC Evaluation of 
Intestinal Transport of Praziquantel Chromatographia 69, 213-217. 
Coles, G.C., 1983. Chemotherapy and the effects of chemotherapeutic agents, In:   Biology of the 
eucestoda. Academic press, London, pp. 581-628. 
Conboy, G., 2009. Cestodes of dogs and cats in North America. Vet Clin North Am Small Anim Pract 
39, 1075-1090, vi. 
Courtney, C.H., Forrester, D.J., 1973. Interspecific interactions between Hymenolepis microstoma 
(Cestoda) and Heligmosomoides polygyrus (Nematoda) in mice. J Parasitol 59, 480-483. 
Cox, F.E., 2004. History of human parasitic diseases. Infect Dis Clin North Am 18, 171-188, table of 
contents. 
Cox, F.E.G., 1993. Modern parasitology: a textbook of parasitology. Boston. 
Craig, P., Ito, A., 2007. Intestinal cestodes. Curr Opin Infect Dis 20, 524-532. 
Cunningham, L.J., Olson, P.D., 2010. Description of Hymenolepis microstoma (Nottingham strain): a 
classical tapeworm model for research in the genomic era. Parasit Vectors 3, 123. 
D'Alessandro, A., Rausch, R.L., 2008. New aspects of neotropical polycystic (Echinococcus vogeli) 
and unicystic (Echinococcus oligarthrus) echinococcosis. Clin Microbiol Rev 21, 380-401, 
table of contents. 
de Amorin, A., Borba, H.R., Carauta, J.P., Lopes, D., Kaplan, M.A., 1999. Anthelmintic activity of the 
latex of Ficus species. J Ethnopharmacol 64, 255-258. 
De Rycke, P.H., 1966. Development of the cestode Hymenolepis microstoma in Mus musculus. Z 
Parasitenkd 27, 350-354. 
Degreef, H., 1999. New Corticosteroids. Skin therapy letter 4, 1-5. 
150 
 
Deplazes, P., 2006. Ecology and epidemiology of Echinococcus multilocularis in Europe. 
Parassitologia 48, 37-39. 
Doenhoff, M.J., Cioli, D., Utzinger, J., 2008. Praziquantel: mechanisms of action, resistance and new 
derivatives for schistosomiasis. Curr Opin Infect Dis 21, 659-667. 
Dorny, P., Praet, N., 2007. Taenia saginata in Europe. Vet Parasitol 149, 22-24. 
Dujardin, F. 1845. Histoire naturelle des helminthes ou vers intestinaux (Paris, Librairie 
Encyclopedique de Roret), p. 684. 
Dunkley, L.C., Mettrick, D.F., 1977. Hymenolepis diminuta: migration, and the rat host's intestinal and 
blood plasma glucose levels following dietary carbohydrates intake. Exp Parasitol 41, 213-
228. 
Dupouy-Camet, J., Peduzzi, R., 2004. Current situation of human diphyllobothriasis in Europe. Euro 
Surveill 9, 31-35. 
Dvorak, J.A., Jones, A.W., Kuhlman, H.H., 1961. Studies on the biology of Hymenolepis microstoma 
(Dujardin, 1845). J Parasitol 47, 833-838. 
El Moussaoui, A., Nijs, M., Paul, C., Wintjens, R., Vincentelli, J., Azarkan, M., Looze, Y., 2001. 
Revisiting the enzymes stored in the laticifers of Carica papaya in the context of their possible 
participation in the plant defence mechanism. Cell Mol Life Sci 58, 556-570. 
Elliott, D.C., 1986. Tapeworm (Moniezia expansa) and its effect on sheep production: the evidence 
reviewed. N Z Vet J 34, 61-65. 
Eom, K.S., Rim, H.J., 1993. Morphologic descriptions of Taenia asiatica sp. n. Korean J Parasitol 31, 1-
6. 
Evans, W.S., Gray, B., Novak, M., 1979. Effect of mebendazole on the larval development of three 
Hymenolepidid cestodes. J Parasitol 65, 31-34. 
Evans, W.S., Hardy, M., Novak, M., 1980. A comparison of the effect of albendazole, cambendazole, 
and thiabendazole on the larval development of three hymenolepidid cestodes. J Parasitol 66, 
935-940. 
Evans, W.S., Novak, M., 1976. The effect of mebendazole on the development of Hymenolepis 
diminuta in Tribolium confusum. Can J Zool 54, 1079-1083. 
Fan, P.C., Chung, W.C., Soh, C.T., Kosman, M.L., 1992. Eating habits of east Asian people and 
transmission of taeniasis. Acta Trop 50, 305-315. 
Flisser, A., Sarti, E., Lightowlers, M., Schantz, P., 2003. Neurocysticercosis: regional status, 
epidemiology, impact and control measures in the Americas. Acta Trop 87, 43-51. 
Folz, S.D., Pax, R.A., Thomas, E.M., Bennett, J.L., Lee, B.L., Conder, G.A., 1987. Detecting in vitro 
anthelmintic effects with a micromotility meter. Vet Parasitol 24, 241-250. 
Fox, J.G., 2007. The mouse in biomedical research, Vol 2, 2 Edition. Academic press, Burlington, San 
Diego, London, 313 p. 
Frankel, M., Maimin, R., Shapiro, B., 1937. Hydrolytic properties of Carica papaya latex and latex 
preparations. Biochem J 31, 1926-1933. 
Galan-Puchades, M.T., Fuentes, M.V., 2009. Diagnosis of human cysticercosis and Taenia asiatica. Am 
J Trop Med Hyg 81, 1165; author reply 1166. 
Gasser, R.B., Williamson, R.M., Beveridge, I., 2005. Anoplocephala perfoliata of horses--significant 
scope for further research, improved diagnosis and control. Parasitology 131, 1-13. 
Ghosh, N.K., Babu, S.P., Sukul, N.C., Ito, A., 1996. Cestocidal activity of Acacia auriculiformis. J 
Helminthol 70, 171-172. 
Goddard, J.P., Reymond, J.L., 2004. Recent advances in enzyme assays. Trends in biotechnology 22, 
363-370. 
Gonzalez, A.E., Garcia, H.H., Gilman, R.H., Tsang, V.C., 2003. Control of Taenia solium. Acta Trop 
87, 103-109. 
Goodall, R.I., 1972. The growth of Hymenolepis microstoma in the laboratory rat. Parasitology 65, 
137-142. 
Goodchild, C.G., Davis, B.O., Jr., 1972. Hymenolepis microstoma cysticercoid activation and 
excystation in vitro (Cestoda). J Parasitol 58, 735-741. 
Gordon, Whitlock, 1939. A new technique for counting nematode eggs in sheep faeces. J. Counc. Sci. 
Ind. Res 12, 50-52. 
Hansson, A., Veliz, G., Naquira, C., Amren, M., Arroyo, M., Arevalo, G., 1986. Preclinical and clinical 
studies with latex from Ficus glabrata HBK, a traditional intestinal anthelminthic in the 
Amazonian area. J Ethnopharmacol 17, 105-138. 
Haq, M.A., 1998. Potential oribatid mite vectors of cestode parasites in Kerala, India. In:  Acarology: 
Proceedings of the 10th International Congress, Canberra. 
151 
 
He, S., Tiuria, R., Retnani, B.E., 1992. Uji biologis aktivitas anthelmintik sari buah nanas muda, daun 
miana dan ranting puring terhadap cacing Aspiculuris tetraptera (Nematoda) dan Hymenolepis 
nana pada mencit putih (Mus musculus albinus). Hemera Zoa 75, 94-110. 
Hinkel, E.T., Jr., 1951. Further studies on the effect of drying conditions and of the chemical treatment 
of papaya latex on the stability of papain. Ann N Y Acad Sci 54, 263-272. 
Holy, J.M., Oaks, J.A., 1989. Cytoskeletal features of the syncytial epidermis of the tapeworm 
Hymenolepis diminuta. Cell Motil Cytoskeleton 13, 41-56. 
Homaei, A.A., Sajedi, R.H., Sariri, R., Seyfzadeh, S., Stevanato, R., 2010. Cysteine enhances activity 
and stability of immobilized papain. Amino acids 38, 937-942. 
Hopkins, C.A., Subramanian, G., Stallard, H., 1972a. The development of Hymenolepis diminuta in 
primary and secondary infections in mice. Parasitology 64, 401-412. 
Hopkins, C.A., Subramanian, G., Stallard, H., 1972b. The effect of immunosuppressants on the 
development of Hymenolepis diminuta in mice. Parasitology 65, 111-120. 
Hotez, P.J., Molyneux, D.H., Fenwick, A., Kumaresan, J., Sachs, S.E., Sachs, J.D., Savioli, L., 2007. 
Control of neglected tropical diseases. N Engl J Med 357, 1018-1027. 
Hrckova, G., Velebny, S., 1997. Effect of praziquantel and liposome-incorporated praziquantel on 
peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia 
(Cestoda). Parasitology 114 ( Pt 5), 475-482. 
Hrckova, G., Velebny, S., Corba, J., 1998. Effects of free and liposomized praziquantel on the surface 
morphology and motility of Mesocestoides vogae tetrathyridia (syn. M. corti; Cestoda: 
Cyclophyllidea) in vitro. Parasitol Res 84, 230-238. 
Huet, J., Looze, Y., Bartik, K., Raussens, V., Wintjens, R., Boussard, P., 2006. Structural 
characterization of the papaya cysteine proteinases at low pH. Biochem Biophys Res Commun 
341, 620-626. 
Huffman, D.C., Guidry, R., 1979. Economic impact of the horse racing industry in Louisiana. Dept. of 
Agricultural Economics and Agribusiness, Louisiana State University and Agricultural and 
Mechanical College, Center for Agricultural Sciences and Rural Development, Agricultural 
Experiment Station, Baton Rouge, La., vi, 55 p. pp. 
Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L.F., Day, T.A., Bennett, J.L., 
1999. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from 
Egyptian villagers. Am J Trop Med Hyg 60, 932-935. 
Ito, A., Wandra, T., Sato, M.O., Mamuti, W., Xiao, N., Sako, Y., Nakao, M., Yamasaki, H., Nakaya, 
K., Okamoto, M., Craig, P.S., 2006. Towards the international collaboration for detection, 
surveillance and control of taeniasis/ cysticercosis and echinococcosis in Asia and the Pacific. 
Southeast Asian J Trop Med Public Health 37 Suppl 3, 82-90. 
Jahed Khaniki, G., Raei, M., Kia, E., Motevalli Haghi, A., Selseleh, M., 2010. Prevalence of bovine 
cysticercosis in slaughtered cattle in Iran. Tropical Animal Health and Production 42, 141-143. 
Jimenez, A.E., Montenegro, V.M., Hernandez, J., Dolz, G., Maranda, L., Galindo, J., Epe, C., 
Schnieder, T., 2007. Dynamics of infections with gastrointestinal parasites and Dictyocaulus 
viviparus in dairy and beef cattle from Costa Rica. Vet Parasitol 148, 262-271. 
Jonxis, J.H., Bekius, H., 1953. The treatment of ascaris infection with velardon. Arch Dis Child 28, 
329-331. 
Joyeux, C., Kobozieff, N., 1928. Recherches sur lÕHymenolepis microstoma 
(Dujardin, 1845). Annales de Parasitologie 6, 59-79. 
Junghanss, T., da Silva, A.M., Horton, J., Chiodini, P.L., Brunetti, E., 2008. Clinical management of 
cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 79, 
301-311. 
Kamiya, M., 2007. Collaborative control initiatives targeting zoonotic agents of alveolar 
echinococcosis in the northern hemisphere. J Vet Sci 8, 313-321. 
Kanyari, P.W.N., Kagira, J.M., Mhoma, R.J., 2009. Prevalence and intensity of endoparasites in small 
ruminants kept by farmers in Kisumu Municipality, Kenya. Livestock Research for Rural 
Development 21. 
Kaplan, R.M., 2002. Anthelmintic resistance in nematodes of horses. Vet Res 33, 491-507. 
Kaplan, R.M., 2004. Drug resistance in nematodes of veterinary importance: a status report. Trends 
Parasitol 20, 477-481. 
Karanikas, I.D., Sakellaridis, T.E., Alexiou, C.P., Siaperas, P.A., Fotopoulos, A.C., Antsaklis, G.I., 
2007. Taenia saginata: a rare cause of bowel obstruction. Trans R Soc Trop Med Hyg 101, 
527-528. 
Kassem, H.H., 2006. Hydatidosis- chinococcosis in Libya (review article). J Egypt Soc Parasitol 36, 
21-26. 
152 
 
Kimmel, J.R., Thompson, E.O., Smith, E.L., 1955. Crystalline papain. V. Cysteic acid and cysteic acid 
peptides from oxidized papain. J Biol Chem 217, 151-159. 
King, C.H., Mahmoud, A.A., 1989. Drugs five years later: praziquantel. Ann Intern Med 110, 290-296. 
Knapp, J., Chirica, M., Simonnet, C., Grenouillet, F., Bart, J.M., Sako, Y., Itoh, S., Nakao, M., Ito, A., 
Millon, L., 2009. Echinococcus vogeli infection in a hunter, French Guiana. Emerg Infect Dis 
15, 2029-2031. 
Konarzycka-Bessler, M., Bornscheuer, U.T., 2003. A high-throughput-screening method for 
determining the synthetic activity of hydrolases. Angew Chem Int Ed Engl 42, 1418-1420. 
Konno, K., Hirayama, C., Nakamura, M., Tateishi, K., Tamura, Y., Hattori, M., Kohno, K., 2004. 
Papain protects papaya trees from herbivorous insects: role of cysteine proteases in latex. Plant 
J 37, 370-378. 
Kotze, A.C., Stein, P.A., Dobson, R.J., 1999. Investigation of intestinal nematode responses to 
naphthalophos and pyrantel using a larval development assay. Int J Parasitol 29, 1093-1099. 
Kumchoo, K., Wongsawad, C., Vanittanakom, P., Chai, J.Y., Rojanapaibul, A., 2007. Effect of 
niclosamide on the tegumental surface of Haplorchis taichui using scanning electron 
microscopy. J Helminthol 81, 329-337. 
Kundu, S., Lyndem, L.M., 2012. In vitro screening for cestocidal activity of three species of Cassia 
plants against the tapeworm Raillietina tetragona. J Helminthol, 1-6. 
Kundu, S., Roy, S., Lyndem, L.M., 2012. Cassia alata L: potential role as anthelmintic agent against 
Hymenolepis diminuta. Parasitology research. 
Kustiawan, I. 2001. Studi Aktivitas Anthelmintik Infus Biji Lamtoro (Leucana leucocephala) 
terhadap Cacing Pita (Hymenolepis nana) pada Mencit (Mus musculus albinus). (Bogor, Fakultas 
Kedokteran Hewan. IPB. ). 
Lacey, E., 1988. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of 
drug resistance to benzimidazoles. Int J Parasitol 18, 885-936. 
Lamtiur, L. 2000. Uji Aktivitas Anthelmintik Infus Biji Pepaya (Carica papaya L.) terhadap 
Mencit Putih (Mus musculus L.) Galur Swiss yang Terinfeksi Cacing Hymenolepis nana. (Jakarta, 
Fakultas Farmasi Universitas 17 Agustus 1945). 
Levecke, B., Behnke, J.M., Ajjampur, S.S., Albonico, M., Ame, S.M., Charlier, J., Geiger, S.M., Hoa, 
N.T., Kamwa Ngassam, R.I., Kotze, A.C., McCarthy, J.S., Montresor, A., Periago, M.V., Roy, 
S., Tchuem Tchuente, L.A., Thach, D.T., Vercruysse, J., 2011. A comparison of the sensitivity 
and fecal egg counts of the McMaster egg counting and Kato-Katz thick smear methods for 
soil-transmitted helminths. PLoS Negl Trop Dis 5, e1201. 
Li, T., Craig, P.S., Ito, A., Chen, X., Qiu, D., Qiu, J., Sato, M.O., Wandra, T., Bradshaw, H., Li, L., 
Yang, Y., Wang, Q., 2006. Taeniasis/cysticercosis in a Tibetan population in Sichuan 
Province, China. Acta Trop 100, 223-231. 
Lightowlers, M.W., Colebrook, A.L., Gauci, C.G., Gauci, S.M., Kyngdon, C.T., Monkhouse, J.L., 
Vallejo Rodriquez, C., Read, A.J., Rolfe, R.A., Sato, C., 2003. Vaccination against cestode 
parasites: anti-helminth vaccines that work and why. Vet Parasitol 115, 83-123. 
Linares, L.M., Rojas, C.F., 2009. Determinacin de resistencia antihelmntica (Moniezia expansa, 
Moniezia benedeni y Thysanosoma actioides) frente a albendazol y febendazol en ovino en 
tres rebaos de La Paz Ð Bolivia. Revista Electrnica de Veterinaria 10. 
Litchford, R.G., 1963. Observations on Hymenolepis microstoma in three laboratory hosts: 
Mesocricetus auratus, Mus musculus, and Rattus morvegicus. J Parasitol 49, 403-410. 
Love, S. 2007. Turning the worm, Industries, N.D.o.P., ed. (New South Wales, NSW Department of 
Primary Industries 
), p. 8. 
Luoga, W., Mansur, F., Buttle, D.J., Duce, I.R., Garnett, M.C., Behnke, J.M., 2011. The anthelmintic 
efficacy of papaya latex in a rodent-nematode model is not dependent on fasting before 
treatment. J Helminthol, 1-6. 
Machnicka, B., Choromanski, L., 1980. The influence of immunosuppression generated by 
Trypanosoma cruzi of the development of Hymenolepis diminuta in CFW mice. Bull Acad Pol 
Sci Biol 27, 739-748. 
Macnish, M.G., Ryan, U.M., Behnke, J.M., Thompson, R.C., 2003. Detection of the rodent tapeworm 
Rodentolepis (=Hymenolepis) microstoma in humans. A new zoonosis? Int J Parasitol 33, 
1079-1085. 
Mansour, T.E., 2002. Chemotherapeutic targets in parasites: contemporary strategies. Cambridge 
University Press, Cambridge, 226 p. 
153 
 
Mantion, G., Bresson-Hadni, S., Vuitton, D.A., Wen, H., Chapuis, Y., Gillet, M., 2008. [Treatment of 
alveolar echinococcosis: a multidisciplinary task]. Bull Acad Natl Med 192, 1151-1157; 
discussion 1157-1158. 
Mason, P., Moffat, J., Cole, D., 2002. Tapeworm in sheep revisited. In:  32nd Seminar of The Society 
of Sheep & Beef Cattle Veterinarians, Wellington, New Zealand, 22-24 May 2002, pp. 147-
151. 
Matthews, J.B., Hodgkinson, J.E., Dowdall, S.M., Proudman, C.J., 2004. Recent developments in 
research into the Cyathostominae and Anoplocephala perfoliata. Vet Res 35, 371-381. 
McCracken, R.O., Lipkowitz, K.B., Dronen, N.O., 1992. Efficacy of albendazole and mebendazole 
against Hymenolepis microstoma and Hymenolepis diminuta. Parasitol Res 78, 108-111. 
McKay, D.M., 2010. The immune response to and immunomodulation by Hymenolepis diminuta. 
Parasitology 137, 385-394. 
McKellar, Q.A., Scott, E.W., 1990. The benzimidazole anthelmintic agents--a review. J Vet Pharmacol 
Ther 13, 223-247. 
Meana, A., Luzon, M., Corchero, J., Gomez-Bautista, M., 1998. Reliability of coprological diagnosis of 
Anoplocephala perfoliata infection. Vet Parasitol 74, 79-83. 
Meana, A., Pato, N.F., Martin, R., Mateos, A., Perez-Garcia, J., Luzon, M., 2005. Epidemiological 
studies on equine cestodes in central Spain: infection pattern and population dynamics. Vet 
Parasitol 130, 233-240. 
Mehlhorn, H., Becker, B., Andrews, P., Thomas, H., Frenkel, J.K., 1981. In vivo and in vitro 
experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron 
microscopic study. Arzneimittelforschung 31, 544-554. 
MEROPS 2009. the peptidase database (Sanger institute). 
Mettrick, D.F., 1971. Hymenolepis diminuta: pH changes in rat intestinal contents and worm migration. 
Exp Parasitol 29, 386-491. 
Mezhlumyan, L.G., Kasymova, T.D., Yuldashev, P.K., 2003. Proteinases from Carica papaya Latex. 
Chemistry of Natural Compounds 39, 223-228. 
Michel, J.F., 1985. Strategies for the use of anthelmintics in livestock and their implications for the 
development of drug resistance. Parasitology 90 ( Pt 4), 621-628. 
Millan, J., Casanova, J.C., 2009. High prevalence of helminth parasites in feral cats in Majorca Island 
(Spain). Parasitol Res 106, 183-188. 
Moazeni, M., Nili, M., 2004. Mixed infection with intestinal tape worms in sheep. Trop Biomed 21, 23-
26. 
Mole, J.E., Horton, H.R., 1973a. Kinetics of papain-catalyzed hydrolysis of -N-benzoyl-L-arginine-p-
nitroanilide. Biochemistry 12, 816-822. 
Mole, J.E., Horton, H.R., 1973b. Kinetics of papain-catalyzed hydrolysis of α-N-benzoyl-L-arginine-p-
nitroanilide. Biochemistry 12, 816-822. 
Molina, C.P., Ogburn, J., Adegboyega, P., 2003. Infection by Dipylidium caninum in an infant. Arch 
Pathol Lab Med 127, e157-159. 
Moss, G.D., 1971. The nature of the immune response of the mouse to the bile duct cestode, 
Hymenolepis microstoma. Parasitology 62, 285-294. 
Muller, R., 2001. Worms and Human Disease second Edition. CABI, 320 pages p. 
Mursof, E.P., He, S., 1991. A Potential Role of Papaya Latex As An Anthelmintic Against Patent 
Ascaridia Galli Infection in Chincken. Hemera zoa 74, 10. 
Nakao, M., McManus, D.P., Schantz, P.M., Craig, P.S., Ito, A., 2007. A molecular phylogeny of the 
genus Echinococcus inferred from complete mitochondrial genomes. Parasitology 134, 713-
722. 
Neira, O.P., Jofre, M.L., Munoz, S.N., 2008. [Dipylidium caninum infection in a 2 year old infant: case 
report and literature review]. Rev Chilena Infectol 25, 465-471. 
Nieuwhof, G.J., Bishop, S.C., 2005. Costs of the major endemic diseases of sheep in Great Britain and 
the potential benefits of reduction in disease impact. Animal Science 81, 23-29. 
Nilsson, O., Ljungstrom, B.L., Hoglund, J., Lundquist, H., Uggla, A., 1995. Anoplocephala perfoliata 
in horses in Sweden: prevalence, infection levels and intestinal lesions. Acta Vet Scand 36, 
319-328. 
Nonaka, N., Hirokawa, H., Inoue, T., Nakao, R., Ganzorig, S., Kobayashi, F., Inagaki, M., Egoshi, K., 
Kamiya, M., Oku, Y., 2008. The first instance of a cat excreting Echinococcus multilocularis 
eggs in Japan. Parasitol Int 57, 519-520. 
Ortiz, A., Madrigal, L., Fernandez, R., Cooke, R.D., 1980. The Storage and Drying Characteristics of 
Papaya (Carica-Papaya L) Latex. J Sci Food Agr 31, 510-514. 
154 
 
Panitz, E., Dodson, R.E., Godfrey, R.W., 2009. Infections of Moniezia expansa (Rudolphi, 1810) in 
Sheep During the Wet and Dry Seasons on St. Croix, U.S. Virgin Islands. Comparative 
Parasitology 73, 179-183. 
Persaud, R., Wang, A., Reardon, C., McKay, D.M., 2007. Characterization of the immuno-regulatory 
response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host. Int J 
Parasitol 37, 393-403. 
Pike, A.W., Chappell, L.H., 1981. Hymenolepis diminuta: worm loss and worm weight loss in long-
term infections of the rat. Exp Parasitol 51, 35-41. 
Prakash, V., Mehrotra, B.N., 1987. Anthelmintic plants in traditional remedies in India. indian journal 
of history of science 22, 332-340. 
Proudman, C.J., Edwards, G.B., 1992. Validation of a centrifugation/flotation technique for the 
diagnosis of equine cestodiasis. Vet Rec 131, 71-72. 
Proudman, C.J., French, N.P., Trees, A.J., 1998. Tapeworm infection is a significant risk factor for 
spasmodic colic and ileal impaction colic in the horse. Equine Vet J 30, 194-199. 
Proudman, C.J., Trees, A.J., 1999. Tapeworms as a cause of intestinal disease in horses. Parasitol 
Today 15, 156-159. 
Read, C.P., 1951. The "crowding effect" in tapeworm infections. J Parasitol 37, 174-178. 
Read, C.P., Kilejian, A.Z., 1969. Circadian migratory behavior of a cestode symbiote in the rat host. J 
Parasitol 55, 574-578. 
Ritonja, A., Rowan, A.D., Buttle, D.J., Rawlings, N.D., Turk, V., Barrett, A.J., 1989. Stem bromelain: 
amino acid sequence and implications for weak binding of cystatin. FEBS Lett 247, 419-424. 
Robbins, B.H., 1930. A proteolytic enzyme in ficin, the anthelmintic principle of Leche de Higueron. 
Journal of Biological Chemistry 87, 251-257. 
Roberts, L.S., Janovy, J.J., 2006. Foundations of Parasitology, 7th Edition. McGraw-Hill, international, 
702 p. 
Rodriguez-Bertos, A., Corchero, J., Castano, M., Pena, L., Luzon, M., Gomez-Bautista, M., Meana, A., 
1999. Pathological alterations caused by Anoplocephala perfoliata infection in the ileocaecal 
junction of equids. Zentralbl Veterinarmed A 46, 261-269. 
Roy, I., Gupta, M.N., 2004. Freeze-drying of proteins: some emerging concerns. Biotechnology and 
applied biochemistry 39, 165-177. 
Ruttenber, A.J., Weniger, B.G., Sorvillo, F., Murray, R.A., Ford, S.L., 1984. Diphyllobothriasis 
associated with salmon consumption in Pacific Coast states. Am J Trop Med Hyg 33, 455-459. 
Ryu, S.H., Bak, U.B., Kim, J.G., Yoon, H.J., Seo, H.S., Kim, J.T., Park, J.Y., Lee, C.W., 2001. Cecal 
rupture by Anoplocephala perfoliata infection in a thoroughbred horse in Seoul Race Park, 
South Korea. J Vet Sci 2, 189-193. 
Satrija, F., Nansen, P., Bjorn, H., Murtini, S., He, S., 1994. Effect of papaya latex against Ascaris suum 
in naturally infected pigs. J Helminthol 68, 343-346. 
Satrija, F., Nansen, P., Murtini, S., He, S., 1995. Anthelmintic activity of papaya latex against patent 
Heligmosomoides polygyrus infections in mice. Journal of Ethnopharmacology 48, 161-164. 
Satrija, F., Retnani, E.B., Ridwan, Y. and Tiuria, R., 2001. POTENTIAL USE OF HERBAL 
ANTHELMINTICS AS ALTERNATIVE ANTIPARASITIC DRUGS FOR SMALL 
HOLDER FARMS IN DEVELOPING COUNTRIES. In:  Livestock Community and 
Environment. Proceedings of the 10th Conference of the Association of Institutions for 
Tropical Veterinary Medicine, Copenhagen, Denmark. 
. 
Scandrett, B., Parker, S., Forbes, L., Gajadhar, A., Dekumyoy, P., Waikagul, J., Haines, D., 2009. 
Distribution of Taenia saginata cysticerci in tissues of experimentally infected cattle. Vet 
Parasitol 164, 223-231. 
Schmidt, G., 1986. Handbook of Tapeworm Identification. CRC Press Inc, 688 p. 
Schmidt, J., 1998a. Effects of benzimidazole anthelmintics as microtubule-active drugs on the synthesis 
and transport of surface glycoconjugates in &lt;i&gt;Hymenolepis microstoma , 
&lt;i&gt;Echinostoma caproni , and &lt;i&gt;Schistosoma mansoni&lt;/i&gt. Parasitology 
Research 84, 362-368. 
Schmidt, J., 1998b. Effects of benzimidazole anthelmintics as microtubule-active drugs on the synthesis 
and transport of surface glycoconjugates in Hymenolepis microstoma, Echinostoma caproni, 
and Schistosoma mansoni. Parasitology research 84, 362-368. 
Schoenian, S. 2009. Tapeworms: problem or not? 
Scholz, T., Garcia, H.H., Kuchta, R., Wicht, B., 2009. Update on the human broad tapeworm (genus 
diphyllobothrium), including clinical relevance. Clin Microbiol Rev 22, 146-160, Table of 
Contents. 
155 
 
Schwab, A.E., Boakye, D.A., Kyelem, D., Prichard, R.K., 2005. Detection of benzimidazole resistance-
associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection 
by albendazole and ivermectin combination treatment. Am J Trop Med Hyg 73, 234-238. 
Selby, G.R., Wakelin, D., 1975. Suppression of the immune response to Trichuris muris in lactating 
mice. Parasitology 71, 77-85. 
Seubert, J., Pohlke, R., Loebich, F., 1977. Synthesis and properties of Praziquantel, a novel broad 
spectrum anthelmintic with excellent activity against Schistosomes and Cestodes. Experientia 
33, 1036-1037. 
Singh, B.P., Dhar, D.N., 1988. Echinococcus granulosus in animals in northern India. Vet Parasitol 28, 
261-266. 
Sinha, S., Sharma, B.S., 2009. Neurocysticercosis: a review of current status and management. J Clin 
Neurosci 16, 867-876. 
Siracusano, A., Teggi, A., Ortona, E., 2009. Human cystic echinococcosis: old problems and new 
perspectives. Interdiscip Perspect Infect Dis 2009, 474368. 
Skotarek, S.L., Colwell, D.D., Goater, C.P., 2010. Evaluation of diagnostic techniques for 
Anoplocephala perfoliata in horses from Alberta, Canada. Vet Parasitol 172, 249-255. 
Smith, W.D., Zarlenga, D.S., 2006. Developments and hurdles in generating vaccines for controlling 
helminth parasites of grazing ruminants. Vet Parasitol 139, 347-359. 
Smout, M.J., Kotze, A.C., McCarthy, J.S., Loukas, A., 2010. A novel high throughput assay for 
anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite 
motility. PLoS Negl Trop Dis 4, e885. 
Smyth, J.D., 1994. Introduction to animal parasitology. Cambridge University Press. 
Smyth, J.D., 1998. THE PHYSIOLOGY OF TAPEWORMS. Biological Reviews 22, 214-238. 
Somero, G.N., 1995. Proteins and temperature. Annual review of physiology 57, 43-68. 
Southworth, J., Harvey, C., Larson, S., 1996. Use of praziquantel for the control of Moniezia expansa in 
lambs. N Z Vet J 44, 112-115. 
Spasskii, A.A., 1954. [False Hymenolepis infection in carnivorous animals]. Doklady Akademii nauk 
SSSR 94, 597-599. 
Stefaniak, J., 2006. [Alveolar echinococcosis due to Echinococcus multilocularis as a common cause of 
diagnostic mistakes in differential diagnosis of the liver cancer]. Pol Arch Med Wewn 116, 
896-902. 
Stepek, G., Behnke, J.M., Buttle, D.J., Duce, I.R., 2004. Natural plant cysteine proteinases as 
anthelmintics? Trends Parasitol 20, 322-327. 
Stepek, G., Buttle, D.J., Duce, I.R., Behnke, J.M., 2006a. Human gastrointestinal nematode infections: 
are new control methods required? Int J Exp Pathol 87, 325-341. 
Stepek, G., Buttle, D.J., Duce, I.R., Lowe, A., Behnke, J.M., 2005. Assessment of the anthelmintic 
effect of natural plant cysteine proteinases against the gastrointestinal nematode, 
Heligmosomoides polygyrus, in vitro. Parasitology 130, 203-211. 
Stepek, G., Curtis, R.H., Kerry, B.R., Shewry, P.R., Clark, S.J., Lowe, A.E., Duce, I.R., Buttle, D.J., 
Behnke, J.M., 2007a. Nematicidal effects of cysteine proteinases against sedentary plant 
parasitic nematodes. Parasitology 134, 1831-1838. 
Stepek, G., Lowe, A.E., Buttle, D.J., Duce, I.R., Behnke, J.M., 2006b. In vitro and in vivo anthelmintic 
efficacy of plant cysteine proteinases against the rodent gastrointestinal nematode, Trichuris 
muris. Parasitology 132, 681-689. 
Stepek, G., Lowe, A.E., Buttle, D.J., Duce, I.R., Behnke, J.M., 2007b. Anthelmintic action of plant 
cysteine proteinases against the rodent stomach nematode, Protospirura muricola, in vitro and 
in vivo. Parasitology 134, 103-112. 
Stepek, G., Lowe, A.E., Buttle, D.J., Duce, I.R., Behnke, J.M., 2007c. The anthelmintic efficacy of 
plant-derived cysteine proteinases against the rodent gastrointestinal nematode, 
Heligmosomoides polygyrus, in vivo. Parasitology 134, 1409-1419. 
Stepek, G., Lowe, A.E., Buttle, D.J., Duce, I.R., Behnke, J.M., 2007d. The anthelmintic efficacy of 
plant-derived cysteine proteinases against the rodent gastrointestinal nematode, 
Heligmosomoides polygyrus, in vivo, Vol 134, 2007/05/04 Edition, 1409-1419 pp. 
Stepek, G., Lowe, A.E., Buttle, D.J., Duce, I.R., Behnke, J.M., 2007e. In vitro anthelmintic effects of 
cysteine proteinases from plants against intestinal helminths of rodents. Journal of 
helminthology 81, 353-360. 
Stephen, A.G., Powls, R., Beynon, R.J., 1993. Activation of oxidized cysteine proteinases by 
thioredoxin-mediated reduction in vitro. Biochem J 291 ( Pt 2), 345-347. 
156 
 
Stojkovic, M., Zwahlen, M., Teggi, A., Vutova, K., Cretu, C.M., Virdone, R., Nicolaidou, P., 
Cobanoglu, N., Junghanss, T., 2009. Treatment response of cystic echinococcosis to 
benzimidazoles: a systematic review. PLoS Negl Trop Dis 3, e524. 
Sukhdeo, M.V., 1992a. Hymenolepis diminuta: effects of decerebration on thermal response behavior. 
Exp Parasitol 74, 300-306. 
Sukhdeo, M.V., 1992b. Intestinal contractions and migration behaviour in Hymenolepis diminuta. Int J 
Parasitol 22, 813-817. 
Sukhdeo, M.V., Kerr, M.S., 1992. Behavioural adaptation of the tapeworm Hymenolepis diminuta to its 
environment. Parasitology 104 ( Pt 2), 331-336. 
Sumner, I.G., Harris, G.W., Taylor, M.A.J., Pickersgill, R.W., Owen, A.J., Goodenough, P.W., 1993. 
Factors effecting the thermostability of cysteine proteinases from Carica papaya. European 
Journal of Biochemistry 214, 129-134. 
Tallima, H., El Ridi, R., 2007a. Praziquantel binds Schistosoma mansoni adult worm actin. Int J 
Antimicrob Agents 29, 570-575. 
Tallima, H., El Ridi, R., 2007b. Re: is actin the praziquantel receptor? International journal of 
antimicrobial agents 30, 566-567. 
Tanaka, R.D., MacInnis, A.J., 1975. An explanation of the apparent reversal of the circadian migration 
by Hymenolepis diminuta (Cestoda) in the rat. J Parasitol 61, 271-280. 
Tandon, V., Das, B., Saha, N., 2003. Anthelmintic efficacy of Flemingia vestita (Fabaceae): Effect of 
genistein on glycogen metabolism in the cestode, Raillietina echinobothrida. Parasitol Int 52, 
179-183. 
Tangpu, V., Temjenmongla, Yadav, A.K., 2006. Anticestodal property of Strobilanthes discolor: an 
experimental study in Hymenolepis diminuta--rat model. Journal of ethnopharmacology 105, 
459-463. 
Theodoropoulos, G., Theodoropoulou, E., Petrakos, G., Kantzoura, V., Kostopoulos, J., 2002. Abattoir 
condemnation due to parasitic infections and its economic implications in the region of 
Trikala, Greece. J Vet Med B Infect Dis Vet Public Health 49, 281-284. 
Thomas, H., Gonnert, R., 1977. The efficacy of praziquantel against cestodes in animals. Z Parasitenkd 
52, 117-127. 
Thompson, R.C.A., 1986. The Biology of Echinococcus and Hydatid Disease. George Allen & Unwin 
(Publishers) Ltd., London, 290 p. 
Utzinger, J., N'Goran, E.K., Ossey, Y.A., Booth, M., Traore, M., Lohourignon, K.L., Allangba, A., 
Ahiba, L.A., Tanner, M., Lengeler, C., 2000. Rapid screening for Schistosoma mansoni in 
western Cote d'Ivoire using a simple school questionnaire. Bull World Health Organ 78, 389-
398. 
van Schalkwyk, P.C., van Wyk, J.A., Morgan, E., Coles, G., 2005. Tapeworm control in sheep. Vet Rec 
157, 298-299. 
van Wyk, J.A., Malan, F.S., Randles, J.L., 1997. How long before resistance makes it impossible to 
control some field strains of Haemonchus contortus in South Africa with any of the modern 
anthelmintics? Vet Parasitol 70, 111-122. 
Vermund, S.H., MacLeod, S., Goldstein, R.G., 1986. Taeniasis unresponsive to a single dose of 
niclosamide: case report of persistent infection with Taenia saginata and a review of therapy. 
Rev Infect Dis 8, 423-426. 
Vines, H.M., Oberbacher, M.F., 1963. Citrus Fruit Enzymes. I. Ascorbic Acid Oxidase in Oranges. 
Plant Physiol 38, 333-337. 
von Samson-Himmelstjerna, G., Coles, G.C., Jackson, F., Bauer, C., Borgsteede, F., Cirak, V.Y., 
Demeler, J., Donnan, A., Dorny, P., Epe, C., Harder, A., Hoglund, J., Kaminsky, R., Kerboeuf, 
D., Kuttler, U., Papadopoulos, E., Posedi, J., Small, J., Varady, M., Vercruysse, J., Wirtherle, 
N., 2009. Standardization of the egg hatch test for the detection of benzimidazole resistance in 
parasitic nematodes. Parasitol Res 105, 825-834. 
VonBonsdorff, B., 1977. Diphyllobothriasis in Man. Academic Press Inc. Ltd., London, 189 p. 
Vuylsteke, P., Bertrand, C., Verhoef, G.E., Vandenberghe, P., 2004. Case of megaloblastic anemia 
caused by intestinal taeniasis. Ann Hematol 83, 487-488. 
Wagland, B.M., Jones, W.O., Hribar, L., Bendixsen, T., Emery, D.L., 1992. A new simplified assay for 
larval migration inhibition. Int J Parasitol 22, 1183-1185. 
Waller, P.J., Bernes, G., Thamsborg, S.M., Sukura, A., Richter, S.H., Ingebrigtsen, K., Hoglund, J., 
2001. Plants as de-worming agents of livestock in the Nordic countries: historical perspective, 
popular beliefs and prospects for the future. Acta Vet Scand 42, 31-44. 
Walti, A., 1938. Crystalline ficin. J Am Chem Soc 60. 
157 
 
Webb, R.A., Hoque, T., Dimas, S., 2007. Expulsion of the gastrointestinal cestode, Hymenolepis 
diminuta by tolerant rats: evidence for mediation by a Th2 type immune enhanced goblet cell 
hyperplasia, increased mucin production and secretion. Parasite Immunol 29, 11-21. 
Weinbach, E.C., Garbus, J., 1969. Mechanism of action of reagents that uncouple oxidative 
phosphorylation. Nature 221, 1016-1018. 
WHO 2006. The control of neglected zoonotic diseases: A route to poverty alleviation. 
Widdhiasmoro, N.P., 2000. Kajian Aktivitas Anthelmintika Ekstrak Buah Mengkudu 
(Morinda citrifolia) terhadap Cacing Hymenolepis nana pada Mencit Putih (Mus musculus 
albinus). MSc. Thesis. Institut Pertanian Bogor, Bogor. 
Wilcox, R.S., Bowman, D.D., Barr, S.C., Euclid, J.M., 2009. Intestinal obstruction caused by Taenia 
taeniaeformis infection in a cat. J Am Anim Hosp Assoc 45, 93-96. 
Wiwanitkit, V., 2004. Overview of hymenolepis diminuta infection among Thai patients. MedGenMed 
6, 7. 
Wiwanitkit, V., 2005. A review of human sparganosis in Thailand. Int J Infect Dis 9, 312-316. 
Wolstenholme, A.J., Fairweather, I., Prichard, R., von Samson-Himmelstjerna, G., Sangster, N.C., 
2004. Drug resistance in veterinary helminths. Trends Parasitol 20, 469-476. 
Yadav, A.K., Tangpu, V., 2008. Anticestodal activity of Adhatoda vasica extract against Hymenolepis 
diminuta infections in rats. J Ethnopharmacol 119, 322-324. 
Yamane, Y., Kamo, H., Bylund, G., Wikgren, B.J., 1986. Diphyllobothrium nihonkaiense sp. nov 
(Cestoda: Diphyllobothriidae)Ñrevised identification of Japanese broad tapeworm. Shimane J 
Med Sci 10, 29-48. 
Zucker, S., Buttle, D.J., Nicklin, M.J., Barrett, A.J., 1985. The proteolytic activities of chymopapain, 
papain, and papaya proteinase III. Biochim Biophys Acta 828, 196-204. 
 
 
